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ABSTRACT 
The public comes into contact with numerous semi-volatile organic chemicals 
(SVOCs) on a daily basis, and there is a lack of knowledge about exposure and health 
effects associated with many SVOCs, particularly newer compounds. Our objective was 
to characterize occupational exposure to SVOCs in nail salon workers, analyze exposure 
to one class of SVOCs in pregnant women and their young children, and examine 
associations between prenatal exposure and birth outcomes.  
From 10 female nail salon workers in the Boston area (2016–2017), we compared 
phthalates, phthalate alternatives, and organophosphate esters (OPEs) or their metabolites 
measured in pre- and post-shift urine samples and silicone wrist bands (SWBs). From 134 
mother infant pairs from the Newborn Epigenetics STudy (NEST), a North Carolina birth 
cohort (2009–2011), we used multivariable and weighted quantile sum (WQS) regression 
models to estimate associations between individual and mixtures of prenatal serum per- 
and polyfluoroalkyl substances (PFAS) concentrations. In a subsample of 84 NEST 
offspring aged 3–6 years enrolled in the Toddlers Exposure to SVOCs in Indoor 
Environments (TESIE) study (2014–2016), we estimated associations of child serum 
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PFAS concentrations with environmental, behavioral, and demographic predictors.  
Among nail salon workers, post-shift urine concentrations were generally higher 
than pre-shift for SVOC metabolites. Correlations between metabolites in urine and 
SWBs suggested occupation as a source of exposure. The PFAS mixture index was 
negatively associated with gestational age at birth among all and male offspring with less 
evidence of an association among females or for other birth outcomes. Diet, drinking 
water, maternal serum PFAS concentrations during pregnancy, and air concentrations 
inside the home were predictors of certain child serum PFAS concentrations.  
Nail technicians are occupationally exposed to SVOCs, with evidence of SWBs as 
a useful exposure assessment tool for future studies. We observed negative associations 
between prenatal PFAS concentrations and gestational length; male offspring may be 
more susceptible than females. Eating habits, drinking water source, prenatal serum 
concentrations, and air concentrations inside the home were predictive of child serum 
PFAS concentrations. Our results suggest that exposure to SVOCs is multi-faceted and of 
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CHAPTER ONE: INTRODUCTION 
Consumer products contain a myriad of chemicals that the public comes into 
contact with daily in their homes, cars, and workplaces. Semi-Volatile Organic 
Compounds (SVOCs), are used in many consumer products for a multitude of reasons. 
There is a lack of knowledge about exposure to and potential public health implications 
associated with many SVOCs, particularly newer compounds. 
 
Semi-Volatile Organic Compounds (SVOCs)  
SVOCs, such as phthalates, organophosphate esters (OPEs), and many per- and 
polyfluoroalkyl substances (PFAS) are organic chemicals that partition between the gas 
and condensed phases of matter, and are used in a broad range of consumer products such 
as stain repellents, pesticides, electronics, personal care products, furniture, and food 
packaging (Weschler & Nazaroff, 2008). In the indoor environment, SVOCs can exist in 
air as vapor, or they can adsorb to airborne particles, dust, and other surfaces including 
the human body (Little et al., 2012). Since SVOCs are usually not chemically bound to 
the products that contain them, they slowly release into the indoor environment, where 
they can persist for years (Weschler & Nazaroff, 2008). SVOC exposure occurs through 
inhalation, ingestion, and dermal absorption (Weschler & Nazaroff, 2008).  
Several SVOCs, such as polybrominated diphenyl ethers (PBDEs), are established 
toxicants that have been banned from commercial use (Weschler & Nazaroff, 2008). 
Other SVOCs are not as well studied, and while some have shown evidence of negative 
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health impacts, such as reproductive and endocrine system effects, researchers know very 
little about the potential health impacts of many others (Weschler & Nazaroff, 2008). 
More than a thousand SVOCs are on the United States (US) EPA’s high-production-
volume (HPV) chemical list, meaning that the US produces or imports more than a 
million pounds of the chemical each year (US EPA, 2007; Weschler & Nazaroff, 2008). 
Due to the large quantities used in consumer products, studies have suggested that 
metabolites of some SVOCs, such as triphenyl phosphate (TPHP), some phthalates, and 
certain PFAS, are nearly ubiquitous in human blood and/or urine, highlighting the need 
for further study of these SVOCs to determine their potential for negative health impacts 
(Calafat et al., 2007; Meeker et al., 2013).  
 
Phthalates 
 Phthalates are man-made SVOCs that are widely used as plasticizers to make 
thousands of consumer products including medical equipment, pharmaceuticals, food 
packaging, vinyl flooring, personal care products, and toys (FDA, 2020; Library of 
Congress. Congressional Research Service, 2008; U.S. Food and Drug Administration, 
2013). In personal care products, they are commonly used to make items such as nail 
polish and hair spray more flexible and less likely to crack, and increases longevity, and 
as a fixative in perfumes (FDA, 2020). Because of their widespread use, exposure to 
many phthalates is ubiquitous or nearly so in the US population (Zota et al., 2014). 
Several phthalates are thought to be harmful to human health, including di-(2-
ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), benzyl butyl phthalate (BBP), 
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diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate 
(DnOP) (Library of Congress. Congressional Research Service, 2008). Dibutyl phthalate 
(DBP), which was historically used in nail polish (Young et al., 2018), for example, is 
associated with birth defects and negative developmental and reproductive system effects 
(ATSDR, 2001; Hauser & Calafat, 2005). Other potential adverse health outcomes 
associated with some phthalates include: preterm birth, early onset puberty, delayed 
psychomotor development in children, cardiovascular, and neurological effects (ATSDR, 
2002, 2001; Harley et al., 2019). Because of health concerns, DBP and other phthalates 
have been replaced by other compounds, including OPEs such as TPHP, terephthalates 
such as di(2-ethylhexyl) terephthalate (DEHTP), or other phthalate alternatives such as 
1,2-cyclohexane dicarboxylic acid, diisononyl ester (DINCH) (Mendelsohn et al., 2016; 
Silva et al., 2017; Young et al., 2018). Less is known about the health impacts of many of 
these SVOCs, but they are thought to be less harmful to public health.  
 
Organophosphate Esters 
OPEs are a group of SVOCs that are commonly used as plasticizers and flame 
retardants (Belcher et al., 2014; Butt et al., 2014; Doherty et al., 2019; Meeker et al., 
2013). TPHP, for example, is used in plastics, polymers, resins, and other consumer 
products including polyurethane foam furniture, polyvinyl chloride plastics, and 
electronics (Belcher et al., 2014; Butt et al., 2014; Hoffman et al., 2014; Meeker et al., 
2013; Meeker & Stapleton, 2010; Mendelsohn et al., 2016; Patisaul et al., 2013; Van den 
Eede et al., 2013; van der Veen & de Boer, 2012). TPHP is also an ingredient in many 
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brands of nail polish as it increases flexibility and longevity, and helps the nail polish 
stick onto the fingernail (CosmeticsInfo, 2016; EWG, 2018; Mendelsohn et al., 2016). 
Use of TPHP is widespread (~10–50 million pounds produced annually); its use in 
consumer products may be increasing as a substitute for toxic compounds such as 
bisphenol A (BPA) (used in plastics) and pentabromodiphenyl ether (pentaBDE) (a 
mixture of PBDEs banned in the US, but previously used as a flame retardant in 
furniture) (Butt et al., 2014; Hoffman et al., 2014; Meeker & Stapleton, 2010; 
Mendelsohn et al., 2016; Pillai et al., 2014; van der Veen & de Boer, 2012).  
Because of its broad use, TPHP is ubiquitous in the indoor environment, and 
people are chronically exposed to it largely through inhalation and ingestion of house 
dust (Butt et al., 2014; Hoffman et al., 2014; Meeker & Stapleton, 2010; Mendelsohn et 
al., 2016; Pillai et al., 2014; van der Veen & de Boer, 2012). Inclusion of SVOCs in 
personal care products can lead to somewhat different exposure pathways; a previous 
study determined that the primary route of exposure to TPHP from applied nail polish is 
through dermal absorption rather than inhalation (Mendelsohn et al., 2016). TPHP is 
metabolized into its diester metabolite, diphenyl phosphate (DPHP) and other phase II 
conjugate metabolites, which can be measured in urine (Butt et al., 2014; Hoffman et al., 
2014; Meeker et al., 2013; Mendelsohn et al., 2016; Van den Eede et al., 2013). Studies 
suggest that metabolites of TPHP are ubiquitous in human urine, underscoring the need 
for future studies to characterize the health risks associated with this SVOC (Butt et al., 
2014; Meeker et al., 2013; Pillai et al., 2014; Van den Eede et al., 2013). The health 
impacts of TPHP exposure in humans are not well understood, however, from 
 
5 
epidemiological, in vitro, and in vivo studies there is evidence that it is associated with 
early onset puberty, impaired metabolic, reproductive, and endocrine system functions, 
increased cytotoxicity and anxiety, and decreased bone health (Meeker et al., 2013; 
Belcher et al., 2014; Patisaul et al., 2013; Pillai et al., 2014; Kojima et al., 2013; Preston 
et al., 2017). 
 
Per- and Polyfluoroalkyl Substances (PFAS)  
PFAS are a group of chemicals that have water and stain-resistant properties; 
many are resistant to degradation by UV radiation, weather, or other chemicals, and as 
such are used in numerous consumer products (Ahrens et al., 2013; ATSDR, 2018; Fraser 
et al., 2012, 2013; Houde et al., 2006). Common products that contain PFAS include 
surfactants, lubricants, semiconductors, paints, adhesives, carpet and upholstery, clothing, 
paper and textile coatings, food packaging, nonstick cookware, stain and water repellants, 
cleaning products, pharmaceuticals, pesticides, personal care products, and fire-fighting 
foam (Ahrens et al., 2013; ATSDR, 2018; Calafat et al., 2007; Fraser et al., 2012, 2013; 
Houde et al., 2006). Likely routes of exposure are through inhalation, ingestion of 
contaminated food (directly from food or from food packaging), drinking water, 
breastmilk, dust, and through skin absorption (ATSDR, 2018; Calafat et al., 2007; Callan 
et al., 2016; Fraser et al., 2012, 2013; Shoeib et al., 2011). 
PFAS are ubiquitous in indoor environments, and can be transported around the 
globe on ocean currents and in the atmosphere (Ahrens et al., 2013; ATSDR, 2018; 
Fraser et al., 2013; Houde et al., 2006; Shoeib et al., 2008, 2011). Because of the 
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chemical properties listed above, PFAS and/or their partial degradation products are of 
particular public health concern due to their persistence and bioaccumulation in the 
environment, water, wildlife, and humans (ATSDR, 2018; Fraser et al., 2012; Houde et 
al., 2006; Shoeib et al., 2008). In human serum, the half-life of perfluorooctanoic acid 
(PFOA), for example, is approximately 3–4 years, demonstrating the persistence of these 
chemicals in the human body (ATSDR, 2018; Houde et al., 2006). 
Studies have shown that several PFAS, including perfluorooctane sulfonic acid 
(PFOS), PFOA, and perfluorononanoic acid (PFNA), are ubiquitous or nearly ubiquitous 
in human serum and blood (ATSDR, 2018; Calafat et al., 2007; Callan et al., 2016; Fraser 
et al., 2012, 2013; Joensen et al., 2009; Kato et al., 2011; Maisonet et al., 2012; Nelson et 
al., 2010). In biomonitoring studies, the most common PFAS typically found in human 
blood/serum is PFOS followed by PFOA with adult males averaging higher 
concentrations than adult females; North Americans (citizens of the US and Canada) 
generally have the highest body burdens of PFAS in the world (Calafat et al., 2007; 
Fraser et al., 2012; Houde et al., 2006; Kato et al., 2011; Nelson et al., 2010). The 
hypothesis that volatile precursors to perfluorinated carboxylic acids (PFCAs) (e.g., 
PFOA) and perfluorinated sulfonates (e.g., PFOS) contribute to body burdens of PFOA 
and PFOS complicates PFAS exposure assessment (Fraser et al., 2012). For example, 
fluorotelomer alcohols (FTOH) can metabolize to form PFOA and other PFCAs, and 
fluorinated sulfonamides (including sulfonamidoethanols (FOSEs)) can metabolize to 
form PFOS (Fraser et al., 2012). Concentrations of PFOS, however, may be changing 
over time as production of PFOS and its precursor chemicals ceased in the US in 2002, 
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and biomonitoring studies have shown a decreasing concentration in serum collected 
since then (Calafat et al., 2007; Fraser et al., 2012; Kato et al., 2011). 
Epidemiological studies have suggested that increased exposure to PFAS may be 
associated with increased blood cholesterol levels and uric acid levels, altered thyroid 
hormone levels, liver damage, and decreased infant head circumference and semen 
quality (ATSDR, 2018; Callan et al., 2016; Dallaire et al., 2009; Joensen et al., 2009; 
Nelson et al., 2010). PFAS can cross the placental barrier potentially affecting the 
developing fetus (Callan et al., 2016; Joensen et al., 2009). Some studies have 
demonstrated an association between elevated PFAS exposure and decreased birth weight 
(Callan et al., 2016; Maisonet et al., 2012). 
 
Nail Salon Workers 
The nail salon industry is one of the fastest growing industries in the US, and the 
number of nail technicians has more than tripled over the past decade and a half (Goldin 
et al., 2014; Thu Quach et al., 2008). In 2018, there were 395,658 nail technicians with 
licenses and 54,386 nail salons in the United States (Nails Magazine, 2018). Women 
make up 96% of those employed in nail salons, many of whom are of reproductive age 
(Roelofs et al., 2008). Nail salon employees encounter a variety of chemicals and 
particulates in the products that they use such as toluene, formaldehyde, and DBP that are 
known to be harmful to human health (Goldin et al., 2014; Roelofs et al., 2008). In 
addition to other harmful chemicals, many brands of nail polish contain SVOCs such as 
TPHP, which the label may or may not list as an ingredient (Mendelsohn et al., 2016; 
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Patel & Steffier, 2000). Recent findings suggest that people that paint their nails daily to 
monthly may have higher levels of DPHP in their urine, suggesting that nail polish is a 
significant source of temporarily elevated exposure to TPHP (Mendelsohn et al., 2016). 
Although the route of exposure to SVOCs from the products they use is poorly 
understood, nail salon workers are likely to be chronically exposed to higher levels of 
these chemicals than the general public. There is growing concern about the health 
impacts of working in a nail salon as this is a vulnerable population made up of a large 
proportion of immigrants.  
 
Early Life Exposures 
 The prenatal period and early childhood are periods of development during which 
individuals may be more susceptible to the negative health impacts associated with 
exposures to SVOCs, some of which may lead to significant short- and long-term health 
consequences (Barker, 2007; Hales et al., 1991). For example, some epidemiological 
studies have suggested that increased prenatal exposure to certain PFAS may be 
associated with adverse birth outcomes (Apelberg et al., 2007; Chen et al., 2012; Johnson 
et al., 2014; Lam et al., 2014; Sagiv et al., 2017; Starling et al., 2017; Woods et al., 
2017b). Sources of exposure to SVOCs and the health consequences associated with 
exposure in children are generally less understood than for adults; it is therefore 





Since there are few previous studies characterizing biomarkers of exposure to 
SVOCs among nail salon workers (Hines et al., 2009; Kwapniewski et al., 2008; Tran & 
Kannan, 2015), pregnant women (Kingsley et al., 2018; Sagiv et al., 2015), and children 
(Harris et al., 2017; Kingsley et al., 2018; Winkens et al., 2017) additional research is 
necessary to better understand exposure to SVOCs among these populations. 
Additionally, there have not been previous studies that have used various biomonitoring 
tools to examine multiple exposure pathways to these SVOCs, including biological 
samples (i.e., urine and/or serum), hand wipes, dust, air, and silicone wristbands (SWBs), 
to gain a better understanding of SVOC exposures among these populations. 
Some epidemiological studies have suggested that increased prenatal exposure to 
certain PFAS may be associated with adverse birth outcomes such as decreased 
gestational age at birth and decreased birth weight (Apelberg et al., 2007; Chen et al., 
2012; Johnson et al., 2014; Lam et al., 2014; Starling et al., 2017; Winkens et al., 2017; 
Woods et al., 2017a). However, other studies suggest that inverse associations reported 
previously with birth weight, particularly those that assessed exposure in late pregnancy 
serum or in cord blood, may be biased because of uncontrolled confounding by plasma 
volume expansion (PVE) and glomerular filtration rate (GFR), which may be associated 
with PFAS concentrations measured in the serum and also birth outcomes (Bach et al., 
2015; Steenland et al., 2018; Verner et al., 2015). Cumulative exposure to low 
concentrations of a multitude of chemicals may be associated with negative health 
effects, even when there is a lack of evidence for health effects associated with the 
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concentration of each individual substance (Carrico et al., 2015; Schecter et al., 2013). 
Pregnant women are likely exposed to mixtures of PFAS that are often highly correlated, 
raising the possibility of confounding, interactions, or cumulative effects between co-
exposures (Braun et al., 2016). However, few previous studies of birth outcomes have 
examined more than one PFAS at a time (Kalloo et al., 2020; Woods et al., 2017b). Thus, 
further research is necessary to estimate the joint effects of multiple PFAS to better 
understand the overall potential health impacts of PFAS exposure on neonates, which 
often occur as mixtures.  
This research aims to address gaps in prior literature and broaden understanding 
of predictors of exposure and the birth outcomes associated with exposure to SVOCs 
among nail salon workers, pregnant women, and their offspring. To achieve these 
objectives, we conducted research among Greater Boston Area nail salon workers, and 
among a cohort of pregnant women enrolled in the Newborn Epigenetics STudy (NEST) 
birth cohort and their offspring enrolled in the Toddlers Exposure to SVOCs in Indoor 
Environments (TESIE) study based in central North Carolina. In the study of nail salon 
workers in the Greater Boston Area, we collected pre- and post-shift urine samples and 
SWBs worn on lapels and wrists from 10 female nail technicians in 2016–2017. We 
characterized occupational exposures to SVOCs by examining their presence on SWBs 
and comparing pre- and post-shift biomarkers in urine. In the NEST and TESIE studies, 
maternal serum samples were collected between 5.6 and 29.6 weeks gestation (mean 12.6 
weeks) between 2009 and 2011 and analyzed for PFAS to examine associations between 
PFAS and birth outcomes, including gestational age at birth and birth weight in 134 
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mother-infant pairs. Additionally, we examined predictors of maternal serum PFAS 
concentrations based on data from medical records and questionnaires administered 
during prenatal visits. Finally, at home visits with TESIE participants (2014–2016), we 
administered questionnaires and collected child serum and environmental samples, and 
used maternal serum samples from the NEST study to characterize predictors of serum 
PFAS concentrations in 84 child participants aged three to six years.  
 The primary aim of Chapter 2 was to use biomarkers measured in urine and 
SWBs to characterize occupational exposure of nail salon workers to phthalates, 
phthalate alternatives, and OPEs. During site visits at salons, we collected pre- and post-
shift urine samples, and asked participants to wear SWBs on their wrists and pinned to 
their lapels over the course of a work day, and analyzed these samples for SVOCs or their 
metabolites. Pre- and post-shift urine concentrations were compared to each other, and 
compared to urinary concentrations of SVOCs from women from the National Health and 
Nutrition Examination Survey to determine occupational exposures. 
 The primary aim of Chapter 3 was to determine if prenatal exposure to PFAS is 
associated with birth outcomes among TESIE study offspring. We utilized prenatal serum 
samples collected from mothers enrolled in the NEST study to determine prenatal PFAS 
exposure. We examined the associations between individual and mixtures of PFAS with 
several birth outcomes, including gestational age at birth, birth weight, and birth weight 
for gestational age z-score. We adjusted for potential confounding variables, including 
mother’s age at delivery, race, education, parity, body mass index at last menstrual 
period, prenatal smoking, and gestational age at blood draw. A secondary aim of Chapter 
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3 was to identify predictors of maternal serum PFAS concentrations based on behavioral 
characteristics, physiology, and sociodemographic factors from medical records and 
questionnaires administered during prenatal visits. 
The aim of Chapter 4 was to identify predictors of child serum PFAS 
concentrations at age three to six years in TESIE child participants. At home visits with 
participants, we collected data on child, maternal, and housing characteristics via 
questionnaire, and also collected dust, hand wipes, and child serum samples. 
Additionally, we obtained maternal serum samples from the NEST study. Serum and 
environmental samples were analyzed for PFAS, and were used along with questionnaire 
data to characterize environmental, demographic, and behavioral predictors of PFAS 
exposure in children. We adjusted for potential confounding variables, including child 
sex, breastfeeding, child body mass index, maternal parity at birth, and maternal 
education at the time the child was sampled. A subset of TESIE children were also asked 
to wear silicone wristbands for 7 days (n=26) and/or have a sorbent-impregnated passive 
air sampler placed in their home for 21 days (n=17) to further characterize predictors of 
PFAS serum concentrations.  
Chapter 5 summarizes the findings from Chapters 2–4, and lists the limitations of 
our studies, the public health implications of our results, and discusses potential 
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Relatively little is known about exposure of nail technicians to semi-volatile 
organic compounds (SVOCs) in nail salons. We collected pre- and post-shift urine 
samples and silicone wrist bands (SWBs) worn on lapels and wrists from 10 female nail 
technicians in the Boston area in 2016–17. We analyzed samples for phthalates, phthalate 
alternatives, and organophosphate esters (OPEs) or their metabolites. Post-shift urine 
concentrations were generally higher than pre-shift for SVOC metabolites; the greatest 
change was for a metabolite of the phthalate alternative di(2-ethylhexyl) terephthalate 
(DEHTP): mono(2-ethyl-5-carboxypentyl) terephthalate (MECPTP) more than tripled 
from 11.7 to 36.6 µg/g creatinine. DEHTP biomarkers were higher in our study 
participants’ post-shift urine compared to 2015–2016 National Health and Nutrition 
Examination Survey females. Urinary MECPTP and another DEHTP metabolite were 
moderately correlated (r=0.37–0.60) with DEHTP on the SWBs, suggesting occupation 
as a source of exposure. Our results suggest that nail technicians are occupationally 
exposed to certain phthalates, phthalate alternatives, and OPEs, with metabolites of 
DEHTP showing the largest increase across a work day. The detection of several of these 
SVOCs on SWBs suggests that they can be used as a tool for examining potential 







Nail salon workers encounter a variety of exposures from the products they use at 
work, including semi-volatile organic compounds (SVOCs), which are added to personal 
care products, including nail polish, to increase flexibility and longevity, improve 
fragrance, and help nail polish adhere to fingernails (CosmeticsInfo, 2016; U.S. Food and 
Drug Administration, 2013). The SVOC most frequently used in nail polish in the past 
was dibutyl phthalate (DBP) (Young et al., 2018), which is associated with birth defects 
and negative developmental and reproductive system effects (ATSDR, 2001; Hauser & 
Calafat, 2005). Because of health concerns, DBP and other phthalates have been replaced 
by compounds claimed to be less harmful to human health: organophosphate esters 
(OPEs) such as triphenyl phosphate (TPHP), terephthalates such as di(2-ethylhexyl) 
terephthalate (DEHTP), or other phthalate alternatives such as 1,2-cyclohexane 
dicarboxylic acid, diisononyl ester (DINCH) (Mendelsohn et al., 2016; Silva et al., 2017; 
Young et al., 2018). However, choosing safer products may be challenging as labels may 
not list all ingredients (Mendelsohn et al., 2016; Young et al., 2018). 
SVOCs partition in the indoor environment between vapor, particles, and 
surfaces, including human skin (Little et al., 2012). Exposure occurs through inhalation, 
ingestion (e.g., via dust), and dermal absorption (Little et al., 2012). The latter can occur 
following contact with products containing SVOCs, indoor surfaces, or air-to-skin 
partitioning (Weschler & Nazaroff, 2008). Many SVOCs are metabolized into 
measurable urinary metabolites (CDC, 2019; Mendelsohn et al., 2016).  
Nail salon workers are likely chronically more exposed to many SVOCs found in 
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nail products than the general public, however, few studies have been conducted on 
SVOC exposure of nail salon workers (Hines et al., 2009; Kwapniewski et al., 2008; Tran 
& Kannan, 2015). Hines et al. (2009) examined occupational exposure to certain 
phthalates, including dimethyl phthalate (DMP), DBP, di-isobutyl phthalate (DiBP), 
benzylbutyl phthalate (BzBP), and di(2-ethylhexyl) phthalate (DEHP), and reported that 
nail salon workers had significantly higher (p<0.05) post-work shift urinary metabolites 
of these chemicals than the U.S. adult population from the National Health and Nutrition 
Examination Survey (NHANES). Kwapniewski et al. (2008) examined pre- versus post-
shift DBP exposure among manicurists and found significantly higher (p<0.05) urinary 
metabolites of DBP in post-shift urine samples compared to pre-shift samples with glove 
use mitigating this effect. Tran and Kannan (2015) analyzed air samples for DMP, DEP, 
DiBP, DBP, BzBP, and DEHP from various indoor environments, and found that hair 
and nail salons had the highest total median concentrations of phthalates, an order of 
magnitude greater than the other indoor environments tested.  
We are not aware of any research on nail technician exposures to newer phthalate 
alternative compounds such as DEHTP and TPHP. We therefore conducted a pilot study 
using urinary biomarkers to characterize pre- versus post-shift exposure to a wide range 
of SVOCs among nail salon workers in the Greater Boston Area. Silicone wristbands 
(SWBs) can be used to estimate SVOC exposure, and may function partly as personal 
passive air samplers, and also sample particulates and surface films (Hammel et al., 
2016); to our knowledge, SWBs have not been previously used with nail salon 
technicians. A secondary goal of this study was to determine whether SWBs can be used 
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as an exposure assessment tool to measure SVOCs encountered during a single work shift 
among nail salon workers. 
 
Materials and Methods 
 
This study was approved by IRBs at Harvard T.H. Chan School of Public Health 
and Boston University School of Public Health. All participants provided informed 
consent in their native language prior to enrollment. The involvement of the Centers for 
Disease Control and Prevention (CDC) laboratory was determined not to constitute 
engagement in human subject research. 
 
Study population 
For this pilot study, we recruited and enrolled 10 nail salon technicians from 
seven nail salons in the Greater Boston, Massachusetts area as previously described 
(Ceballos et al., 2019). Eligible nail salon workers were non-smoking females greater 
than 18 years of age employed full time (≥35 hours per week) in nail salons primarily 
offering nail salon services. Participants were compensated for their time. 
We assessed exposure of nail salon workers to SVOCs—focusing on exposure to 
phthalates, phthalate alternatives (e.g., DINCH, DEHTP), and organophosphate esters 
(OPEs)—over the course of one work shift between November 2016 and June 2017 
(Table 2.1 shows analytes and abbreviations). Upon enrollment, we scheduled a sampling 
visit for a shift where the participant had worked the previous day. We employed a 
Vietnamese translator during sampling visits when necessary. Prior to our study visit, we 
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asked participants not to apply nail polish to themselves within 72 hours before sampling. 
We collected pre- and post-shift spot urine samples on site, and asked participants to 
wear a SWB on their wrist and pinned to their lapel. Due to one participant opting not to 
wear one of the SWBs, and misplacement of another, we collected nine each of SWBs 
pinned to lapels and worn on wrists. At the end of the work shift, we administered a 
questionnaire including both work-related and non-work-related questions on factors that 
potentially contribute to exposure.   
 
Urine Sampling 
Participants provided spot urine samples (~30mL) in sterile polypropylene 
containers using nitrile gloves to prevent contamination. Samples were stored on ice and 
transported to the Beth Israel Deaconess Medical Center (BIDMC) laboratory. Samples 
were stored at -20º C, thawed and aliquoted into 3mL polypropylene microvials and 
stored at -80º C until shipped for analysis.  
Urine samples were analyzed at the Division of Laboratory Services at the 
National Center for Environmental Health, CDC (Atlanta, GA) for creatinine and 
metabolites of SVOCs as previously described (Jayatilaka et al., 2017; Silva et al., 2007, 
2017). Briefly, urinary conjugates of target analytes were first hydrolyzed by enzymatic 
hydrolysis. We then extracted the deconjugated urinary metabolites using solid phase 
extraction, separated the target analytes from each other and other compounds present in 
urine using high-performance liquid chromatography, and quantified the target 
biomarkers using isotope-dilution tandem mass spectrometry. During analysis, we 
 
19 
included a duplicate urine aliquot from two separate participant samples for each SVOC 
compound for quality assurance/quality control. The relative percent difference between 
samples for SVOC compounds included in our analyses above the limit of detection 
(LOD) (Table 2.1) ranged from 0% – 13.1% for phthalates, 0.4% – 5.7% for phthalate 
alternatives, and 0.8 – 30.4% for OPEs.  
 
Passive Air Sampling  
SWBs were prepared for sampling as previously described (Hammel et al., 2016). 
Briefly, researchers purchased commercially available SWBs 
(www.24hourwristbands.com), solvent-cleaned and dried them in a fume hood, wrapped 
them in aluminum foil, and placed them in pre-cleaned amber glass jars until use. We 
collected four field blank SWBs during the course of the study, which were transported to 
randomly selected study nail salons, removed from the amber jars and aluminum foil, 
rewrapped immediately, and placed on ice. At the end of each participant’s work shift, 
we collected and wrapped the SWBs in aluminum foil and placed them in amber jars in 
coolers on ice, and transported them to BIDMC laboratory for storage at -20º C until 
shipped for analysis. All SWBs were handled with nitrile gloves. 
SWBs were analyzed at Duke University as previously described (Anderson et al., 
2017; Hammel et al., 2016). Briefly, SWBs were weighed but not washed before 
analysis, spiked with internal standards dTDCPP and 13C12 TPHP, extracted, concentrated 
and analyzed by gas chromatography mass spectrometry (GC/MS). Recoveries of 
dTDCPP and 13C12 TPHP averaged 93.3% and 68.9%, respectively, for all samples. Since 
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the field blanks account for residual background levels that may be present on all SWBs, 
the LOD (Table 2.1) was calculated as three times the standard deviation of the levels 
measured in the field blanks. SVOC concentrations in SWBs were blank corrected using 
the average concentrations measured in the field blanks. Results were expressed as ng/g 
SWB.  
 Since participants had different work-shift lengths, and thus SWBs were worn for 
different durations, we also controlled for work shift length in our analyses (Table S2.2 
and S3). However, we do not know whether the chemicals are in the linear or saturation 
phase of uptake on the SWBs during the nail technicians’ work shifts, as to our 
knowledge a calibration study of the uptake of these chemicals in SWBs has not been 
published. Because of this, and the fact that these work shift-duration-adjusted data were 
almost perfectly correlated with the unadjusted data (Table S2.1), we focus on the 
unadjusted data in our results section. 
 
Statistical Analysis 
Where instrumental readings were unavailable, urine and SWB non-detected data 
points were imputed using NDExpo’s regression on order statistics (ROS) application: a 
robust method to handle non-detects, described by Helsel18. We conducted statistical 
analyses for compounds detected in at least 50% of samples. We used the Shapiro-Wilk 
test to examine whether SVOC concentrations were normally distributed; as 
concentrations were approximately log-normally distributed, we log-transformed data, 
and report geometric means (GM), geometric standard deviations (GSD), medians, and 
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ranges. We used paired t-tests to compare: 1) SVOC levels on SWBs worn on the lapels 
versus wrists and 2) pre- and post-shift creatinine-corrected SVOC urinary metabolite 
concentrations. Post-shift urine concentrations of MECPTP, however, were not normally 
or log-normally distributed, and we used the nonparametric Wilcoxon Rank Sum test to 
compare the pre- and post-shift samples. We computed Spearman correlations between 
parent SVOCs in SWBs (a measure of external exposure during the shift) and their 
metabolites in urine, using the difference between post- and pre-shift creatinine-corrected 
concentration (an estimate of total exposure during the work shift). Statistical 
significance was set at p<0.05. We compared nail technician creatinine-corrected urinary 
SVOC metabolites to those found in the general U.S. female population aged 3 and older 
in the NHANES 2015–2016 presented in the National Report on Human Exposure to 
Environmental Chemicals updated tables, the first time such data were available for 
DEHTP; the exception was for OPE metabolites for which we used NHANES 2013–2014 
data of U.S. females aged 6 and older (CDC, 2019; Silva et al., 2019). We performed all 








Participant characteristics are presented in Table 2.2. A detailed description of 
personal protective equipment utilized by participants was described previously (Ceballos 
et al., 2019). 
 
SVOCs in Urine  
Descriptive statistics of the SVOC metabolites detected in participant urine, along 
with the post-/pre- shift change in SVOC concentrations are listed in Table 2.3. While the 
majority of post-shift creatinine-corrected GM urinary SVOC metabolite concentrations 
were similar or higher than pre-shift urinary concentrations, none reached statistical 
significance. Despite this, the post-shift GM concentration was more than triple that of 
the pre-shift samples for MECPTP. There was a general trend for higher urinary 
metabolite concentrations in post-shift urine samples among many but not all participants 
(Figure S2.1, supplemental material). 
Table 2.3 also presents a comparison of our results with females in NHANES. 
Most SVOC metabolites were similar or higher in the U.S. female population than in our 
study population’s post-shift urine samples, however metabolites of DEHTP (MECPTP 
and MEHHTP) were higher in post-shift urine samples from our study participants than 





SVOCs in Air 
A few of the participants’ SWB concentration results were estimated above the 
highest point on the calibration curve for individual SVOCs, including one each with 
high levels of DBP, DEHP, and DEHTP, and one with high levels of both DiNP and 
DEHTP; these values were included in the overall analyses. Descriptive statistics of the 
SVOC concentrations detected in lapel and wrist SWBs, along with the differences in 
SVOC concentrations and correlations between lapel/wrist are listed in Table 2.4. With 
the exception of TCIPP and TDCIPP, SVOC levels in lapel SWBs were higher compared 
with those worn on participants’ wrists; however, none of these differences reached 
statistical significance (Table 2.4, Figure S2.2). Correlations between concentrations of 
SVOCs detected in lapel and wrist SWBs varied; only the phthalate alternative DEHA 
reached statistical significance (r=0.81, p<0.05). 
 
Air vs. Urine SVOCs 
The correlations between differences between pre- and post-shift urinary SVOC 
metabolites and their parent compounds detected in SWBs are shown in Table 2.5. For 
DEHP, although not statistically significant, the difference in post- compared to pre-shift 
urinary concentrations was more correlated with SWBs worn on the lapel than on the 
wrist. The difference between pre- and post-shift shift urinary metabolites of DEHTP 







To our knowledge, our pilot study is the first to characterize nail salon worker 
exposure to phthalates, phthalate alternatives and organophosphate esters, using both 
biomonitoring and silicone wristbands (SWBs), a relatively novel tool. This study 
provides evidence of exposure to many of these compounds and demonstrates the 
usefulness of SWBs. 
Our most striking finding was evidence suggesting nail salon workers are 
occupationally exposed to the phthalate alternative DEHTP, with post-shift urinary 
concentrations of a DEHTP metabolite (MECPTP) more than triple the concentrations of 
pre-shift concentrations. This change was moderately correlated with DEHTP levels on 
SWBs, suggesting an occupational exposure source rather than primarily other exposure 
sources such as diet that are unlikely to be picked up by SWBs. Increases of MECPTP 
during the day have previously been observed in general populations, however these 
increases were generally lower than what we observed for our pre- to post-shift change 
(e.g. 1.6 times from NHANES compared to 3.1 times in our study, respectively), and 
further research is necessary to better understand this trend (Silva et al., 2019).  
Concentrations of DEHTP metabolites (MECPTP and MEHHTP) in nail 
technician post-shift urine samples were also higher than what was observed in 
NHANES. This difference may be underestimated, as there is a significant downward 
trend in GM concentrations of MECPTP and MEHHTP (along with some other SVOCs) 
in NHANES with increasing age, and the NHANES female population includes children 
18 and younger (Silva et al., 2019), while our study population only enrolled adult 
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females over age 18. Although DEHTP is used as a replacement for the phthalate DEHP, 
literature on DEHTP exposure is relatively sparse, but suggests increasing exposure in 
the U.S. and Europe (Nagorka et al., 2011; Silva et al., 2017, 2019). Due to the lack of 
studies examining the health consequences associated with DEHTP exposure in humans 
to date, we do not fully understand whether increasing human exposure or long-term 
exposure to low levels of it will negatively impact human health. Metabolites of DEHTP 
are generally higher in females than in males (Silva et al., 2019), suggesting exposure via 
personal care products or a similar source linked to behavioral differences between males 
and females. Interestingly, DEHTP is not a traditional SVOC in nail polish and we do not 
know the source of the DEHTP in nail salons. Although DEHTP may be present in some 
nail polishes, we found no evidence for this in a recent nail product study (Young et al., 
2018). DEHTP is likely present in other personal care products or materials used in nail 
salons, such as lotions, waxes, or skin scrubbing exfoliants. 
Previous studies have found higher concentrations of certain phthalates (e.g., DEP 
and DBP) in nail salons compared to other indoor environments (Tran & Kannan, 2015), 
and higher concentrations of certain SVOC urinary metabolites from nail salon workers 
compared to the U.S. general population (e.g. MBP and MEHP) (Hines et al., 2009). 
While there was an upward trend for SVOC urinary metabolites from pre- to post-shift in 
our study, none reached statistical significance, perhaps due to small sample size. 
Exposure to many phthalates, phthalate alternatives, and OPEs is ubiquitous in the U.S. 
due to their common usage in personal care and other consumer products (CDC, 2019; 
Silva et al., 2007, 2019). Some SVOCs are also present in food or food packaging, a 
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potential explanation for the lack of correlation between urine and SWBs for some 
compounds as SWBs do not capture dietary exposure sources.  
Post-shift urinary concentrations from our study participants were generally lower 
than concentrations from U.S. females from NHANES, with the exception of urinary 
metabolites of DEHTP, TCEP, and TPHP (CDC, 2019; Silva et al., 2019). As use of 
some of the more toxic phthalates such as DBP and DEHP have been reduced and 
replaced in the U.S. over time with alternatives such as DEHTP due to potential health 
concerns, concentrations of urinary metabolites such as MBP and MEHP have decreased, 
while metabolites from phthalate alternatives such as MECPTP and MEHHTP have 
increased (Koch et al., 2017; Silva et al., 2019; Zota et al., 2014). Factors that may partly 
explain the lower urinary metabolite concentrations from our participants include that 
NHANES includes females under 18, which our study excludes, and that the NHANES 
data were largely from an earlier time period (2013–2014 and 2015–2016) than our study 
(2016–2017).  
Our pilot study demonstrated relatively high detection frequencies of a number of 
SVOCs on SWBs after having been worn by nail salon workers for only one shift (e.g., 6 
to 11 hours). Little is known about the kinetics of uptake of SVOCs by SWBs and we are 
aware of only one previously published occupational exposure study (of polycyclic 
aromatic hydrocarbons) (O’Connell et al., 2014). The fact that SWBs not only function as 
passive air monitors, but can pick up material from contact with surfaces and skin was 
evident in SWBs utilized by our study participants, as many appeared dusty and/or had 
debris on the surface upon collection at the end of the work shift. Interestingly, TPHP 
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concentrations on lapel and wrist SWBs were not correlated, perhaps suggesting that 
different exposure sources of these compounds are encountered based on contact with 
skin and surfaces (more likely with wrist SWBs) versus those in the air (more likely with 
lapel SWBs). More research is needed to understand this difference and its implications 
for exposure routes. The results for DEHTP also add to the small body of literature 
validating the use of SWBs with biomonitoring results (Hammel et al., 2016, 2018; 
O’Connell et al., 2014). 
The replacement of phthalates with alternatives, and the corresponding increased 
exposure to the latter, is of concern since often we do not fully understand the toxicity of 
the alternatives (Lakind & Birnbaum, 2010). For example, DEHTP is thought of as a 
safer alternative to DEHP, a known male reproductive toxicant, since it has not been 
shown to cause reproductive toxicity (Gray et al., 2000). However, exposure to DEHTP 
may be associated with other health concerns. A dietary study of DEHTP fed to F-344 
rats over 104 weeks found reduced weight gain and exacerbated geriatric retinal 
degeneration with chronic, high dietary exposure (6,000 or 12,000 ppm) (Deyo, 2008). 
TPHP, another replacement chemical found in nail polish, has recently been identified as 
an endocrine disrupter that may be negatively associated with thyroid function and 
reproductive health (Carignan et al., 2017; Meeker & Stapleton, 2010; Preston et al., 
2017). Future, larger biomonitoring studies of nail salon workers will help to verify and 
identify replacement chemicals of particular concern from changes in formulations to 
products used in nail salons. 
Our study has a number of limitations, particularly the small sample size that 
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limited statistical power. We used the difference between post- and pre-shift metabolite 
concentrations in urine as a measure of exposure during the work day, but while this 
approach has several advantages (e.g., assessing exposure across inhalation, dermal and 
other routes), it also has disadvantages. The appearance of metabolites in urine has a time 
lag due to pharmacokinetics (e.g., absorption, metabolism rate). As we were not able to 
collect urine later in the day after the shift (or the following first morning void), we may 
have missed some exposure. The human half-lives of many of these compounds is not 
known, but believed to be on the order of hours to days. Thus, if we collected 
participants’ urine for a longer time period (e.g. 24 or 48 hours after their work shift) we 
would likely obtain a better understanding of these occupational exposures. As we only 
sampled participants on days when they had worked the previous day, pre-shift urine 
samples may partly reflect previous occupational exposure for the relatively more 
persistent SVOCs. A potential explanation of why we generally saw higher 
concentrations on SWBs pinned to participants’ lapels compared to the ones worn on 
their wrists is that those on the wrist may have been covered up by participants’ sleeves, 
thus in future studies it would be beneficial to ensure that all SWBs are exposed to salon 
air for the duration of participants’ work shifts. Additionally, asking participants to wear 
SWBs during working hours on multiple work days during a given work week may have 
captured more information on occupational SVOC exposures. We did not attempt to 
assess exposure at home, while commuting, or via diet.  
Strengths of our study of nail salon workers include the use of biomonitoring, 
demonstration of the use of SWBs, collection of these samples in a sometimes difficult to 
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reach population, and analysis for a wide spectrum of SVOCs. An additional strength is 
the paired use of biomonitoring and SWB data, which suggested that the increase of 
urinary DEHTP metabolites was due to occupational exposure rather than other sources 
such as diet.  
Higher concentrations of SVOC urinary metabolites detected in post-shift urine 
samples compared to pre-shift samples and the presence of parent compounds detected on 
SWBs worn during the work shift indicate that nail salon workers are occupationally 
exposed to SVOCs. The higher concentrations of DEHTP metabolites in our study 
population compared to the U.S. female population from the NHANES study, and the 
more than tripling of pre- to post-shift concentrations of MECPTP measured in urine 
suggests that nail salon workers are exposed to DEHTP during the work day. Finally, the 
detection of several phthalates, phthalate alternatives, and OPEs on SWBs worn during 
the work shift indicates that SWBs can be used as an exposure assessment tool for nail 
salon workers for future studies. Future, larger biomonitoring studies with more statistical 
power, and a longer sampling timeframe would help further clarify which SVOCs nail 
technicians are exposed to at work. Finally, it would be useful to compare the SVOCs 
detected on SWBs to active air samples collected during the work day to validate the 




Table 2.1. Parent Compounds and Metabolites† Examined in Silicone WristBands (SWBs) and Urine Among Nail Salon Workers 
(2016–2017) in the Greater Boston Area 
                    Parent Compound in SWB                                                    Urinary Metabolite                                 
Name Acronym LOD£ Name Acronym LOD¥ 
Phthalates      
  Butylbenzyl phthalate BBzP 6.7 Monobenzyl phthalate MBzP 0.3 
  Di-n-butyl phthalate DBP 1,120 Mono-hydroxybutyl phthalate MHBP 0.4 
 Mono-n-butyl phthalate MBP 0.4 
  Di-iso-butyl phthalate DiBP 17.6 Mono-isobutyl phthalate MiBP 0.8 
   Mono-hydroxy-isobutyl phthalate MHiBP 0.4 
  Diethyl phthalate DEP 31.5 Monoethyl phthalate MEP 1.2 
  Dimethyl phthalate DMP 1.8 Not measured   
  Di(2-ethylhexyl) phthalate DEHP 9.3 Mono-2-ethylhexyl phthalate MEHP 0.8 
 Mono-2-ethyl-5-hydroxyhexyl phthalate MEHHP 0.4 
  Mono-2-ethyl-5-oxohexyl phthalate MEOHP 0.2 
  Mono-2-ethyl-5-carboxypentyl phthalate MECPP 0.4 
  Di-isodecyl phthalate# DiDP# # Mono carboxyisononyl phthalate MCNP 0.2 
  Di-isononyl phthalate DiNP 17.2 Mono-isononyl phthalate MiNP 0.9 
 Mono carboxyisooctyl phthalate MCOP 0.3 
   Monooxononyl phthalate MONP 0.4 
  Di-n-octyl phthalate#  DOP# # Mono-3-carboxypropyl phthalate MCPP 0.4 
Phthalate Alternatives      
  1,2-Cyclohexane dicarboxylic acid, diisononyl   
ester#  
DINCH# # Cyclohexane-1 2-dicarboxylic acid 
monohydroxy isononyl ester 
MHiNCH 0.4 
  Cyclohexane-1 2-dicarboxylic acid 
monocarboxyisooctyl ester 
MCOCH 0.5 
  Diethylhexyl adipate DEHA 1.8 Not measured   
  Trioctyltrimellitate TOTM 0.04 Not measured   
  Di(2-ethylhexyl) terephthalate DEHTP 1.3 Mono-2-ethyl-5-carboxypentyl terephthalate MECPTP 0.2 
  Mono-2-ethyl-5-hydrohexyl terephthalate MEHHTP 0.4 





Table 2.1 (Continued). Parent Compounds and Metabolites† Examined in Silicone Wrist Bands (SWBs) and Urine Among Nail 
Salon Workers (2016–2017) in the Greater Boston Area 
                    Parent Compound in SWB                                                    Urinary Metabolite                                 
Name Acronym LOD£ Name Acronym LOD¥ 
Organophosphate Esters      
  Tris(1-chloro-2-propyl) phosphate TCIPP 6.7 Bis(1-chloro-2-propyl) phosphate MBzP 0.3 
  Tris(2-chloroethyl) phosphate 
  Tris(1,3-dichloro-2-propyl) phosphate 
TCEP 
TDCIPP 
30.6 Bis-2-chloroethyl phosphate MHBP 0.4 
1.2 Bis(1,3-dichloro-2-propyl) phosphate MBP 0.4 
  Tri-n-butyl phosphate TBuP # Dibutyl phosphate MiBP 0.8 
  Triphenyl phosphate TPHP 6.1 Diphenyl phosphate MHiBP 0.4 
Brominated Flame Retardant    MEP 1.2 
  2-ethylhexyl-2,3,4,5-tetrabromobenzoate# EH-TBB# # 2,3,4,5-tetrabromobenzoic acid   





Table 2.2. Characteristics of 10 Nail Salon Participants, Greater Boston Area (2016–2017) 
Participant Characteristics N Participants 
(n=10) 
Median Range 
Current Age  45 21 – 64† 
Country of Origin (Primary Language Spoken) 
     USA (English) 4   
     Vietnam (Vietnamese) 6   
Occupational Title    
     Nail Technician 8   
     Nail Salon Owner 2   
Employment History    
     Full-Time in Nail Salon  10 <1 – 23† 
     Part-Time in Nail Salon  6 <1 – 33† 
Hours worked    
     Per Week  40 20 – 50£ 
     Day of Sampling  9 6 – 11£ 
Number of Procedures    
     Regular Manicure 
     Acrylic Manicure 
     Gel Manicure 





 1 – 5¥ 
3 – 9¥ 
1 – 4¥ 
1¥ 
     Pedicure 8  1 – 3¥  
†Years 
£Hours 





Table 2.3. Descriptive Statistics for Creatinine-Corrected SVOC metabolites examined in Pre- and Post-Shift Urine 
Samples from Nail Salon Workers in the Greater Boston Area (2016–2017)  
 Pre-shift urine Concentrations (µg/g) (n=10) Post-shift urine Concentrations (µg/g) (n=10) [Post/Pre Shift]  NHANES# 























Phthalates         
     MBzP 70 1.6 2.7 1.2 <0.3 – 14.0 70 1.9 2.7 1.9 <0.3 – 12.2 0.3 5.2 
     MHBP 50 0.79 2.0 0.7 <0.4 – 2.5 40 N/A N/A <0.4 <0.4 – 3.0 N/A 1.13 
     MBP 90 7.2 2.0 7.6 <0.4 – 24.0 90 8.7 2.5 9.1 <0.4 – 50.3 1.5 11.7 
     MiBP 90 4.5 1.7 4.4 <0.8 – 12.3 70 5.1 1.8 5.8 <0.8 – 11.4 0.6 9.75 
     MHiBP 80 2.1 1.3 1.9 <0.4 – 3.6 60 1.8 1.6 1.8 <0.4 – 4.8 -0.3 3.27 
     MEP 100 27.9 2.0 22.0 11.2 – 86.7 100 37.9 3.1 30.7 12.8 – 515 10.0 43.6 
     MEHP 50 1.2 2.8 1.2 <0.8 – 9.8 40 N/A N/A <0.8 <0.8 – 4.4 N/A N/A 
     MEHHP 90 4.0 2.4 3.1 <0.4 – 15.9 90 5.1 2.4 7.4 <0.4 – 15.3 1.1 6.29 
     MEOHP 90 2.6 2.5 2.3 <0.2 – 11.1 90 3.3 2.7 3.8 <0.2 – 11.2 0.7 4.08 
     MECPP 100 7.4 2.3 6.2 3.0 – 39.1 100 8.7 2.0 9.4 3.7 – 28.9 1.3 9.98 
     MCNP 70 0.9 3.0 0.7 <0.2 – 6.2 70 1.2 2.6 0.9 <0.2 – 4.8 0.3 1.90 
     MiNP 10 N/A N/A <0.9 <0.9 – 4.8 10 N/A N/A <0.9 <0.9 – 4.9 N/A N/A 
     MCOP 90 2.9 2.0 3.4 <0.3 – 7.4 90 4.2 2.2 4.4 <0.3 – 17.2 1.3 9.06 
     MONP 50 0.9 2.1 0.9 <0.4 – 2.7 60 1.4 2.7 1.1 <0.4 – 6.7 0.5 2.32 
     MCPP 30 N/A N/A <0.4 <0.4 – 2.2 30 N/A N/A <0.4 <0.4 – 2.4 N/A 1.24 
GM = Geometric Mean; GSD = Geometric Standard Deviation; LOD = Limit of Detection; N/A Not calculated: proportion of results below limit 
of detection was too high to provide a valid result 
#NHANES phthalate and phthalate alternative data collected in 2015–2016, organophosphate esters and brominated flame retardant data 






Table 2.3 (Continued). Descriptive Statistics for Creatinine-Corrected SVOC metabolites examined in Pre- and Post-Shift Urine 
Samples from Nail Salon Workers in the Greater Boston Area (2016–2017)  





























Phthalate Alternatives       
     MHiNCH 20 N/A N/A <0.4 <0.4 – 2.3 20 N/A N/A <0.4 <0.4 – 2.0 N/A N/A 
     MCOCH 20 N/A N/A <0.5 <0.5 – 2.7 20 N/A N/A <0.5 <0.5 – 2.7 N/A N/A 
     MECPTP 100 11.7 3.3 17.4 1.0 – 50.1 100 36.6 4.3 26.9 11.5 – 1,286 24.9 22.5 
     MEHHTP 100 6.1 2.1 6.4 1.5 – 22.7 100 9.5 3.4 7.4 2.1 - 166 3.4 5.45 
Organophosphate Esters      
     BCIPP 90 0.5 2.3 0.6 <0.1 – 1.6 90 0.7 2.3 0.8 <0.1 – 2.4 0.2 N/A 
     BCEP 60 0.6 4.5 0.5 <0.1 – 4.3 70 0.6 2.5 0.5 <0.1 – 2.0 0.0 0.476 
     BDCIPP 80 0.8 2.2 0.8 <0.1 – 2.4 90 0.8 2.0 0.7 <0.1 – 2.4 0.0 0.993 
     DBuP 50 0.4 4.4 0.3 <0.1 – 7.6 20 N/A N/A <0.1 <0.1 – 9.1 N/A 0.227 
     DPHP 90 1.1 2.9 0.8 <0.1 – 6.5 90 1.3 2.1 1.3 <0.1 – 4.1 0.2 1.13 
Brominated Flame Retardant     
     TBBA 10 N/A N/A <0.05 <0.05 – 0.3 0 N/A N/A <0.05 <0.05 N/A N/A 
GM = Geometric Mean; GSD = Geometric Standard Deviation; LOD = Limit of Detection; N/A Not calculated: proportion of results below limit 
of detection was too high to provide a valid result 
#NHANES phthalate and phthalate alternative data collected in 2015–2016, organophosphate esters and brominated flame retardant data 





Table 2.4. Descriptive Statistics for SVOCs Examined in Silicone Wristbands (SWBs) Worn During a Work Shift by Nail Salon 
Workers in the Greater Boston Area (2016–2017)  
 Lapel SWB Concentrations (ng/g) (n=9) Wrist SWB Concentrations (ng/g) (n=9) [Lapel/Wrist]  Wrist/Lapel 























Phthalates             
      BBzP 44.4 N/A N/A <6.7 <6.7 – 45.7 22.2 N/A N/A <6.7 <6.7 – 22.3 N/A N/A 
      DBP 0.0 N/A N/A <1,120 All <1,120 11.1 N/A N/A <1,120 <1,120 – 1,697 N/A N/A 
      DiBP 33.3 N/A N/A <17.6 <17.6 – 56.1  33.3 N/A N/A <17.6 <17.6 – 143 N/A N/A 
      DEP 22.2 N/A N/A <31.5 <31.5 – 576 22.2 N/A N/A <31.5 <31.5 – 967 N/A N/A 
      DMP 33.3 N/A N/A <1.8 <1.8 – 3.8 33.3 N/A N/A <1.8 <1.8 – 5.8 N/A N/A 
      DEHP 100 195 4.3 251 27.0 – 3,572 55.6 29.6 22.5 42.4 <9.3 – 2,004 6.6 0.17 
      DiNP 88.9 182 4.1 200 <17.2 – 1,339 55.6 32.7 31.0 50.7 <17.2 – 4,719 5.6 -0.21 
Phthalate Alternatives       
      DEHA 77.8 4.5 18.9 5.0 <1.8 – 1,364 55.6 1.8 25.6 2.3 <1.8 – 260 2.5 0.81* 
      TOTM 100 2.8 6.5 2.2 0.17 – 70.5 55.6 0.41 89.9 1.4 <0.04 – 493 6.8 0.67 
      DEHTP 100 105 4.3 81.9 11.1 – 1,636 77.8 21.8 29.1 20.8 <1.3 – 5,817 4.8 0.21 
Organophosphate Esters        
      TCIPP 77.8 29.2 3.5 40.9 <6.7 – 161 88.9 39.7 4.3 39.5 <6.7 – 199 0.73 0.48 
      TCEP 11.1 N/A N/A <30.6 <30.6 – 56.2 0.0 N/A N/A <30.6 All <30.6 N/A N/A 
      TDCIPP 77.8 3.5 4.1 3.3 <1.2 – 27.4 88.9 8.8 3.8 15.7 <1.2 – 35.0 0.39 0.14 
      TPHP 88.9 153 4.3 257 <6.1 – 1,006 100 95.8 3.4 132 11.8 – 368 1.6 0.07 
GM = Geometric Mean; GSD = Geometric Standard Deviation; LOD = Limit of Detection; #Spearman Correlation 
N/A Not calculated: proportion of results below method detection limit was too high to provide a valid result 
*Spearman correlation statistically significant (p<0.05) 
Note: Not all compounds listed in Table 2.1 were measured in SWBs 
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Table 2.5. Correlations between SVOCs in Silicone Wristbands (SWBs) and 
Creatinine-Corrected Urinary Metabolites in Post-Shift minus Pre-shift Urine 
Samples from Nail Salon Workers in the Greater Boston Area (2016–2017) 
  Spearman correlation coefficients for 
Difference of post-shift and pre-shift urine/  
SWB Parent Compound Urinary Metabolite Lapel SWB Wrist SWB 
Phthalates    
     DEHP MEHP 0.18 0.15 
     MEHHP 0.28 0.18 
MEOHP 0.17 0.07 
MECPP 0.63 0.22 
     DiNP MCOP 0.27 0.45 
 MONP -0.08 0.30 
Phthalate Alternatives    
     DEHTP MECPTP 0.60 0.37 
MEHHTP 0.38 0.57 
Organophosphate Esters 
     TCIPP BCIPP -0.40 -0.30 
     TDCIPP BDCIPP -0.10 0.20 





Figure S2.1. Comparison of Creatinine-Corrected Pre- and Post-Shift 
Concentrations* of Phthalates, Phthalate Alternatives, and Organophosphate Esters 
(ng/g) Detected ≥50% in Individual Nail Salon Workers’ Urine in the Greater 
Boston Area (2016–2017) 
 
 
      
























































































































































































Figure S2.1 (Continued). Comparison of Creatinine-Corrected Pre- and Post-Shift 
Concentrations* of Phthalates, Phthalate Alternatives, and Organophosphate Esters 
(ng/g) Detected ≥50% in Individual Nail Salon Workers’ Urine in the Greater 
Boston Area (2016–2017) 
  
  



























































































































































































Figure S2.1 (Continued). Comparison of Creatinine-Corrected Pre- and Post-Shift 
Concentrations* of Phthalates, Phthalate Alternatives, and Organophosphate Esters 
(ng/g) Detected ≥50% in Individual Nail Salon Workers’ Urine in the Greater 
Boston Area (2016–2017) 
 
        
 
*Concentrations <LOD replaced  
 
Figure S2.2. Concentrations of SVOCs Detected ≥50% on Silicone Wristbands 
Worn on the Lapel or Wrist During a Work Shift by Nail Salon Workers in the 
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Table S2.1. Correlations between SVOCs in Silicone Wrist Bands (SWBs) measured 
in ng/g and SVOC concentrations measured in SWBs corrected for work shift 
length (ng/g)-hr from Nail Salon Workers in the Greater Boston Area (2016–2017) 
 Spearman correlation coefficients 
SWB Parent Compound Lapel SWB Wrist SWB 
Phthalates   
     DEHP 1.0 1.0 
     DiNP 1.0 1.0 
Phthalate Alternatives   
     DEHA 1.0 1.0 
     TOTM 0.98 1.0 
     DEHTP 0.98 1.0 
Organophosphate Esters  
     TCIPP 1.0 1.0 
     TDCIPP 1.0 1.0 




Table S2.2. Descriptive Statistics for SVOCs Examined in Silicone Wrist Bands (SWBs) Worn During a Work Shift 
Adjusted for Work-Shift Duration by Nail Salon Workers in the Greater Boston Area (2016–2017)  




























Phthalates             
      BBzP 44.4 N/A N/A <MDL <MDL – 5.1 22.2 N/A N/A <MDL <MDL – 2.0 N/A N/A 
      DBP 0.0 N/A N/A N/A N/A 11.1 N/A N/A <MDL <MDL – 179 N/A N/A 
      DiBP 33.3 N/A N/A <MDL <MDL – 6.2  33.3 N/A N/A <MDL <MDL – 13.0 N/A N/A 
      DEP 22.2 N/A N/A <MDL <MDL – 52.4 22.2 N/A N/A <MDL <MDL – 87.9 N/A N/A 
      DMP 33.3 N/A N/A <MDL <MDL – 0.43 33.3 N/A N/A <MDL <MDL – 0.53 N/A N/A 
      DEHP 100 21.9 4.0 25.1 4.5 – 397 55.6 3.5 19.2 4.5 <MDL – 182 6.3 0.17 
      DiNP 88.9 20.5 3.9 22.3 <MDL – 149 55.6 3.9 26.4 5.3 <MDL – 429 5.3 -0.21 
Phthalate Alternatives       
      DEHA 77.8 0.51 16.9 0.46 <MDL – 152 55.6 0.22 21.8 0.25 <MDL – 23.6 2.3 0.81* 
      TOTM 100 0.31 5.9 0.29 0.03 – 7.8 55.6 0.05 76.4 0.15 <MDL – 44.8 6.2 0.64 
      DEHTP 100 11.8 3.9 9.0 1.9 – 182 77.8 2.6 25.7 33.7 <MDL – 529 4.5 0.21 
GM = Geometric Mean; GSD = Geometric Standard Deviation; MDL = Method Detection Limit; #Spearman Correlation 
N/A Not calculated: proportion of results below method detection limit was too high to provide a valid result 
*Spearman correlation statistically significant (p<0.05) 





Table S2.2 (Continued). Descriptive Statistics for SVOCs Examined in Silicone Wrist Bands (SWBs) Worn During a 
Work Shift Adjusted for Work-Shift Duration by Nail Salon Workers in the Greater Boston Area (2016–2017)  




























Organophosphate Esters        
      TCIPP 77.8 3.3 3.9 4.5 <MDL – 19.5 88.9 4.7 4.5 4.4 <MDL – 33.2 0.70 0.48 
      TCEP 11.1 N/A N/A <MDL <MDL – 6.2 0.0 N/A N/A <MDL N/A N/A N/A 
      TDCIPP 77.8 0.39 4.8 0.44 <MDL – 4.6 88.9 1.1 3.7 1.8 <MDL – 3.7 0.35 0.43 
      TPHP 88.9 17.2 4.7 33.8 <MDL – 134 100 11.4 3.5 12.0 1.3 – 49.0 1.5 0.10 
GM = Geometric Mean; GSD = Geometric Standard Deviation; MDL = Method Detection Limit; #Spearman Correlation 
N/A Not calculated: proportion of results below method detection limit was too high to provide a valid result 
*Spearman correlation statistically significant (p<0.05) 











Table S2.3. Correlations between SVOCs in Silicone Wristbands (SWBs) and Creatinine-
Corrected Urinary Metabolites in Post-Shift minus Pre-shift Urine Samples Adjusted for 
Work-Shift Duration from Nail Salon Workers in the Greater Boston Area (2016–2017) 
  Spearman correlation coefficients for Difference of post-shift and pre-shift urine/  
SWB Parent Compound Urinary Metabolite Lapel SWB Wrist SWB 
Phthalates    
     DEHP MEHP 0.18 0.15 
     
MEHHP 0.28 0.18 
MEOHP 0.17 0.07 
MECPP 0.63 0.22 
     DiNP MCOP 0.27 0.45 
 MONP -0.08 0.30 
Phthalate Alternatives    
     DEHTP MECPTP 0.52 0.33 MEHHTP 0.33 0.55 
Organophosphate Esters 
     TCIPP BCIPP -0.17 -0.30 
     TDCIPP BDCIPP -0.10 0.40 
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Per- and polyfluoroalkyl substances (PFAS) are commonly used as water and stain 
repellents in consumer products and can contaminate drinking water sources. Research 
suggests that prenatal PFAS exposure may impact fetal growth and development, but 
findings remain mixed and little is known about joint effects of PFAS mixtures. The goal 
of this study was to examine associations between maternal serum concentrations of 
PFAS during pregnancy and birth outcomes.  
Methods 
Study participants included 134 mother-child pairs from the North Carolina-based TESIE 
Study (2009–2011). Sera collected between 5.6 and 29.6 weeks gestation (mean 12.6 
weeks) were analyzed for ten PFAS by on-line solid-phase extraction coupled with high-
performance liquid chromatography-tandem mass spectrometry. We used multivariable 
regression models to estimate total and sex-specific associations of individual PFAS with 
gestational age at birth, birth weight, and birth weight for gestational age z-score. We 
used weighted quantile sum regression to derive a PFAS mixture index and estimated the 
association of this index with birth outcomes.  
Results 
In WQS regression models, the PFAS mixture index was negatively associated with 
gestational age at birth among all (β = -3.2 [-6.1, -0.31] days) offspring. The linear 
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isomer of perfluorooctanoic acid (n-PFOA) contributed most to this association (weight = 
0.32). The PFAS mixture index was also negatively associated with gestational age at 
birth among male offspring (β = -6.2 [-11.1, -1.3] days). Similarly, n-PFOA (weight = 
0.42) contributed most to this association. A weaker and less precise negative association 
was observed between the PFAS mixture index and gestational age at birth among female 
offspring (β = -0.82 [-4.3, 2.6] days). We observed less evidence of associations between 
the PFAS mixture index and birth weight for all (β = -78.7 [-219, 61.3] grams) and male 
(β = -191 [-393, 10.6] grams) offspring; there was some evidence of confounding by 
plasma volume expansion and/or glomerular filtration rate. Furthermore, gestational age 
at birth likely contributed to this association. Associations with birth weight for 
gestational age z-score were weaker and less consistent. 
Conclusion 
We observed negative associations between some prenatal PFAS concentrations and birth 
outcomes, particularly gestational length. Our data suggest that male offspring may be 
more susceptible than females. Our results also highlight the importance of examining 
associations between mixtures of multiple PFAS and birth outcomes rather than 
individual PFAS. Finally, we found evidence that the mechanism of the association 
observed between PFAS concentrations and birth weight may be through reduced 







Per- and polyfluoroalkyl substances (PFAS) are a group of man-made fluorinated 
chemicals that have water and stain-resistant properties and have been in production since 
the 1950s. PFAS are resistant to environmental degradation (ATSDR, 2018; Calafat et 
al., 2007; CDC, 2019). PFAS have commonly been used in fire-fighting foams, food 
packaging and consumer products such as carpet, upholstery, and clothing (ATSDR, 
2018). As such, PFAS are ubiquitous in indoor environments and are commonly detected 
in human serum and blood (ATSDR, 2018; Calafat et al., 2007; Fraser et al., 2013; 
Houde et al., 2006; Manzano-Salgado et al., 2017; Sagiv et al., 2015; Shoeib et al., 2011; 
Starling et al., 2017). Routes of exposure include inhalation of contaminated air and dust; 
ingestion of food (directly from food or from food packaging), drinking water, 
breastmilk, and dust; and direct contact with items containing PFAS (such as personal 
care products). PFAS are able to cross the placental barrier, leading to exposure to the 
developing fetus (ATSDR, 2018; Verner et al., 2016). 
According to the Developmental Origins of Health and Disease hypothesis, early 
life exposures to harmful chemicals, potentially during critical windows of development, 
may lead to significant short- and long-term health consequences (Barker, 2007; Hales et 
al., 1991). Some epidemiological studies have suggested that increased prenatal exposure 
to certain PFAS may be associated with adverse birth outcomes such as decreased 
gestational age at birth and decreased birth weight (Apelberg et al., 2007; Chen et al., 
2012; Johnson et al., 2014; Lam et al., 2014; Sagiv et al., 2017; Starling et al., 2017; 
Woods et al., 2017b). However, other studies, including a meta-analysis, suggest that 
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inverse associations reported previously with birth weight, particularly those that 
assessed exposure in late pregnancy serum or in cord blood, may be exaggerated because 
of uncontrolled confounding by plasma volume expansion (PVE) and glomerular 
filtration rate (GFR) (Bach et al., 2015; Steenland et al., 2018; Verner et al., 2015). Low 
GFR later in pregnancy could confound the association between PFAS and birth 
outcomes because GFR is associated with both decreased birth weight and gestational age 
at birth, as well as with increased PFAS maternal serum concentrations (Park et al., 2018; 
Steenland et al., 2018). 
Few previous studies of birth outcomes have examined more than one PFAS at a 
time (Kalloo et al., 2020; Woods et al., 2017b). However, in reality, people are likely 
exposed to mixtures of PFAS that are often highly correlated, raising the possibility of 
confounding, interactions, or cumulative effects between co-exposures (Braun et al., 
2016). Cumulative exposure to low concentrations of a multitude of chemicals may be 
associated with negative health effects, even when there is a lack of evidence for health 
effects associated with the concentration of each individual substance (Carrico et al., 
2015; Schecter et al., 2013). Thus, although most studies have examined impacts of 
individual PFAS only, estimating the joint effects of multiple PFAS is necessary to 
understand the overall potential health impacts of PFAS exposure, which often occur as 
mixtures of PFAS.  
The primary objective of this study was to estimate associations of mixtures of 
maternal serum PFAS concentrations during pregnancy with three outcome measures: 
gestational age at birth, birth weight, and birth weight for gestational age z-score, a 
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measure of fetal growth. We estimated associations for individual PFAS, and also used 
weighted quantile sum (WQS) regression to estimate cumulative associations for multiple 
PFAS with a weighted PFAS mixture index (Carrico et al., 2015). Given previous 
literature demonstrating that serum PFAS concentrations vary by behavioral 
characteristics, physiology, and sociodemographic factors (Calafat et al., 2007; Sagiv et 
al., 2015, 2017), a secondary objective was to examine these factors as predictors of 





This study is in collaboration with the Newborn Epigenetics STudy (NEST) at 
Duke University that examined the associations between prenatal diet, nutrition, and 
epigenetic modifications with health outcomes including obesity in childhood or later in 
life (Hoyo et al., 2011). As previously described, eligible women were at least 18 years of 
age, pregnant, and received prenatal care at the Duke University Division of Maternal 
and Fetal Medicine (DMFM) (Hoyo et al., 2011). The NEST study enrolled 
approximately 2,585 pregnant women that were 4–24 weeks pregnant (2005–2011). 
Race/ethnicity for this cohort was approximately 27% non-Hispanic White, 40% non-
Hispanic Black, and 29% Hispanic. NEST study researchers administered questionnaires, 
collected participant serum samples during pregnancy, and obtained labor and birth 
outcome data from medical records (Hoyo et al., 2011). 
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The Toddlers Exposure to Semi-Volatile Organic Chemicals (SVOCs) in Indoor 
Environments (TESIE) study is a sub-sample of NEST, with participation restricted to 
children aged 3–6 years at recruitment. As previously described, TESIE aimed to 
evaluate pre- and postnatal exposures to SVOCs and examine associations with health 
outcomes in about 200 NEST offspring (Hoffman et al., 2018). Briefly, TESIE 
researchers re-contacted families that participated in the NEST study between 2014 and 
2016 through mailed letters, emails, and follow-up phone calls, and invited them to 
participate. A total of 203 children from 190 homes enrolled in the TESIE study. We 
excluded participants that were missing exposure information (n=36; due to insufficient 
serum volume remaining or maternal non-consent to the PFAS analysis), missing data on 
both birth weight and gestational age at birth (n=6), multiple births (n=20), or whose 
mothers were classified as ‘other’ race (n=3) due to the small number in this category. 
After exclusions, 134 infants were included in our analyses. Mothers provided informed 
consent for their child’s participation in TESIE and for use of their data and archived 
serum from the original NEST study. The Duke University Institutional Review Board 
approved human subject protocols. The involvement of the Centers for Disease Control 
and Prevention (CDC) laboratory was determined not to constitute engagement in human 
subjects research. 
 
Birth Outcomes and Potential Confounding Variables 
Gestational age at birth, birth weight, and data on potential confounders, including 
 
51 
information on demographics, education, parity, body mass index (BMI), prenatal 
smoking, and gestational age at blood draw were abstracted from medical records and 
questionnaires. Birth weight for gestational age z-score reflects fetal growth, and allows 
us to evaluate if an infant deviates from the sex- and gestational age-specific population 
mean birth weight (i.e. to control for sex and gestational age) in our models (Curtis et al., 
2016; Oken et al., 2003). We used the online calculator from the International Fetal and 
Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Project to 
calculate sex-specific birth weight for gestational age z-scores from our gestational age at 
birth, birth weight, and infant sex data (INTERGROWTH-21st, 2017). As previously 
described, the INTERGROWTH-21st Project is a multi-center, multi-ethnic, international, 
population-based project that aims to provide researchers with international newborn 
standards to compare infants born to geographically diverse mothers who are generally 
healthy, well-nourished, and receive adequate prenatal care (i.e., infants who are at low 
risk of fetal growth impairment) (Villar et al., 2014). The INTERGROWTH 21st Project 
birth weight for gestational age z-scores were based on sex-specific mean birth weight for 
completed weeks and days of gestation and were converted to a standardized z-score 
(Villar et al., 2014).  
 
Quantification of PFAS in Serum 
NEST researchers collected maternal serum samples during pregnancy (mean 
gestational age: 12.6 weeks; range 5.6 to 29.6 weeks). Sera were stored at -80 ºC at Duke 
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University until shipped to the Division of Laboratory Sciences at the CDC for analysis. 
Serum was analyzed for PFAS using on-line solid-phase extraction coupled with high-
performance liquid chromatography-isotope dilution-tandem mass spectrometry (Kato et 
al., 2011). Maternal sera were analyzed for the following PFAS: linear and branched 
perfluorooctane sulfonic acid (PFOS) (n-PFOS and Sm-PFOS, respectively), linear and 
branched perfluorooctanoic acid (PFOA) (n-PFOA and Sb-PFOA, respectively), 
perfluorononanoic acid (PFNA), perfluorohexane sulfonic acid (PFHxS), 
perfluorodecanoic acid (PFDA), perfluorooctane sulfonamide (FOSA), 2-(N-methyl-
perfluorooctane sulfonamide) acetic acid (MeFOSAA), and 2-(N-ethyl-perfluorooctane 
sulfonamide) acetic acid (EtFOSAA). We added the concentrations of the linear and 
branched isomers of both PFOS and PFOA to obtain total PFOS and total PFOA, 
respectively, to compare to the PFOS and PFOA data from the National Health and 
Nutrition Examination Survey (NHANES), a nationally representative sample of U.S. 
general population (CDC, 2019), which did not examine the linear and branched isomers 
separately during the same time frame. 
 
Statistical analyses 
Instrument values of maternal serum PFAS concentrations were not available 
from the laboratory when concentrations were below the limit of detection (LOD) of 0.1 
ng/mL (range 0 to 134 samples <LOD). We therefore assigned a value of the LOD 
divided by the square root of two to samples below the LOD. PFAS that were detected in 
>65% of participants were included in our analyses. We examined univariate 
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distributions of all outcomes, exposures, and covariates to assess normality. We 
compared the geometric mean maternal serum PFAS concentrations from participants of 
our study to serum PFAS concentrations measured between 2009 and 2010, the closest 
available years to when our study serum samples were collected, in female NHANES 
participants aged 19 to 44 years. We examined correlations between maternal serum 
PFAS concentrations using Spearman correlations.  
We used robust regression models with the MM estimation method to estimate 
associations of individual PFAS concentrations with birth outcomes in separate models. 
This  method can withstand a high proportion of outliers and maintain its robustness, and 
has higher statistical efficiency than some other methods for dealing with outliers (SAS, 
2008). Given the presence of outliers in our data, we chose to use robust regression to 
reduce the impact of those outliers on effect estimates. Birth weight and birth weight for 
gestational age z-score were approximately normally distributed; however, gestational 
age at birth was left skewed, and neither normally nor log-normally distributed. Both the 
outcomes and serum PFAS concentration variables were modeled as untransformed, 
continuous variables. We calculated the interquartile range (IQR) as Q3–Q1, where Q3 is 
the value of the 75th percentile and Q1 is the value of the 25th percentile of the 
concentration for each PFAS. Associations are reported as the change in birth outcome 
per IQR increase in PFAS.  
We examined the association of the cumulative effect of multiple PFAS with birth 
outcomes using WQS regression, a method to evaluate associations of chemical mixtures 
with health outcomes, which can be used for studies with small to moderate sample sizes 
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and highly correlated exposures (Carrico et al., 2015; Czarnota et al., 2015; Gennings et 
al., 2013). For continuous outcome variables (y), WQS regression assumes that the 
outcome is a linear function of a weighted index of the exposure variables modeled as 
quantiles (e.g., qi=0,1,2,3) with all mixture components acting in the same direction and 
no interaction between exposures: 
 , 
where the term in parentheses is the index, wi is the weight for exposure i (assumed non-
negative with all weights summing to one), z is a vector of confounders and e is an error 
term. WQS generates a beta coefficient (b1) for the index, which represents the change in 
birth outcome for a one-unit increase in the derived index representing quartiled PFAS, 
where each PFAS is weighted based on its overall contribution to the association with the 
outcome.  
 We set the number of bootstrap samples used in parameter estimation to 100. In 
the WQS models, one must place a constraint on whether the weights are derived from 
models where the β values are positive or negative. We selected the direction of the 
constraint as negative for all models, since, based on a priori knowledge, we 
hypothesized that serum PFAS concentrations would be negatively associated with the 
birth outcomes.  
To identify potential confounders, we used a priori knowledge to create a 
Directed Acyclic Graph (DAG) of the relationship between maternal serum PFAS 
concentrations and birth outcomes. Our multivariable and WQS models were adjusted for 
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maternal age at delivery, maternal race/ethnicity (non-Hispanic white, non-Hispanic 
black, Hispanic), maternal education, parity, maternal smoking during pregnancy, 
maternal BMI at last menstrual period (LMP) (based on self-reported weight and height), 
and gestational age at blood draw. We also conducted stratified analyses by infant sex 
because infant sex is a potential effect measure modifier of the relationship between 
prenatal PFAS exposure and birth weight and gestational age at birth (Lauritzen et al., 
2017; Manzano-Salgado et al., 2017). 
As a secondary objective, we examined the association of maternal serum PFAS 
concentrations with sociodemographic and behavioral factors using multivariable linear 
regression. These factors included maternal age at delivery, maternal race/ethnicity, 
maternal education, parity, maternal smoking during pregnancy, maternal BMI at LMP, 
and gestational age of the fetus at blood draw. All predictor variables were included 
simultaneously in adjusted models. Maternal serum PFAS concentrations were log-
normally distributed; therefore, we log-transformed those concentrations prior to analysis 
to examine predictors of PFAS concentrations. We report these associations as percent 
change in PFAS per unit change in predictor (% change = (eβ-1)*100). 
Some participants had missing data on maternal education (n=3, ~2%), smoking 
during pregnancy (n=2, ~1.5%), and BMI at LMP (n=1, ~0.75%). We used multiple 
imputation with 10 imputations using the robust regression method in the proc mi 
procedure in SAS(SAS, 2015), and then combined results using proc mianalyze based on 
Rubin’s rule (Rubin, 2004). In the WQS models, we did not use multiple imputation, as 
to our knowledge at the time of analysis that method had not been developed yet for 
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WQS regression. Instead, we replaced the missing mothers’ education and prenatal 
smoking variables with the most frequent categories (college graduate and non-smoker, 
respectively), and BMI at LMP with the median BMI at LMP (26.5 kg/m2). To ensure 
that substitution and multiple imputation did not introduce bias in the WQS and robust 
regression models, we compared results from the analyses with complete cases with those 
that included the replaced values. 
We conducted several additional sensitivity analyses for the associations between 
PFAS and birth outcomes. 1) In our models examining the association between prenatal 
serum PFAS concentrations and birth outcomes, we restricted participants to those whose 
maternal serum was drawn in the 1st trimester to reduce potential confounding by GFR 
(Table S3.2). 2) We adjusted for gestational age at birth in models of serum PFAS 
concentrations and birth weight (Table S3.3). 3) We included all PFAS in a single 
mutually-adjusted model (Table S3.4). 4) We fit WQS regression models with the 
direction of association constrained to positive (versus negative in the main analyses) 
(Table S3.5). 
We used the gWQS package version 2.0.1 in RStudio (version 3.4.2 (2017-09-
28)); The R Foundation for Statistical Computing) to analyze the WQS regression models 
(Renzetti et al., 2016). We performed all other statistical analyses using SAS statistical 






We included 134 mother-child pairs in our final analyses. Compared to 
participants, excluded mothers (n=69) had many similar characteristics including: age 
(median 29 versus 30 years, respectively), education (61% versus 64% had some college 
or a college degree), smoking during pregnancy (83% versus 85% reported not smoking), 
and BMI at LMP (median 26.5 versus 26.3 kg/m2). However, there were some 
differences. Mothers of excluded infants were more likely to self-identify as Hispanic 
compared to those who were included (30% versus 15%, respectively) and were slightly 
more likely to be married or living with a partner (76% versus 69%, respectively). 
Excluded babies, on average, had shorter gestational ages at birth (median 38.1 versus 
39.5 weeks, respectively) and lower birth weights (2,965 g versus 3,354 g, respectively), 
likely due to the inclusion of non-singleton births in that group, and were less likely to be 
the first child born to their mothers (28% versus 35%, respectively). 
 
Participant characteristics 
Participant characteristics are presented in Table 3.1. Mothers in our study ranged 
from 19 to 44 years (median 29 years). Approximately 45% of mothers self-identified as 
non-Hispanic white, 40% as non-Hispanic black, and 15% as Hispanic. Most mothers in 
our study had at least some college education (61%), at least one previous child (64%), 
were overweight or obese at LMP (58%), and did not smoke during pregnancy (83%). 
The majority of maternal serum samples were collected during the 1st trimester (67%). A 
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little over half of the offspring in our study were male (56%), most infants were born at 
full term (≥37 completed weeks gestation, 92%), and most had normal birth weights 
(≥2,500 grams, 89%).  
 
PFAS detection and correlations 
We detected n-PFOS, n-PFOA, Sm-PFOS, PFHxS, and PFNA in 100%, and 
PFDA in 88.8% of maternal serum samples (Table 3.2). We detected Sb-PFOA 
MeFOSAA, and EtFOSAA and FOSA in fewer than 40% of maternal serum samples; 
therefore, we did not include these PFAS in further statistical analyses. Linear PFOS and 
PFOA had the highest geometric mean concentrations (4.3 and 1.8 ng/mL, respectively). 
Compared to U.S. females aged 19 to 44 from NHANES, maternal serum PFAS 
concentrations in our study were fairly similar (Table 3.2).  
In general, maternal serum PFAS concentrations were moderately to highly 
correlated (r=0.37–0.75) (Table 3.3). The exception was for PFDA and PFHxS, which 
were only weakly correlated (r=0.08). Linear and branched PFOS had the highest 
correlation coefficient (r=0.75). 
 
Gestational age at birth 
In adjusted models of individual PFAS, we observed a negative association 
between maternal serum n-PFOA and gestational age at birth among all offspring (β for 
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IQR increase=-2.2 [95% CI: -4.2, -0.25] days), with n-PFOS and Sm-PFOS also 
exhibiting negative, albeit weaker, associations (β = -0.30 [-1.7, 1.1] days and β = -0.44 [-
2.1, 1.2] days, respectively) (Figure 3.1a, Table S3.1). In sex-stratified models, n-PFOA 
was negatively associated with gestational age at birth among male offspring (β = -3.6 [-
6.6, -0.70] days), with PFNA and Sm-PFOS exhibiting weaker negative associations (β = 
-2.2 [-5.1, 0.78] days and β = -0.59 [-2.6, 1.4] days, respectively). Among females, we 
observed weak inverse associations between PFAS and gestational age at birth (range -
0.78 to -2.8 days per IQR increase), with the exception of PFNA and PFHxS, but 
estimates were imprecise. The largest decreases in gestational age at birth among female 
offspring were for n-PFOA, Sm-PFOS, and n-PFOS: each IQR increase was associated 
with a 2.8 day decrease in gestational age at birth for n-PFOA and Sm-PFOS (95% CIs: -
5.9, 0.19 days and -6.3, 0.67 days, respectively), and a 2.5 day decrease for n-PFOS (95% 
CI: -5.8, 0.76). 
From WQS models, for each quartile increase in the derived PFAS mixture index, 
we observed a decrease of 3.2 (95% CI: -6.1, -0.31) days of gestation in all offspring 
(Figure 3.1a, Table S3.1). Linear PFOA, whose association with gestational age at birth 
was the largest in magnitude from among all individual PFAS, was also the strongest 
contributor to the WQS index (mean weight=32%).  In sex-stratified models, the mixture 
index was associated with a reduction of 6.2 (95% CI: -11.1, -1.3) days of gestation 
among male offspring, with linear PFOA contributing the most to this association (mean 
weight=42%) (Table 3.4). Among female offspring, the association of the mixture index 




In adjusted models among all offspring, there were weak negative associations 
between most PFAS, except PFHxS and PFNA, and birth weight (range of βs: -3.8 to -
79.2 grams per IQR increase), though the associations lacked precision (Figure 3.1b and 
Table S3.1). The largest decrease in birth weight for all offspring was observed for n-
PFOA: birth weight decreased by 79.2 (95% CI: -196, 37.9) grams for each IQR increase.  
PFNA was negatively associated with birth weight among male offspring in sex-
stratified models: each IQR increase was associated with a 185-gram decrease in birth 
weight (95% CI = -341, -29.9 grams). All other individual PFAS were weakly negatively 
associated with birth weight among male offspring (range of βs: -12.5 to -134 grams per 
IQR increase), though these associations lacked precision. Among females, results were 
not as precise for most PFAS.  
From WQS models, for each quartile increase in the derived PFAS mixture index, 
we observed a decrease of 78.7 grams (95% CI = -219, -61.3 grams) in all offspring 
(Figure 3.1b, Table S3.1). n-PFOA, whose association with birth weight had the largest 
magnitude from among all individual PFAS, was also the strongest contributor to the 
WQS index (mean weight=54%). In sex-stratified models, the mixture index was 
associated with a reduction of 191 grams (95% CI = -393, 10.6 grams) at birth among 
male offspring, with n-PFOA contributing the most to this association (mean 




Birth weight for gestational age z-score 
Overall, results for associations between maternal serum PFAS and birth weight 
for gestational age z-score were less precise and closer to the null than the other two birth 
outcomes of interest. In adjusted models of birth weight for gestational age z-score that 
included all offspring, the largest effect estimate was for n-PFOS (β = -0.11 [-0.29, 0.07] 
points), which was also the case in sex-stratified models among male offspring only (β = 
-0.13 [-0.33, 0.06] points) (Figure 3.1c, Table S3.1). Among female offspring, n-PFOS 
also had the largest effect estimate, though the association was positive (β = 0.11 [-0.34, 
0.56] points). 
The results of adjusted WQS regression models for the association between the 
PFAS mixture index and birth weight for gestational age z-score appeared close to null 
for all offspring (β = -0.03 [-0.29, 0.23] points). In sex-stratified models, the mixture 
index was associated with a reduction of 0.11 (95% CI = -0.44, 0.23) points of birth 
weight for gestational age z-score among male offspring, with linear Sm-PFOS 
contributing the most to this association (mean weight=27%) (Table 3.4).    
 
Predictors of maternal serum PFAS concentrations 
Associations between maternal serum PFAS with potential predictors, reported as 
percent change in PFAS, are shown in Table 3.5. The strongest predictor of maternal 
serum PFAS concentrations in our analyses was maternal parity; mothers with previous 
children had lower serum PFAS concentrations than nulliparous mothers for all PFAS 
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(range: 21–74% lower for parous compared to nulliparous mothers). We also saw a 
general negative trend in maternal serum PFAS concentration with increasing week of 
gestational age at blood draw (range: 0.27–0.36% decrease in ng/mL per week) for all 
PFAS. With the exception of n-PFOS, black mothers generally had lower concentrations 
of serum PFAS than white mothers (range: 2–9% lower for black compared to white 
mothers), though these estimates were imprecise. Hispanic mothers generally had lower 
concentrations of some PFAS (n-PFOS, n-PFOA, Sm-PFOS, and PFHxS, range: 4-37%) 
than white mothers, but not PFNA or PFDA (range: 27.5–48.8%), though some of these 
estimates also lacked precision. With the exception of PFNA, mothers with a college 
degree generally had higher concentrations of serum PFAS compared to mothers with a 
high school diploma or GED (range: 6–24% higher), though this trend of mothers with 
higher education having higher concentrations of PFAS than those with lower education 
did not hold when we compared mothers with a college degree to those with some 
college or less than a high school degree.  
 
Sensitivity Analyses 
 When we compared results from the analyses with complete cases with those that 
included the replaced missing covariate data in WQS models, we obtained very similar 
results (results not shown). In analyses restricted to maternal serum drawn in the 1st 
trimester, we found inverse associations between maternal serum PFAS concentrations 
and gestational age at birth that were generally similar or of greater magnitude compared 
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to our original analyses, for both individual PFAS models and WQS models (Table S3.2). 
Associations between maternal serum PFAS concentrations and the other two birth 
outcomes from analyses restricted to 1st trimester maternal serum samples were closer to 
the null or more positive than estimates from primary analyses, indicating potential 
confounding by PVE and/or GFR in the models that included participants with maternal 
serum collected later in pregnancy. In models of birth weight in which we additionally 
controlled for gestational age at birth as a covariate in the model, results were generally 
similar in direction, but of lower magnitude compared to the original analyses, suggesting 
that some of the association between serum PFAS concentrations and birth weight can be 
attributed to gestational age at birth (Table S3.3). When we included all PFAS in a single 
mutually adjusted model (Table S3.4), we found evidence of confounding by co-exposure 
in the individual PFAS models (the change in effect estimates for all PFAS changed by 
>10%). However, many of the individual PFAS were moderately to highly correlated, 
which suggests possible multicollinearity in the models that included all PFAS, which is 
why we examined these models only as sensitivity analyses. This multicollinearity 
underlines the importance of implementing an approach such as WQS regression that can 
accommodate correlated data and limits confounding by co-exposure by including all 
PFAS in the model. An assumption in WQS regression is that the mixture components 
act in the same direction. As mentioned above, this assumption is likely violated for some 
of our analyses among females, because associations between some of the individual 
PFAS and birth outcomes were in opposite directions. Table S3.5 displays the 
comparison of WQS associations between maternal serum PFAS and birth outcomes 
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when the WQS components were set as positive versus negative. The index effects were 




 In sex-stratified models, we observed a negative association between the PFAS 
mixture index and gestational age at birth among male offspring, while the association 
was not as strong among females. The results for the other birth outcomes were not as 
clear. While it appears that there is a weak negative association between PFAS and birth 
weight among male offspring, we found evidence of confounding by physiology in that 
association, and that the mechanism of the association between prenatal serum PFAS 
concentrations and birth weight may in part be through shortened gestational length.  
 
PFAS and Birth Outcomes 
To our knowledge, our study is one of only a handful published that examined the 
cumulative effect of a mixture of prenatal PFAS on birth outcomes. Two of these studies 
examined birth outcomes in the Health Outcomes and Measures of Environment 
(HOME) Study, a prospective birth cohort study based out of Cincinnati, Ohio that 
recruited participants between 2003 and 2006 (Kalloo et al., 2020; Woods et al., 2017b). 
Woods et al. (2017) used Bayesian hierarchical linear models to examine the association 
between a mixture of different chemicals and birth weight in 272 mother-child pairs and 
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found that the average association between PFAS class and birth weight was -10.6 grams 
(95% credible interval=-51.5, 34.0). However, blood was collected during the 2nd 
trimester and authors did not control for PVE, GFR, or gestational age at blood draw; 
thus, there is potential for uncontrolled confounding by physiology. Kalloo et al. (2020) 
used k-means clustering to cluster mothers with similar chemical exposure patterns into 
three groups as well as principal component analysis (PCA) to identify six principal 
components (PCs) that explained >50% of the variance in biomarker concentrations in 
380 mother-child pairs. In their adjusted analyses, they did not find an association 
between any of the clusters or PCs and gestational age at birth or birth weight for 
gestational age z-score (Kalloo et al., 2020). One explanation on why the findings from 
Kalloo et al. may have differed from our results of a negative association between some 
PFAS and gestational age at birth was that they included metals and other chemicals in 
addition to PFAS in the clusters and PCs they examined, and did not focus solely on 
PFAS. Thus, those cluster or PC profiles may not overall have been associated with 
gestational age at birth, while individual chemicals, such as PFAS, inside those clusters 
or PCs may have been. 
Our findings of a negative association between individual prenatal PFAS and 
gestational age at birth are consistent with prior studies. In a Danish cohort of 3,535 
mother-infant pairs, a doubling of PFOS, PFOA, PFNA, and perfluoroheptane sulfonatic 
acid (PFHpS) measured in 1st trimester maternal plasma was negatively associated with 
gestational age at birth (PFOS: β = -1.1 [-1.4, -0.4] days; PFOA: β = -0.4 [-1.0, 0.3] days; 
PFNA: β = -1.0 [-1.7, -0.3] days; and PFHpS: β = -1.2 [ -1.9, -0.5] days) (Meng et al., 
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2018). These estimates were smaller in magnitude but had greater precision (likely 
because of a much larger sample size) compared to our study (doubling of maternal 
serum PFOS, PFOA, and PFNA and gestational age at birth in all offspring from our 
study: β = -3.3 (-8.3, 1.7); -6.5 (-12.1, -0.87); and -7.1(-13.0, -1.3) days, respectively) 
(results not shown). Similarly, among an urban/suburban birth cohort in the northeastern 
United States (Project Viva) (n=1,645), PFOS and PFNA were negatively associated with 
gestational age at birth (per IQR increase, PFOS: β = -0.10 [-0.19, 0.00] weeks; PFNA: β 
= -0.07 [-0.17, 0.02] weeks) (Sagiv et al., 2017). These associations were also smaller in 
magnitude, but more precise than our findings (likely due to larger sample size) (PFOS: β 
= -0.21 [-0.50, 0.07] weeks; PFNA β = -0.37 [-0.65, -0.10] weeks).  
Despite some previous study findings that suggested prenatal exposure to certain 
PFAS was negatively associated with birth weight, a recent meta-analysis (Steenland et 
al., 2018) determined that when blood was drawn close to conception or early in 
pregnancy, there was little evidence of an association between prenatal PFOA exposure 
(they did not examine exposure to other PFAS) and birth weight (β = -1.0 [-2.4, 0.4] 
grams). Steenland et al. (2018) suggested that since PVE and GFR increase throughout 
and peak towards the end of pregnancy, collecting serum samples later in pregnancy can 
lead to a decrease in maternal serum PFAS concentrations. Low PVE and GFR are 
associated with decreased birth weight and increased PFAS in serum (Steenland et al., 
2018). Thus, studies that collected blood samples later in pregnancy and observed 
associations between PFOA and birth weight may be confounded by PVE or GFR. In our 
study, approximately a third of study participants had maternal serum collected after the 
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1st trimester, which could lead to potential confounding by PVE or GFR, as evidenced by 
the attenuated associations in analyses restricted to 1st trimester serum collection. 
Although two-thirds of our maternal serum samples were collected in the 1st trimester, 
and we control for gestational age at blood draw in our models, our results for the 
associations between birth weight and PFAS could have residual confounding by 
physiology, because we did not directly measure PVE or GFR. 
 Results for the association between maternal serum PFAS concentrations and 
birth weight for gestational age z-score were mostly null. This is mirrored in the Maternal 
Infant Research on Environmental Chemicals (MIREC) Study of 1,705 mother-infant 
pairs that found a weak inverse association in Bayesian hierarchical modeling between 
birth weight for gestational age z-score and prenatal PFOA with the null value included 
in the credible interval (log10 β = -0.10, 95% credible interval [-0.34, 0.13]) (Ashley-
Martin et al., 2017). Similarly, among Project VIVA participants (n=1,645), researchers 
found only a weak inverse association between birth weight for gestational age z-score 
and an IQR increase in PFOS (β = -0.04 [-0.08, 0.01] points) and PFNA (β = -0.06 [-0.11, 
-0.01] points) (Sagiv et al., 2017). Because our overall results suggest that prenatal serum 
PFAS concentrations are negatively associated with gestational age at birth, with less 
evidence of an association between PFAS and birth weight, it is plausible that the weak 






We observed that the estimated effect of the PFAS mixture index on gestational 
age at birth among male offspring was of greater magnitude and higher precision than the 
estimate for females, and that males were more susceptible to adverse effects of the 
PFAS mixture index than female offspring for all birth outcomes. n-PFOA appeared to be 
the strongest contributor to the PFAS mixture index effect between exposure and birth 
outcomes among male offspring. Few studies that we are aware of found sex differences 
similar to our findings, and each only for a specific PFAS and not for the other individual 
PFAS they examined. One study with similar mean concentrations of PFAS to ours, 
reported a sex difference for PFOS, with males having an odds ratio (OR) of 1.9 (95% CI 
= 0.98, 3.68) of being low birth weight for every doubling of PFOS in 1st trimester 
maternal plasma, while females had an OR of 0.73 (p-value for sex interaction = 0.01) 
(Manzano-Salgado et al., 2017).  Another study with similar PFOA, but higher PFOS 
concentrations than measured in our study found a significant difference in the 
association between birth weight among male offspring (β = -526 [-828, -222] grams) for 
each ln-unit increase in PFOA compared to female offspring (β = -156 [-541, 228] grams) 
(p-value for sex interaction = 0.046) (Lauritzen et al., 2017). A third study with higher 
concentrations of PFOS and similar concentrations of PFNA to those measured in our 
study found a slight difference in the association between maternal serum PFOS and 
PFNA concentrations and gestational age at birth between males and females (β = -0.19 
versus 0.01 weeks for PFOS and β = -0.19 versus 0.03 for PFNA for males compared to 
females, respectively) (Sagiv et al., 2017). Most other previous studies examining sex-
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specific effects of prenatal PFAS exposure on birth weight did not find sex differences 
(Sagiv et al., 2017; Shoaff et al., 2018; Starling et al., 2017).  
 
Potential mechanisms for associations between PFAS and birth outcomes 
Although the exact mechanisms are unknown, several studies have examined 
potential mechanisms for the association between PFAS and birth outcomes. A recent 
study observed an inverse association between some prenatal PFAS exposures and 
maternal fasting glucose concentrations in mid-pregnancy; the authors suggested that 
reduced availability of maternal glucose could negatively impact the developing fetus 
(Starling et al., 2017). Another study reported associations between PFOS exposure and 
decreased maternal triglycerides and polyunsaturated fatty acids (PUFAs), which are 
important sources of energy for the developing fetus. A decrease in triglycerides and 
PUFAs could impair growth and development, thus negatively impacting birth outcomes 
(Kishi et al., 2015). Maternal PFOS exposure was inversely associated with 
glucocorticoids in another study, which are necessary for fetal development including 
lung and heart maturation during pregnancy, and could potentially lead to an inverse 
association between PFAS and birth outcomes (Goudarzi et al., 2017). PFAS exposure 
was found to be associated with altered thyroid hormone levels in some previous studies, 
which could impact thyroid function, which is necessary for development, and lead to 
potential negative impacts on birth outcomes (de Cock et al., 2014; Y. Wang et al., 2014). 
Finally, an in vitro study determined that certain PFAS disrupted estrogen and androgen 
receptors, with a mixture of PFAS having more than an additive effect on antagonization 
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of the androgen receptor (Kjeldsen & Bonefeld-Jørgensen, 2013). Previous studies have 
demonstrated that androgen is associated with birth weight (F. de Zegher et al., 1998; 
Francis de Zegher et al., 1999). Although a mechanism has yet to be determined for the 
sex-specific association that we observed between prenatal serum PFAS concentrations 
and birth outcomes, a possible explanation is that prenatal PFAS exposure may alter 
androgen and estrogen levels in the developing fetus. An alteration of these sex hormones 
could lead to different effects in male versus female offspring.  
 
Predictors of maternal serum PFAS concentrations 
Similar to previous studies (ATSDR, 2018; Calafat et al., 2007; Manzano-Salgado 
et al., 2017; Sagiv et al., 2015, 2017; Siebenaler et al., 2017; Starling et al., 2017), many 
PFAS were detected in study participants, and PFOS and PFOA had the highest 
concentrations. As also observed in previous studies (Boronow et al., 2019; CDC, 2019), 
there was some variability in maternal serum PFAS concentrations between racial/ethnic 
groups, with non-Hispanic whites trending towards higher PFAS concentrations than 
non-Hispanic black and Hispanic mothers. With the exception of those who had a high 
school diploma or GED, mothers with a college degree or higher tended to have higher 
serum concentrations of certain PFAS compared to those with less education. This is 
mostly consistent with previous studies that have noted a clear trend of increasing 
concentrations of certain PFAS with increased education (Calafat et al., 2007; Sagiv et 
al., 2015). Consistent with previous studies, parous mothers in our study had lower 
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concentrations of serum PFAS, on average, than nulliparous mothers, likely due to 
placental transfer during pregnancy and/or excretion of PFAS through breastmilk (Kishi 
et al., 2015; Sagiv et al., 2015). Finally, similar to previous findings (Mamsen et al., 
2019; Sagiv et al., 2017), we observed that PFAS concentrations generally decreased 
with increasing week of pregnancy during which maternal serum samples were collected, 
which may be due to PVE and increased GFR. 
  
Strengths and limitations 
A major strength of this study is that we estimated the effect of a PFAS mixture 
on birth outcomes, which reduces the potential for mutual confounding by other PFAS 
and allows us to determine which PFAS contribute most to the PFAS mixture index 
effect on birth outcomes. Another strength of this study is the ethnic/racial diversity of 
the participant population, which allows us to generalize our results to a broader 
population. We were able to quantify maternal serum concentrations of both linear and 
branched isomers of PFOS and PFOA, which to our knowledge has not been examined in 
previous studies of PFAS and birth outcomes. We collected most of the maternal serum 
samples analyzed for prenatal PFAS in the 1st trimester (67.2%), which reduces the 
impact of confounding by physiology. Finally, we have information on several different 
prenatal factors, allowing us to control for many potential confounders.  
A major limitation of this study is the relatively small sample size, which limited 
the precision of our estimates and precluded the use of more flexible statistical methods 
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for mixtures (e.g., Bayesian kernel machine regression). WQS may not be the most 
appropriate method of examining the cumulative effect of exposure to PFAS on birth 
outcomes for all of our analyses, given that we found that the assumption that the 
components all act in the same direction was violated for some of the models, particularly 
among females. Although we largely collected serum early in pregnancy, and controlled 
for gestational age at blood draw in our models, a potential limitation of our study is that 
PVE and changes in GFR during pregnancy may confound the association between 
prenatal PFAS and birth weight (Bach et al., 2015; Steenland et al., 2018; Verner et al., 
2015). We did not measure albumin or creatinine (potential markers for PVE and GFR, 
respectively) as other studies (e.g., Project VIVA) have done (Sagiv et al., 2017), and 
thus could not control for those measures. We did not have data on some potentially 
important confounders of the association between PFAS and birth outcomes, including 
interpregnancy interval, income, and diet, which could potentially affect PFAS exposure, 
birth weight, and gestational age at birth (Sagiv et al., 2015). We did control for 
race/ethnicity, parity, maternal age, and maternal education, which may serve as proxies 




We found evidence of an inverse association between the PFAS mixture index 
and gestational age at birth, particularly among male offspring. The association was 
driven by n-PFOA. Associations between maternal serum PFAS and the other birth 
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outcomes were not as precise and potentially confounded by physiology. Our finding of a 
sex-specific effect of PFAS on birth outcomes should be confirmed in larger studies that 
also evaluate interactive effects and control for PVE and GFR.    
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Table 3.1. Characteristics of mothers and infants participating in the TESIE birth outcomes 
study, central North Carolina, 2009–2011 (N=134)  
Participant characteristic N (%) Mean (SD) Range 
 Maternal age at delivery (years)  29.6 (5.6) 19 – 44 
     <27 years 44 (32.8)   
     27–32 years 47 (35.1)   
     33+ years 43 (32.1)   
 Maternal race/ethnicity    
     White, Non-Hispanic 60 (44.8)   
     Black, Non-Hispanic 54 (40.3)   
     Hispanic 20 (14.9)   
Marital Status    
     Never Married 33 (24.6)   
     Married 71 (53.0)   
     Living with Partner 21 (15.7)   
     Divorced/Separated 3 (2.2)   
     Other 3 (2.2)   
     Missing 3 (2.2)   
 Maternal education    
     Some College or College Graduate 82 (61.2)   
     High School Graduate/GED 21 (15.7)   
     <High School 28 (20.9)   
     Missing 3 (2.2)   
 Parity (previous births)  1 (1.2) 0 – 5 
     0 47 (35.1)   
     1+ 86 (64.2)   
     Missing 1 (0.7)   
Maternal BMI at LMP (kg/m2)  27.3 (7.0) 16.2 – 58.5  
     Underweight or normal (<25) 56 (41.8)   
     Overweight or obese (≥25) 77 (57.5)   
     Missing 1 (0.7)   
 Maternal prenatal smoking    
     Yes 21 (15.7)   
     No 111 (82.8)   
     Missing 2 (1.5)   
 Offspring Sex    
     Male 75 (56.0)   
     Female 59 (44.0)   
 Gestational age at blood draw (weeks)  12.6 (4.8) 5.6 – 29.6 
     1st trimester 90 (67.2)   
     2nd trimester 41 (30.6)   
     3rd trimester 3 (2.3)   
 Gestational age at birth (weeks)  39.2 (2.0) 29.9 – 41.7 
     <37 weeks 11 (8.2)   
     37+ weeks 123 (91.8)   
Birth Weight for Gestational Age Z-Score 
(points) 
 0.30 (1.1) -1.9 – 4.0 
     <0 53 (39.6)   
     >0 77 (57.5)   
     Missing 4 (3.0)   
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Birth Weight (grams)  3,337 (616) 1,490 – 5,422 
     <2,500 grams 11 (8.2)   
     ≥2,500 grams 119 (88.8)   
     Missing 4 (3.0)   
GED = General Equivalency Diploma, BMI = body mass index = kg/m2, LMP = last menstrual period 
 
Table 3.2. Maternal serum concentrations of PFAS (ng/mL) among TESIE birth outcomes 
study participants (2009–2011) and among U.S. Females (2009–2010) 
  TESIE Study Participants NHANES* 
PFAS N (%) >LOD† IQR GM (95% CI) GM (95% CI) 
PFOS 134 (100) 3.2 5.8 (5.3, 6.3) 5.7 (5.6, 5.8) 
n-PFOS 134 (100) 2.8 4.3 (4.0, 4.7) N/A 
PFOA 134 (100) 1.3 1.9 (1.7, 2.0) 2.2 (2.1, 2.3) 
n-PFOA 134 (100) 1.2 1.8 (1.6, 1.9) N/A 
Sm-PFOS 134 (100) 1.0 1.4 (1.2, 1.5) N/A 
PFHxS 134 (100) 0.70 0.95 (0.86, 1.0) 0.86 (0.77, 0.96) 
PFNA 134 (100) 0.40 0.77 (0.72, 0.83) 1.0 (0.91, 1.1) 
PFDA 119 (88.8) 0.10 0.22 (0.20, 0.25) 0.24 (0.15, 0.34) 
Sb-PFOA 52 (38.8) N/A N/A N/A 
MeFOSAA 27 (20.1) N/A N/A 0.16 (0.07, 0.25) 
EtFOSAA 1 (0.7) N/A N/A <LOD 
FOSA 0 (0.0) N/A <LOD <LOD 
Note: PFAS = per- and polyfluoroalkyl substances; PFOS = linear and branched PFOS combined; n-
PFOS = linear PFOS; Sm-PFOS = branched PFOS; PFOA = linear and branched PFOA combined; n-
PFOA = linear PFOA;  
Sb-PFOA = branched PFOA; N/A = Not available; LOD = limit of detection; IQR = Interquartile 
Range 
GM = geometric mean; 95% CI = 95% confidence interval 
*Serum PFAS concentrations from U.S. NHANES females aged 19 to 44 years, 2009–2010.  
NHANES= National Health and Nutrition Examination Survey (CDC, 2019) 
†LOD = 0.1 ng/mL 
 
Table 3.3. Spearman correlations between TESIE birth outcomes study maternal serum 
PFAS concentrations, central North Carolina, 2009–2011 (N=134) 
 n-PFOS n-PFOA Sm-PFOS PFHxS PFNA PFDA 
n-PFOS 1.0 0.57 0.75 0.53 0.59 0.48 
n-PFOA  1.0 0.63 0.61 0.68 0.40 
Sm-PFOS   1.0 0.64 0.48 0.37 
PFHxS    1.0 0.37 0.08 
PFNA     1.0 0.66 





Table 3.4. Estimated average weights from adjusted Weighted Quantile Sum regression and rank of importance for contributions 
of each PFAS to overall association of PFAS on birth outcomesa among TESIE study participants, central North Carolina, 2009–
2011  
  Gestational Age at Birth 
 All Offspring (n=134) Male Offspring (n=75)   Female Offspring (n=59) 
 β=-3.2 (-6.1, -0.31)               β=-6.2 (-11.1, -1.3)             β=-0.82 (-4.3, 2.6) 
PFAS Weight (Rank)  Weight (Rank) Weight (Rank) 
n-PFOS 0.09 (5)  0.06 (5) 0.04 (6) 
n-PFOA 0.32 (1)  0.42 (1) 0.16 (3) 
Sm-PFOS 0.14 (4)  0.27 (2) 0.13 (4) 
PFHxS 0.19 (2)  0.13 (3) 0.36 (1) 
PFNA 0.17 (3)  0.06 (4) 0.25 (2) 
PFDA 0.08 (6)  0.05 (6) 0.05 (5) 
  Birth Weight 
 All Offspring (n=130) 
β=-78.7 (-219, 61.3) 
Male Offspring (n=74) 
               β=-191 (-393, 10.6) 
 
PFAS Weight (Rank)  PFAS Weight (Rank) 
n-PFOS 0.04 (6)  0.02 (6) 0.04 (6) 
n-PFOA 0.54 (1)  0.43 (1) 0.54 (1) 
Sm-PFOS 0.06 (4)  0.11 (3) 0.06 (4) 
PFHxS 0.05 (5)  0.08 (5) 0.05 (5) 
PFNA 0.21 (2)  0.28 (2) 0.21 (2) 
PFDA 0.11 (3)  0.09 (4) 0.11 (3) 
  Birth weight for Gestational Age Z-Score 
 All Offspring (n=130) 
β=-0.03 (-0.29, 0.23) 
Male Offspring (n=74) 
               β=-0.11 (-0.44, 0.23) 
 All Offspring (n=130) 
β=-0.03 (-0.29, 0.23) 
PFAS Weight (Rank)  PFAS Weight (Rank) 
n-PFOS 0.11 (4)  0.18 (4) 0.11 (4) 
n-PFOA 0.15 (3)  0.22 (3) 0.15 (3) 
Sm-PFOS 0.24 (2)  0.27 (1) 0.24 (2) 
PFHxS 0.30 (1)  0.26 (2) 0.30 (1) 
PFNA 0.08 (6)  0.007 (6) 0.08 (6) 
PFDA 0.11 (5)  0.07 (5) 0.11 (5) 





Table 3.5. Associations between maternal serum PFAS concentrations (ng/mL) and predictorsa, in mutually adjusted models, 
among TESIE study participants, central North Carolina, 2009–2011 (N=134) 
 Percent Change  (95% Confidence Interval) 
Characteristic n-PFOS n-PFOA Sm-PFOS PFHxS PFNA PFDA 

















































































































PFAS = per- and polyfluoroalkyl substances; HS = high school; GED = General Equivalency Diploma 
aAll models mutually adjusted for mother’s age at delivery, race/ethnicity, education, smoking status during pregnancy, BMI at last menstrual period, 
parity, and gestational age of fetus at blood draw. 




Figure 3.1. Adjusteda associations of A. gestational age at birth (days) and B. birth 
weight (grams) per IQR increase in maternal serum PFAS for individual PFAS 
compounds and per quartile increase in WQS index, among all offspring1, male 
offspring2, and female offspring3 participants of the TESIE birth outcomes study, 
Central North Carolina, 2009–2011 
A.
 
 aAdjusted for mother’s age at delivery, race, education, parity, body mass index at last menstrual 
period, prenatal smoking, and gestational age at blood draw, and gestational age at birth 
1n = 134; 2n = 75; 3n = 59 
 B. 
 
aAdjusted for mother’s age at delivery, race, education, parity, body mass index at last menstrual 
period, prenatal smoking, and gestational age at blood draw, and gestational age at birth 
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Figure 3.1. (Continued) Adjusted
a
 associations of change in C. birth weight for gestational 
age z-score (points) with change in maternal serum PFAS IQR for individual PFAS 




, and female 
offspring
3




aAdjusted for mother’s age at delivery, race, education, parity, body mass index at last menstrual 
period, prenatal smoking, and gestational age at blood draw, and gestational age at birth 
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Table S3.1. Associations between maternal serum PFAS (per IQRa increase for individual PFAS, or per quartile 
increase in WQS PFAS mixture index) and gestational age at birth (days), birth weight (grams), and birth weight for 
gestational age z-score (points) for participants of the TESIE birth outcomes study, central North Carolina, 2009–2011 
 Gestational Age at Birth 
 All Offspring (n=134) Male Offspring (n=75) Female Offspring (n=59) 
 Unadjusted Adjustedc Unadjusted Adjustedc Unadjusted Adjustedc 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -0.36 (-1.7, 0.95) -0.30 (-1.7, 1.1) 0.28 (-1.1, 1.7) 0.18 (-1.5, 1.9) -2.7 (-5.4, 0.06) -2.5 (-5.8, 0.76) 
n-PFOA -0.49 (-2.2, 1.2) -2.2 (-4.2, -0.25) 0.55 (-1.5, 2.6) -3.6 (-6.6, -0.70) -2.0 (-4.8, 0.75) -2.8 (-5.9, 0.19) 
Sm-PFOS -0.14 (-1.4, 1.1) -0.44 (-2.1, 1.2) 0.35 (-1.0, 1.7) -0.59 (-2.6, 1.4) -1.7 (-4.5, 1.1) -2.8 (-6.3, 0.67) 
PFHxS 0.59 (-0.66, 1.9) 0.47 (-0.98, 1.9) 0.51 (-0.88, 1.9) 0.19 (-1.6, 2.0) 0.85 (-1.7, 3.4) 1.6 (-1.3, 4.5) 
PFNA 0.41 (-0.80, 1.6) -0.08 (-1.4, 1.3) 0.19 (-2.1, 2.5) -2.2 (-5.1, 0.78) 0.48 (-1.1, 2.0) 0.29 (-1.5, 2.0) 
PFDA 0.11 (-0.51, 0.72) 0.11 (-0.62, 0.84) 0.18 (-0.45, 0.81) 0.23 (-0.69, 1.2) -0.23 (-1.7, 1.3) -0.78 (-2.3, 0.75) 
WQS -2.1 (-4.7, 0.53) -3.2 (-6.1, -0.31) -3.2 (-7.4, 1.0) -6.2 (-11.1, -1.3) -0.69 (-3.6, 2.2) -0.82 (-4.3, 2.6) 
 Birth Weight 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
 Unadjusted Adjustedc Unadjusted Adjustedc Unadjusted Adjustedc 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -52.4 (-136, 31.6) -48.4 (-135, 38.7) -68.1 (-168, 32.2) -89.2 (-196, 17.4) 16.0 (-164, 196) -89.2 (-196, 17.4) 
n-PFOA -87.0 (-192, 17.8) -79.2 (-196, 37.9) -61.8 (-209, 85.4) -134 (-314, 45.5) -106 (-264, 51.2) -38.3 (-198, 121) 
Sm-PFOS -34.9 (-117, 46.9) -38.3 (-135, 57.9) -32.7 (-131, 65.4) -88.3 (-213, 36.6) -37.0 (-207, 133) 7.1 (-171, 185) 
PFHxS 3.3 (-80.2, 86.9) 13.1 (-75.0, 101) 4.7 (-102, 112) -14.0 (-135, 107) -1.7 (-149, 145) 19.2 (-124, 162) 
PFNA -102 (-208, 4.3) 35.0 (-48.0, 118) -84.3 (-229, 60.1) -185 (-341, -29.9) 77.0 (-18.8, 173) 100 (18.4, 182) 
PFDA 14.2 (-25.3, 53.6) -3.8 (-47.3, 39.8) 18.7 (-27.6, 65.0) -12.5 (-70.6, 45.5) -2.0 (-87.1, 83.1) 16.8 (-60.0, 93.5) 
WQS -59.3 (-181, 62.5) -78.7 (-219, 61.3) -87.3 (-262, 87.5) -191 (-393, 10.6) -26.1 (-183, 131) 13.7 (-177, 204) 
 Birth weight for Gestational Age Z-Score 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
 Unadjusted Adjustedc Unadjusted Adjustedc Unadjusted Adjustedc 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
PFAS = per- and polyfluoroalkyl substances; CI = Confidence Interval 
aIQR (ng/mL) for n-PFOS=2.8, n-PFOA=1.2, Sm-PFOS=1.0, PFHxS = 0.70, PFNA = 0.40, PFDA = 0.10 
bRobust Regression Analysis 





Table S3.1 (Continued). Associations between maternal serum PFAS (per IQRa increase for individual PFAS, or per 
quartile increase in WQS PFAS mixture index) and gestational age at birth (days), birth weight (grams), and birth 
weight for gestational age z-score (points) for participants of the TESIE birth outcomes study, central North Carolina, 
2009–2011 
 Birth weight for Gestational Age Z-Score 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
 Unadjusted Adjustedc Unadjusted Adjustedc Unadjusted Adjustedc 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -0.10 (-0.28, 0.07) -0.11 (-0.29, 0.07) -0.11 (-0.29, 0.08) -0.13 (-0.33, 0.06) 0.09 (-0.32, 0.50) 0.11 (-0.34, 0.56) 
n-PFOA -0.03 (-0.25, 0.19) -0.02 (-0.27, 0.22) 0.05 (-0.23, 0.32) 0.04 (-0.30, 0.37) -0.13 (-0.50, 0.23) -0.05 (-0.46, 0.37) 
Sm-PFOS -0.04 (-0.20, 0.13) -0.05 (-0.25, 0.15) -0.01 (-0.19, 0.17) -0.03 (-0.26, 0.20) -0.05 (-0.44, 0.34) 0.04 (-0.43, 0.51) 
PFHxS -0.03 (-0.20, 0.13) -0.03 (-0.21, 0.14) 0.006 (-0.18, 0.19) -0.003 (-0.21, 0.20) -0.09 (-0.42, 0.25) -0.09 (-0.46, 0.29) 
PFNA 0.11 (-0.05, 0.27) 0.07 (-0.09, 0.24) 0.08 (-0.16, 0.32) -0.04 (-0.29, 0.22) -0.18 (-0.56, 0.20) 0.01 (-0.46, 0.48) 
PFDA 0.05 (-0.04, 0.13) 0.003 (-0.09, 0.09) 0.05 (-0.03, 0.14) -0.01 (-0.12, 0.09) 0.04 (-0.15, 0.24) 0.05 (-0.15, 0.24) 
WQS -0.09 (-0.30, 0.12) -0.03 (-0.29, 0.23) -0.11 (-0.39, 0.16) -0.11 (-0.44, 0.23) -0.07 (-0.41, 0.27) -0.009 (-0.42, 0.40) 
PFAS = per- and polyfluoroalkyl substances; CI = Confidence Interval 
aIQR (ng/mL) for n-PFOS=2.8, n-PFOA=1.2, Sm-PFOS=1.0, PFHxS = 0.70, PFNA = 0.40, PFDA = 0.10 
bRobust Regression Analysis 







Table S3.2. Sensitivity Analysis: Associations between maternal serum PFAS (per IQRa increase for individual PFAS, or per 
quartile increase in WQS PFAS mixture index) and gestational age at birth (days), birth weight (grams), and birth weight for 
gestational age z-score (points), comparing all participants to those that had serum samples collected during the 1st trimester for 
participants of the TESIE birth outcomes study, central North Carolina, 2009–2011 
 Gestational Age at Birth 
 All Offspring1 Male Offspring3 Female Offspring5 
 All Participantsb 1st Trimest Serumb All Participantsb 1st Trimest Serumb All Participantsb 1st Trimest Serumb 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -0.30 (-1.7, 1.1) -0.27 (-2.2, 1.7) 0.18 (-1.5, 1.9) 0.15 (-2.3, 2.6) -2.5 (-5.8, 0.76) -2.5 (-6.6, 1.7) 
n-PFOA -2.2 (-4.2, -0.25) -4.0 (-6.7, -1.4) -3.6 (-6.6, -0.70) -5.6 (-9.3, -2.0) -2.8 (-5.9, 0.19) -3.6 (-8.0, 0.68) 
Sm-PFOS -0.44 (-2.1, 1.2) -0.46 (-2.3, 1.4) -0.59 (-2.6, 1.4) -0.97 (-3.3, 1.4) -2.8 (-6.3, 0.67) -2.5 (-7.1, 2.1) 
PFHxS 0.47 (-0.98, 1.9) 0.83 (-0.89, 2.6) 0.19 (-1.6, 2.0) 0.10 (-2.1, 2.3) 1.6 (-1.3, 4.5) 1.4 (-2.6, 5.4) 
PFNA -0.08 (-1.4, 1.3) -0.63 (-2.6, 1.3) -2.2 (-5.1, 0.78) -5.3 (-9.6, -0.88) 0.29 (-1.5, 2.0) -0.88 (-4.8, 3.1) 
PFDA 0.11 (-0.62, 0.84) -0.14 (-1.1, 0.83) 0.23 (-0.69, 1.2) -0.58 (-1.8, 0.63) -0.78 (-2.3, 0.75) -1.5 (-3.6, 0.69) 
WQS -3.2 (-6.1, -0.31) -3.0 (-6.2, 0.26) -6.2 (-11.1, -1.3) -6.8 (-12.1, -1.4) -0.82 (-4.3, 2.6) -1.7 (-6.8, 3.5) 
 Birth weight 
 All Offspring2 Male Offspring4 Female Offspring6 
 All Participantsb 1st Trimest Serumb All Participantsb 1st Trimest Serumb All Participantsb 1st Trimest Serumb 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -48.4 (-135, 38.7) -14.5 (-125, 95.5) -89.2 (-196, 17.4) -40.9 (-174, 91.8) -89.2 (-196, 17.4) -40.9 (-174, 172) 
n-PFOA -79.2 (-196, 37.9) -104 (-249, 42.2) -134 (-314, 45.5) -146 (-335, 43.0) -38.3 (-198, 121) -26.1 (-240, 196) 
Sm-PFOS -38.3 (-135, 57.9) -17.6 (-121, 85.7) -88.3 (-213, 36.6) -67.1 (-186, 51.6) 7.1 (-171, 185) 52.0 (-157, 143) 
PFHxS 13.1 (-75.0, 101) 41.0 (-55.3, 137) -14.0 (-135, 107) -45.1 (-173, 83.1) 19.2 (-124, 162) -27.0 (-197, 261) 
PFNA 35.0 (-48.0, 118) 29.7 (-79.0, 138) -185 (-341, -29.9) -82.2 (-298, 134) 100 (18.4, 182) 86.6 (-22.8, 188) 
PFDA -3.8 (-47.3, 39.8) 15.9 (-38.3, 70.2) -12.5 (-70.6, 45.5) 35.6 (-32.7, 104) 16.8 (-60.0, 93.5) 84.4 (-3.0, 91.8) 
WQS -78.7 (-219, 61.3) -34.2 (-203, 135) -191 (-393, 10.6) -218 (-448, 11.6) 13.7 (-177, 204) 25.6 (-181, 232) 
PFAS = per- and polyfluoroalkyl substances; CI = Confidence Interval;  
aIQR (ng/mL) for n-PFOS=2.8 and 2.7, n-PFOA=1.2 and 1.4, Sm-PFOS=1.0 and 1.0, PFHxS = 0.70 and 0.70, PFNA = 0.40 and 0.50, PFDA = 
0.10 and 0.10 for all and 1st trimester serum participants, respectively 
bAdjusted for mother’s age at delivery, race, education, parity, body mass index at last menstrual period, prenatal smoking, and gestational age at 
blood draw 
1n=134 for All participants and 90 for participants with serum collected in the 1st trimester; 2n=130 for All participants and 88 for participants 




3n=75 for All male participants and 49 for male participants with serum collected in the 1st trimester; 4n=74 for All male participants and 48 for 
male participants with serum collected in the 1st trimester 
5n=59 for All female participants and 40 for female participants with serum collected in the 1st trimester; 6n=56 for All female participants and 40 
for female participants with serum collected in the 1st trimester 
 
Table S3.2 (Continued). Sensitivity Analysis: Associations between maternal serum PFAS (per IQRa increase for individual PFAS, 
or per quartile increase in WQS PFAS mixture index) and gestational age at birth (days), birth weight (grams), and birth weight 
for gestational age z-score (points), comparing all participants to those that had serum samples collected during the 1st trimester 
for participants of the TESIE birth outcomes study, central North Carolina, 2009–2011 
 Birth weight for Gestational Age Z-Score 
 All Offspring2 Male Offspring4 Female Offspring6 
 All Participantsb 1st Trimest Serumb All Participantsb 1st Trimest Serumb All Participantsb 1st Trimest Serumb 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -0.11 (-0.29, 0.07) -0.001 (-0.22, 0.22) -0.13 (-0.33, 0.06) -0.05 (-0.32, 0.25) 0.11 (-0.34, 0.56) 0.13 (-0.12, 0.63) 
n-PFOA -0.02 (-0.27, 0.22) 0.02 (-0.29, 0.32) 0.04 (-0.30, 0.37) 0.03 (-0.38, 0.53) -0.05 (-0.46, 0.37) 0.04 (-0.59, 0.60) 
Sm-PFOS -0.05 (-0.25, 0.15) 0.03 (-0.18, 0.23) -0.03 (-0.26, 0.20) -0.04 (-0.28, 0.23) 0.04 (-0.43, 0.51) 0.08 (-0.57, 0.31) 
PFHxS -0.03 (-0.21, 0.14) 0.07 (-0.12, 0.26) -0.003 (-0.21, 0.20) -0.01 (-0.26, 0.21) -0.09 (-0.46, 0.29) -0.13 (-0.48, 0.65) 
PFNA 0.07 (-0.09, 0.24) 0.12 (-0.10, 0.34) -0.04 (-0.29, 0.22) 0.07 (-0.38, 0.45) 0.01 (-0.46, 0.48) 0.003 (-0.50, 0.59) 
PFDA 0.003 (-0.09, 0.09) 0.03 (-0.08, 0.14) -0.01 (-0.12, 0.09) 0.11 (-0.03, 0.21) 0.05 (-0.15, 0.24) 0.14 (-0.38, 0.63) 
WQS -0.03 (-0.29, 0.23) 0.05 (-0.28, 0.37) -0.11 (-0.44, 0.23) -0.19 (-0.60, 0.21) -0.009 (-0.42, 0.40) 0.18 (-0.32, 0.68) 
PFAS = per- and polyfluoroalkyl substances; CI = Confidence Interval;  
aIQR (ng/mL) for n-PFOS=2.8 and 2.7, n-PFOA=1.2 and 1.4, Sm-PFOS=1.0 and 1.0, PFHxS = 0.70 and 0.70, PFNA = 0.40 and 0.50, PFDA = 
0.10 and 0.10 for all and 1st trimester serum participants, respectively 
bAdjusted for mother’s age at delivery, race, education, parity, body mass index at last menstrual period, prenatal smoking, and gestational age at 
blood draw 
1n=134 for All participants and 90 for participants with serum collected in the 1st trimester; 2n=130 for All participants and 88 for participants 
with serum collected in the 1st trimester 
3n=75 for All male participants and 49 for male participants with serum collected in the 1st trimester; 4n=74 for All male participants and 48 for 
male participants with serum collected in the 1st trimester 
5n=59 for All female participants and 40 for female participants with serum collected in the 1st trimester; 6n=56 for All female participants and 40 
for female participants with serum collected in the 1st trimester 
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Table S3.3. Sensitivity Analysis: Associations between maternal serum PFAS (per 
IQRa increase for individual PFAS, or per quartile increase in WQS PFAS mixture 
index) and birth weight (grams), comparing models adjusted and not adjusted for 
gestational age at birth for participants of the TESIE birth outcomes study, central 
North Carolina, 2009–2011 
 Birth Weightb 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
PFAS β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -48.4 (-135, 38.7) -89.2 (-196, 17.4) -89.2 (-196, 17.4) 
n-PFOA -79.2 (-196, 37.9) -134 (-314, 45.5) -38.3 (-198, 121) 
Sm-PFOS -38.3 (-135, 57.9) -88.3 (-213, 36.6) 7.1 (-171, 185) 
PFHxS 13.1 (-75.0, 101) -14.0 (-135, 107) 19.2 (-124, 162) 
PFNA 35.0 (-48.0, 118) -185 (-341, -29.9) 100 (18.4, 182) 
PFDA -3.8 (-47.3, 39.8) -12.5 (-70.6, 45.5) 16.8 (-60.0, 93.5) 
WQS -78.7 (-219, 61.3) -191 (-393, 10.6) 13.7 (-177, 204) 
 Birth Weightb  Additionally Adjusted for Gestational Age at Birth 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
PFAS β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -38.1 (-113, 36.7) -59.2 (-139, 20.8) 55.9 (-136, 248) 
n-PFOA -2.4 (-108, 104) 11.9 (-133, 157) -13.0 (-191, 165) 
Sm-PFOS -15.3 (-98.3, 67.7) -17.7 (-112, 76.4) 33.0 (-166, 232) 
PFHxS -14.3 (-87.6, 59.0) -7.3 (-92.0, 77.5) -47.4 (-212, 117) 
PFNA 27.5 (-42.3, 97.4) -38.2 (-154, 77.3) -28.8 (-228, 171) 
PFDA 0.15 (-37.3, 37.6) -8.5 (-52.0, 35.0) 16.9 (-67.0, 101) 
WQS -9.8 (-125, 106) -53.2 (-212, 106) -9.6 (-181, 161) 
PFAS = per- and polyfluoroalkyl substance; CI = Confidence Interval 
aIQR (ng/mL) for n-PFOS=2.8, n-PFOA=1.2, Sm-PFOS=1.0, PFHxS = 0.70, PFNA = 0.40, PFDA = 
0.10 
bAdjusted for mother’s age at delivery, race, education, parity, body mass index at last menstrual 




Table S3.4. Sensitivity Analysis: Associations between maternal serum PFAS (per IQRa increase for individual PFAS, or per quartile 
increase in WQS PFAS mixture index) and gestational age at birth (days), birth weight (grams), and birth weight for gestational age z-
score (points), comparing models with individual PFAS and mutually adjusted for all PFAS for participants of the TESIE birth 
outcomes study, central North Carolina, 2009–2011 
 Gestational Age at Birth 
 All Offspring (n=134) Male Offspring (n=75) Female Offspring (n=59) 
 Individual PFASb All PFASb Individual PFASb All PFASb Individual PFASb All PFASb 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -0.30 (-1.7, 1.1) -0.41 (-2.6, 1.8) 0.18 (-1.5, 1.9) 1.6 (-1.8, 4.9) -2.5 (-5.8, 0.76) -1.2 (-5.9, 3.5) 
n-PFOA -2.2 (-4.2, -0.25) -3.6 (-6.2, -0.93) -3.6 (-6.6, -0.70) -4.2 (-9.5, 0.97) -2.8 (-5.9, 0.19) -5.0 (-10.9, 0.98) 
Sm-PFOS -0.44 (-2.1, 1.2) 0.07 (-2.5, 2.7) -0.59 (-2.6, 1.4) -1.1 (-5.0, 2.9) -2.8 (-6.3, 0.67) -1.7 (-6.4, 3.1) 
PFHXS 0.47 (-0.98, 1.9) 1.3 (-0.32, 3.0) 0.19 (-1.6, 2.0) 1.7 (-0.75, 4.1) 1.6 (-1.3, 4.5) 2.2 (-0.54, 5.0) 
PFNA -0.08 (-1.4, 1.3) 0.58 (-0.97, 2.1) -2.2 (-5.1, 0.78) -1.7 (-6.6, 3.2) 0.29 (-1.5, 2.0) 3.9 (-2.3, 10.0) 
PFDA 0.11 (-0.62, 0.84) 0.44 (-0.41, 1.3) 0.23 (-0.69, 1.2) 0.16 (-0.93, 1.2) -0.78 (-2.3, 0.75) -0.06 (-2.0, 1.9) 
 Birth Weight 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
 Individual PFASb All PFASb Individual PFASb All PFASb Individual PFASb All PFASb 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -48.4 (-135, 38.7) -91.1 (-223, 40.3) -89.2 (-196, 17.4) -145 (-347, 57.5) -89.2 (-196, 17.4) 56.3 (-203, 316) 
n-PFOA -79.2 (-196, 37.9) -176 (-336, -15.5) -134 (-314, 45.5) -227 (-558, 105) -38.3 (-198, 121) -167 (-460, 126) 
Sm-PFOS -38.3 (-135, 57.9) 28.1 (-123, 179) -88.3 (-213, 36.6) 11.6 (-226, 249) 7.1 (-171, 185) -17.2 (-283, 248) 
PFHXS 13.1 (-75.0, 101) 54.4 (-43.2, 152) -14.0 (-135, 107) 66.0 (-84.1, 216) 19.2 (-124, 162) 28.6 (-130, 187) 
PFNA 35.0 (-48.0, 118) 97.3 (4.7, 190) -185 (-341, -29.9) 147 (-157, 452) 100 (18.4, 182) 88.1 (-167, 343) 
PFDA -3.8 (-47.3, 39.8) 20.0 (-29.5, 69.5) -12.5 (-70.6, 45.5) 23.5 (-43.7, 90.7) 16.8 (-60.0, 93.5) 17.0 (-88.9, 123) 
 Birth weight for Gestational Age Z-Score 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
 Individual PFASb All PFASb Individual PFASb All PFASb Individual PFASb All PFASb 
PFAS β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
n-PFOS -0.11 (-0.29, 0.07) -0.22 (-0.51, 0.06) -0.13 (-0.33, 0.06) -0.27 (-0.61, 0.07) 0.11 (-0.34, 0.56) 0.28 (-0.34, 0.90) 
n-PFOA -0.02 (-0.27, 0.22) -0.12 (-0.47, 0.22) 0.04 (-0.30, 0.37) 0.11 (-0.44, 0.66) -0.05 (-0.46, 0.37) 0.21 (-0.63, 1.0) 
Sm-PFOS -0.05 (-0.25, 0.15) 0.10 (-0.22, 0.42) -0.03 (-0.26, 0.20) 0.15 (-0.28, 0.57) 0.04 (-0.43, 0.51) -0.09 (-0.74, 0.56) 
PFHXS -0.03 (-0.21, 0.14) 0.02 (-0.18, 0.22) -0.003 (-0.21, 0.20) 0.006 (-0.26, 0.27) -0.09 (-0.46, 0.29) -0.09 (-0.47, 0.30) 
PFNA 0.07 (-0.09, 0.24) 0.14 (-0.05, 0.33) -0.04 (-0.29, 0.22) 0.0002 (-0.35, 0.35) 0.01 (-0.46, 0.48) -0.46 (-1.3, 0.37) 
PFDA 0.003 (-0.09, 0.09) 0.03 (-0.08, 0.13) -0.01 (-0.12, 0.09) 0.02 (-0.11, 0.14) 0.05 (-0.15, 0.24) 0.04 (-0.22, 0.30) 




aIQR (ng/mL) for n-PFOS=2.8, n-PFOA=1.2, Sm-PFOS=1.0, PFHxS = 0.70, PFNA = 0.40, PFDA = 0.10 




Table S3.5. Sensitivity Analysis: Associations between maternal serum PFAS (per 
quartile increase in WQS PFAS mixture index) and gestational age at birth (days), 
birth weight (grams), and birth weight for gestational age z-score (points), 
comparing WQS components set as negative and positive for participants of the 
TESIE birth outcomes study, central North Carolina, 2009–2011 
 Gestational Age at Birth 
 All Offspring (n=134) Male Offspring (n=75) Female Offspring (n=59) 
 Adjusteda Adjusteda Adjusteda 
PFAS β (95% CI) β (95% CI) β (95% CI) 
WQS β = Negative -3.2 (-6.1, -0.31) -6.2 (-11.1, -1.3) -0.82 (-4.3, 2.6) 
WQS β = Positive -0.87 (-3.8, 2.1) -2.1 (-6.6, 2.4) 1.3 (-1.7, 4.4) 
 Birth Weight 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
 Adjusteda Adjusteda Adjusteda 
PFAS β (95% CI) β (95% CI) β (95% CI) 
WQS β = Negative -78.7 (-219, 61.3) -191 (-393, -10.6) 13.7 (-177, 204) 
WQS β = Positive -33.9 (-184, 116) -149 (-376, 78.8) 33.1 (-163, 230) 
 Birth weight for Gestational Age Z-Score 
 All Offspring (n=130) Male Offspring (n=74) Female Offspring (n=56) 
 Adjusteda Adjusteda Adjusteda 
PFAS β (95% CI) β (95% CI) β (95% CI) 
WQS β = Negative -0.03 (-0.29, 0.23) -0.11 (-0.44, 0.23) -0.009 (-0.42, 0.40) 
WQS β = Positive 0.04 (-0.22, 0.30) 0.06 (-0.31, 0.43) 0.08 (-0.32, 0.47) 
PFAS = per- and polyfluoroalkyl substances; CI = Confidence Interval 
aAdjusted for mother’s age at delivery, race, education, parity, body mass index at last menstrual 
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Per- and polyfluoroalkyl substances (PFAS) are a group of widely used chemicals that 
are resistant to stains, grease, water, and other agents. Many persist within both indoor 
and outdoor environments leading to human exposure. We examined environmental, 
demographic, and behavioral predictors of serum PFAS concentrations in children aged 
three to six years enrolled in a North Carolina-based prospective cohort study.  
Methods 
Mothers from the Newborn Epigenetics STudy (NEST) (n=73) and their 3 to 6 year old 
children (n=84) enrolled in the Toddlers Exposure to Semi-Volatile Organic Chemicals 
(SVOCs) in Indoor Environments (TESIE) study. Maternal prenatal serum samples were 
collected during pregnancy (median 11.1 weeks gestation) (2009-2011). During home 
visits (2014-2016), we collected data on child, maternal, and housing characteristics via 
questionnaire and also collected dust, handwipe, and child serum samples. A subset of 
participants were asked to wear silicone wristbands for 7 days (n=26) and/or to have a 
sorbent-impregnated passive air sampler (SIP) placed in their home for 21 days (n=17). 
We used multivariable robust regression models to estimate associations of child serum 
PFAS concentrations with predictors.  
Results 
Children that ate out (e.g., restaurant or take-out foods) at least once per week averaged 
0.41 ng/mL (95% CI=0.03, 0.79) higher serum PFOA concentrations than those that ate 
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out less frequently. Those that ate microwave popcorn more than once per month 
averaged 0.14 ng/mL (95% CI=0.004, 0.27) higher serum PFHxS concentrations than 
those that ate less. Compared to children that drank primarily well water, children that 
drank municipal water averaged 0.58 ng/mL higher serum concentrations of PFOA (95% 
CI=0.05, 1.1). PFAS detected in maternal serum was positively associated with several 
PFAS detected in child serum, including: PFHxS (β=0.13, 95% CI=0.01, 0.26) and n-
PFOS (β=0.10, 95% CI=0.02, 0.19). PFAS detected in air was positively associated with 
several PFAS detected in child serum, including: MeFOSE in air and child serum PFHxS 
(β=0.21, 95% CI=0.08, 0.35), PFOS (β=2.2, 95% CI=1.7, 2.8), n-PFOS (β=1.6, 95% 
CI=1.1, 2.1), and Sm-PFOS (β=0.64, 95% CI=0.55, 0.73); and EtFOSE in air and child 
serum Sm-PFOS (β=3.6, 95% CI=1.5, 5.8). 
Discussion 
We found that several behaviors and characteristics in children, their mothers, and their 
home environments influenced child serum PFAS concentrations. Eating habits, drinking 
water source, maternal serum PFAS concentrations, and PFAS air concentrations inside 
the home were predictive of child serum PFAS concentrations. Taken together, our 





Per- and polyfluoroalkyl substances (PFAS) are a group of over 4,500 chemicals 
that have been produced since the mid-twentieth century (Z. Wang et al., 2017). Because 
of their chemical and physical properties, PFAS are added to materials to  make them 
resistant to stains, grease, water, and other agents, and they are widely used in consumer 
and industrial products such as firefighting foams, food packaging, non-stick cookware, 
carpet, and textiles (Schultz et al., 2003). Many PFAS persist within the environment and 
bioaccumulate, with estimated human elimination half-lives of years for some PFAS 
(ATSDR, 2018). PFAS have also been detected in ground and surface water used as 
sources of drinking water (Schultz et al., 2003).  
Because of their widespread use, certain PFAS are ubiquitous in indoor and 
outdoor environments. People are exposed to them through hand-to-mouth transfer and 
inhalation or ingestion of contaminated air, food, water, or dust (ATSDR, 2018; Balk et 
al., 2019; Barton et al., 2020; Boronow et al., 2019; Brantsæter et al., 2013; Daly et al., 
2018; Fraser et al., 2012; Hansen et al., 2016; Hu et al., 2019; Pitter Gisella et al., n.d.; 
Poothong et al., 2020; Schultz et al., 2003; Timmermann et al., 2019). Additionally, 
PFAS can cross the placental barrier and are present in breast milk, exposing fetuses and 
infants (ATSDR, 2018; Manzano-Salgado et al., 2015). Occupational studies have 
demonstrated that workers in facilities that use or manufacture PFAS have the highest 
exposure levels; however, PFAS are ubiquitous in human serum from the general 
population of the United States (ATSDR, 2018; Schultz et al., 2003). Epidemiological 
studies indicate that exposure to some PFAS is associated with negative health outcomes 
 
92 
in humans, including cholesterol-, thyroid-, liver-, asthma-, immune-, reproductive-, and 
fertility-related impacts (ATSDR, 2018).  
Some previous studies have found that child characteristics such as history of 
breastfeeding, BMI, age, fast food consumption frequency, and whether or not they slept 
in a room with carpeting or a rug were predictive of concentrations of certain PFAS in 
serum or plasma (Harris et al., 2017; Kingsley et al., 2018; Winkens et al., 2017). 
Additionally, mothers’ prenatal plasma or serum PFAS concentrations, age, race, parity, 
and educational achievement, along with family and census tract income have been found 
in some studies to be predictive of children’s plasma or serum concentrations of certain 
PFAS (Harris et al., 2017; Kingsley et al., 2018).  
Since young children are still developing, they may be more susceptible to the 
negative health impacts associated with PFAS exposure than adults. Sources of exposure 
in children are generally less understood than among adults; it is therefore important to 
better characterize predictors of children’s serum PFAS concentrations. We aimed to 
identify predictors of serum PFAS concentrations in children aged three to six years 
enrolled in a North Carolina-based prospective cohort study. We examined associations 
with maternal prenatal serum, house dust, and handwipe PFAS concentrations along with 
housing, drinking water, demographic, and behavioral characteristics. In a smaller 
subsample of the study population, we also examined associations between child serum 








Figure 4.1 displays a flow chart for the study population and the varying sample 
sizes for the biological and environmental samples that we used to estimate predictors of 
child serum PFAS concentrations. Individuals previously participating in the Newborn 
Epigenetics STudy (NEST) were approached and asked to participate in the Toddlers 
Exposure to Semi-Volatile Organic Chemicals (SVOCs) in Indoor Environments 
(TESIE) study. The NEST study enrolled 2,595 pregnant women aged 18 years or older 
who received prenatal care at the Duke University Division of Maternal and Fetal 
Medicine between 2005 and 2011. The women were asked to participate in a prospective 
study examining associations between prenatal factors, epigenetic modifications, and 
health outcomes in their offspring (Hoyo et al., 2011). Mothers in the NEST study were 
administered demographic and exposure-related questionnaires and provided prenatal 
serum samples (median 11.1 weeks gestation; range 5.6 to 29.6 weeks) that were 
archived. The racial and ethnic distribution within the NEST study included 
approximately 27% non-Hispanic white, 40% non-Hispanic black, and 29% Hispanic 
participants.  
Two hundred and three NEST study participant children aged 3 to 6 years were 
recruited from 190 homes into the TESIE study between 2014 and 2016 through mailed 
letters, emails, and follow-up phone calls as previously described (Hoffman et al., 2018). 
TESIE researchers conducted a home visit with each child participant to collect further 
information. Ninety TESIE participants provided blood samples during home visits and 
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were included in our current study. As several sets of siblings were included in the TESIE 
dataset, a single sibling from each of four sets of two siblings and one set of three siblings 
was randomly selected to participate in our study while the others were excluded, leaving 
84 participants. At home visits we collected the children’s height and weight, house dust 
and handwipe samples, and information on child and home environment characteristics 
through direct observation and questionnaires (Hoffman et al., 2018). We asked a subset 
of TESIE participants to wear silicone wristbands (n=33) and/or to have passive air 
monitors placed in their homes (n=17), which were collected at home visits. Only 26 
participants returned their wristbands at the end of the sampling period. Mothers provided 
informed consent for their child’s participation in TESIE and for use of their data from 
the original NEST study. The Duke University Institutional Review Board approved 
human subject protocols. 
 
Serum Collection and Analysis 
 Certified phlebotomists collected maternal serum samples at prenatal 
appointments (median 16.6 weeks gestation, range 4.9 to 38.1 weeks gestation, during 
2009-2011) and child samples at home visits (median 4.4 years, range 3.2 to 6.1 years, 
during 2014-2016) in serum separator tubes. We processed and stored serum samples at -
20º C at Duke University until they were shipped to the Division of Laboratory Sciences 
at the Centers for Disease Control and Prevention (CDC) for analysis. As previously 
described, serum was analyzed for PFAS using an on-line solid-phase extraction method 
coupled with high-performance liquid chromatography-tandem mass spectrometry 
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(Hoffman et al., 2018; Kuklenyik et al., 2005). Sera samples were analyzed for 2-(N-
ethyl-perfluorooctane sulfonamide) acetic acid (EtFOSAA), 2-(N-methyl-perfluorooctane 
sulfonamide) acetic acid (MeFOSAA), perfluorodecanoic acid (PFDA), perfluorohexane 
sulfonic acid (PFHxS), perfluorononanoic acid (PFNA), total perfluorooctanoic acid 
(PFOA), linear and branched PFOA (n-PFOA and Sb-PFOA, respectively), total 
perfluorooctane sulfonatic acid (PFOS), linear and branched PFOS (n-PFOS and Sm-
PFOS, respectively), and perfluorooctane sulfonamide (PFOSA). The limit of detection 
(LOD) for all PFAS was 0.1 ng/mL; values below the LOD were replaced with LOD/2 
for statistical analyses (range 0% to 100% of samples <LOD for children and 0% to 
100% of samples <LOD for mothers). 
 
Handwipe Collection and Analysis 
 TESIE researchers collected handwipes during home visits with child participants 
using cotton twill wipes (4 x 4 in., MG Chemicals) pre-cleaned and wrapped in aluminum 
foil as previously described by Stapleton et al.22 The wipes were soaked with 3 mL 
isopropyl alcohol and used by gloved researchers to wipe the entire surface of both hands 
and between each finger of the child participants. Once collected, the handwipes were 
wrapped in aluminum foil and stored at -20º C until analysis. Laboratory analysis was 
previously described23, briefly, handwipes were spiked with internal standards, including 
13C 6:2 FTOH, 13C 8:2 FTOH, deuterated MeFOSE, and deuterated EtFOSE, extracted 
by sonication, concentrated, and cleaned. The samples were concentrated to ~1 mL and 
analyzed using gas chromatography-mass spectrometry (GC/MS). Recovery of the 
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internal standards was assessed and field blanks (n=14) were analyzed for quality 
assurance and quality control. Method detection limits (MDLs) were calculated as 3 
times the standard deviation of the levels in the field blanks; values below the MDL were 
replaced with the value LOD/2 for statistical analyses.  
 
Dust Collection and Analysis 
 Participants were asked not to vacuum their home for two days prior to home 
visits. At home visits, TESIE researchers used an Eureka Mighty Mite vacuum that 
included a cellulose thimble within the hose attachment to vacuum the entire exposed 
floor area of the main living room, as previously described.24 To prevent cross-
contamination, the vacuum hose was cleaned with soap and water and solvent rinsed with 
methanol between home visits.23 The thimbles containing house dust were wrapped in 
aluminum foil and stored at -20º C until analysis. Laboratory analysis was previously 
described25; briefly, dust samples were sieved prior to extraction and extracted similarly 
to the handwipes. Lab blanks and house dust standard reference material (n=5 each; SRM 
2585 National Institute of Standards and Technology (NIST), Gaithersburg, MD) were 
analyzed with each batch for quality assurance and quality control and are reported in 
Hall et al. 2020. Method detection limits (MDLs) were calculated as 3 times the standard 
deviation of the levels in the lab blanks; values below the MDL were replaced with the 




Wristband Collection and Analysis 
 During the second half of the study, child participants in the TESIE study were 
given silicone wristbands to wear as personal sampling devices for seven days. As 
previously described26, commercially available child-sized silicone wristbands 
(24hourwristbands.com, Houston, TX) were cleaned and dried in a fume hood, wrapped 
in aluminum foil, and placed in labeled 40 mL amber jars. The children were asked to 
wear the silicone wristbands continuously for seven days during all activities, including 
sleeping and bathing. After seven days, wristbands were wrapped in aluminum foil at 
home, placed back in the amber jars, and returned to our laboratory where they were 
stored at -20º C until analysis. Twenty-six of the wristbands were returned (the remainder 
(n=7) were not returned). To analyze the wristbands, they were cut using solvent-rinsed 
scissors, spiked with internal standards, extracted and the extracts were concentrated. The 
concentrated extracts were filtered to remove large particles, cleaned, concentrated to ~1 
mL and analyzed by GC/MS. Recovery of internal standards was assessed along with 
field blanks and lab blanks for quality assurance and quality control. Method detection 
limits (MDLs) were calculated as 3 times the standard deviation of the levels in the field 
blanks; values below the MDL were replaced with the value LOD/2 for statistical 
analyses.  
 
Passive Air Sampler Collection and Analysis  
 A smaller, convenience sample of willing participants (n=17) had passive air 
samplers placed in their homes during the study. At home visits, polyurethane foam 
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passive air samplers sorbent-impregnated with XAD-4 resin (SIPs), as previously 
described27,28, were placed at least 1 meter off the ground in an area that was not likely to 
be disturbed in the main living room of the participants’ homes. The SIPs were left 
undisturbed in the home and collected after 21 days and then stored at -20° C until 
analysis. SIPs were extracted, concentrated, cleaned, and analyzed by GC/MS. To 
convert the total amount of PFAS measured on the SIPs (ng) to air concentrations 
(ng/m3), we divided the total by the estimated air volume sampled during the time period 
the SIPs were in participants’ homes. We assumed that participants’ homes had an indoor 
temperature of 22° C for the duration of the 21 days that they were sampled. Prior to this 
study, we conducted a small calibration study for the SIPs in a home over the course of 
21 days. Due to changing air concentrations and a small number of data points in our 
calibration study, estimated air volumes used in this study were based on previous 
studies18,27,28, although our estimate of the air sampling rates were similar in magnitude to 
those previously estimated in the literature (e.g. 3.4 m3/day vs. 3.6 m3/day 8:2 FTOH). 
Estimated air volumes were as follows: 6:2 FTOH=65 m3, 8:2 FTOH=76 m3, 10:2 
FTOH=73 m3, EtFOSE=76 m3, MeFOSE=75 m3. 
 
Predictor Data 
 At the home visit, parents were asked to complete questionnaires containing 
information about child, parent, housing, and water characteristics. Children’s height and 
weight were measured by trained study personnel. In addition to the maternal serum, 
handwipe, dust, wristband, and air samples, we considered potential predictors of child 
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serum PFAS, including the following characteristics of the child: sex, age at serum 
collection, history of breastfeeding, body mass index (BMI), frequency of hand washing, 
frequency of eating out and eating microwave popcorn, time spent at home or in the car, 
and the season that the child’s serum sample was collected (determined using the week of 
home visit). We considered the following maternal characteristics: age at child 
participant’s birth, race, parity at the time of the child’s birth, education, and whether the 
mother was married or cohabitating. Finally, we considered the following water and 
housing-related characteristics: whether the home was supplied with municipal water or 
well water; use of any type of water filter (e.g., whole house, refrigerator, pitcher); 
consumption of usually bottled, usually tap, or a mixture of both types of water; type of 
home the child lived in (i.e., mobile home or trailer, apartment, one family attached 
house, or one family detached house); year the home was built; number of years living in 
the current home; carpeting in the child’s bedroom, room where child most often played, 
and/or living room; and frequency of vacuuming per month.  
 
Statistical Analyses 
PFAS detected in >65% of participants were included in analyses. We examined 
univariate distributions of PFAS measured in all samples to assess normality. We 
calculated descriptive statistics of covariates and PFAS measured in all media. We 
compared the geometric mean PFAS concentrations from children in our study to child 
participants aged 3 to 5 years in the National Health and Nutrition Examination Survey 
(NHANES), a nationally representative sample of U.S. citizens, collected between 2013 
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and 2014, the closest available ages and years of collection to when our study children’s 
samples were collected (CDC, 2019). We compared serum PFAS concentrations from 
maternal participants of our study to those of female NHANES participants aged 19 to 40 
years measured between 2009 and 2010 (n=364), the closest available years to when our 
maternal serum samples were collected (CDC, 2019). We calculated Spearman 
correlations between PFAS measured in child serum and PFAS in maternal serum, 
handwipes, dust, wristbands, and air. Statistical significance was set at p<0.05.  
Shapiro-Wilk tests were used to assess normality of the outcome, children’s 
serum concentrations, none of which were normally or log-normally distributed. 
Additionally, there were some outliers of concern in the data set; we therefore used 
robust regression models with the MM estimation method (SAS, 2008) to estimate 
associations of child serum PFAS concentrations with predictors. This method can 
withstand a high proportion of outliers and maintain its robustness, and has higher 
statistical efficiency than some other methods of dealing with outliers (SAS, 2008). All 
variables were modeled as continuous untransformed variables.  
Predictor variables were added one at a time to multivariable models and adjusted 
for a set of core variables: child sex, breastfeeding history, child BMI, maternal race 
(non-Hispanic black and Hispanic versus non-Hispanic white), maternal parity at the time 
of the child’s birth (nulliparous versus parous), and maternal education at the time the 
child’s serum was drawn. Due to small sample sizes, multivariable models estimating 
associations between child serum PFAS and air or wristband PFAS concentrations were 




Some participants had missing data on breastfeeding duration (4.8%), maternal 
parity (4.8%), and whether the mother was married or cohabitating (1.2%). We used 
multiple imputation with 10 imputations using the robust regression method in the proc 
mi procedure in SAS(SAS, 2015) to impute these missing data, and then combined 
results using proc mianalyze based on Rubin’s rule(Rubin, 2004). We performed all 









Participant, housing, and water characteristics are presented in Table 4.1. 
Children in our study were 3 to 6 years (mean 4.4 years) of age. Approximately 61% of 
child participants were male. Approximately half (51%) of the children in our study had 
breastfed for three or more months. For 50% of the children, guardians reported that they 
ate out more than one time per week, and 44% of children ate microwave popcorn more 
than one time per month. Mothers in our study ranged in age from 19 to 40 years (mean 
29.7 years). Approximately 45% of mothers self-identified as non-Hispanic white, 42% 
as non-Hispanic black, and 11% as Hispanic. Most mothers (60%) in our study had at 
least one previous pregnancy when the child participant was born. The majority of 
maternal serum samples were collected during the 1st trimester (58%). Most participants 
reported drinking municipal (87%) versus well (13%) water, and most participants 
obtained drinking water from Durham, NC (73%) rather than from other water sources 
(26%).  
 
PFAS detection and correlations 
Table 4.2 displays concentrations of PFAS detected in child and maternal serum 
samples compared to those detected in the U.S. population from the NHANES study. 
PFOS had the highest geometric mean serum concentration among both children and 
mothers, 2.6 and 6.0 ng/mL, respectively. Geometric mean child serum PFAS 
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concentrations in our study were similar or slightly lower than those detected in U.S. 
children aged 3 to 5 years from NHANES. When we compared females aged 19 to 40 
from the NHANES study to prenatal serum samples from mothers in our study, we found 
that geometric mean serum PFAS concentrations were fairly similar.  
PFAS concentrations in child serum samples were moderately to highly positively 
correlated with each other (rs=0.37 to 0.99), all of which reached statistical significance 
(p<0.05) (Table S4.1). Linear and total PFOA were highly correlated with each other 
(rs=0.97), and linear and branched PFOS were highly correlated with total PFOS (rs=0.99 
and 0.91, respectively) and with each other (rs=0.86). PFHxS was moderately to highly 
correlated with total, linear, and branched PFOS (rs=0.72, 0.69, and 0.78, respectively) 
and with total and linear PFOA (rs=0.60 and 0.65, respectively). Linear and branched 
PFOA were moderately to highly correlated with total PFOS (rs=0.67 and 0.71, 
respectively), linear PFOS (rs=0.66 and 0.70, respectively), and branched PFOS (rs=0.68 
and 0.70, respectively).  
In general, prenatal maternal serum PFAS concentrations were weakly to 
moderately positively correlated with child serum concentrations (rs=0.02 to 0.32). 
(Table S4.2). Correlations between maternal and child PFHxS (rs=0.27), PFOA 
(rs=0.30), n-PFOA (rs=0.30), PFOS (rs=0.25), n-PFOS (rs=0.28), and Sm-PFOS (rs=0.23) 
all reached statistical significance. 
PFAS detected and measured in environmental samples are presented in Table 
4.3. 6:2 FTOH had the highest geometric mean concentration in handwipe, wristband, 
 
104 
and air samples (78.0 ng/wipe, 167 ng/g, and 3.2 ng/m3, respectively), while 8:2 FTOH 
had the highest geometric mean concentration in dust samples (1,512 ng/g).  
Correlations between child serum PFAS and environmental samples are listed in 
Table S4.3. PFAS in handwipes and dust were generally weakly correlated with child 
serum PFAS concentrations (rs=-0.18 to 0.15 for handwipes and rs=-0.11 to 0.24 for 
dust). PFAS detected in wristbands were slightly more correlated with child serum PFAS 
(either positively or negatively) than with handwipes and dust (rs=-0.24 to 0.41). PFAS 
detected in air samples were the most highly correlated of our environmental samples 
with child serum PFAS (rs=-0.02 to 0.64) with several, including PFOS in serum and 
MeFOSE in air (rs=0.49), reaching statistical significance. However, some of the highest 
correlations between PFAS in child serum and air samples were between PFAS in serum 
that could not be derived from the correlated compounds in air, such as PFHxS in serum 
and 6:2 and 8:2 FTOH in air (rs=0.64 and 0.50, respectively) and PFOA in serum and 
EtFOSE in air (rs=0.49). 
 
Predictors of child serum PFAS concentrations 
Based on results from regression models investigating associations between child 
serum PFAS concentrations and the core set of predictor variables (i.e., child sex, 
breastfeeding history, child BMI, maternal race, maternal parity, maternal education), the 
strongest predictor of child serum PFAS concentration was maternal race (Figure 4.2a 
and Table S4.1). Compared to non-Hispanic white mothers, children of non-Hispanic 
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black mothers had lower concentrations of PFHxS (β=-0.20 ng/mL, 95% CI=-0.36, -
0.04), PFOA (β=-0.46 ng/mL, 95% CI=-0.89, -0.03), n-PFOA (β=-0.49 ng/mL, 95% CI=-
0.87, -0.12), PFOS (β=-0.71 ng/mL, 95% CI=-1.4, -0.08), n-PFOS (β=-0.53 ng/mL, 95% 
CI=-1.1, -0.01), and Sm-PFOS (β=-0.19 ng/mL, 95% CI=-0.34, -0.04) (p<0.05 for all 
listed PFAS). Associations were not as clear for children with Hispanic mothers 
compared to those with non-Hispanic white mothers, likely due to the relatively small 
number of participants with Hispanic mothers (n=9). Compared to females, male children 
generally had lower serum PFAS concentrations, with PFNA having the most precise 
effect estimate; on average, males had 0.11 ng/mL lower serum PFNA concentrations 
than females (95% CI=-0.21, -0.02).  
None of the other core model variables strongly predicted child serum PFAS 
concentrations. However, the data suggest that children that had ever breastfed generally 
had higher concentrations of serum PFAS than children that had never breastfed (range: 
0.09 ng/mL [95% CI=-0.04, 0.35] to 0.65 ng/mL [95% CI=-0.14, 1.4] higher). Children 
whose mothers were nulliparous prior to their birth generally had higher serum PFAS 
concentrations than those whose mothers had had a previous child (range: 0.01 ng/mL 
[95% CI=-0.09, 0.12] to 0.39 ng/mL [95% CI=-0.23, 1.0] higher). Also, children whose 
mothers had less than some college education generally had lower concentrations of 
serum PFAS than those whose mothers completed at least some college (range: -0.32 
ng/mL [95% CI=-1.2, 0.53] to 0.01 ng/mL [95% CI=-0.22, 0.25]).  
Children that ate out one or more times per week had, on average, 0.41 ng/mL 
(95% CI=0.03, 0.79) and 0.32 ng/mL (95% CI=-0.01, 0.65) higher serum PFOA and n-
 
106 
PFOA concentrations compared to those that ate out less frequently (Figure 4.2c and 
Table S4.4). Children that ate microwave popcorn more than one time per month had 
higher serum PFHxS concentrations (β=0.14 ng/mL, 95% CI=0.004, 0.27) than those that 
ate less microwave popcorn. Generally, the season that the child’s serum was collected 
did not appear to be associated with serum PFAS concentrations; however, serum that 
was collected in the fall had 0.61 ng/mL higher concentrations of PFOA compared to 
serum that was collected in the winter (95% CI=0.13, 1.1). Compared to children that 
drank primarily well water, children that drank municipal water averaged 0.58 ng/mL 
higher serum concentrations of PFOA (95% CI=0.05, 1.1) (Figure 4.2b2 and Table 
S4.4). Other characteristics were generally not associated with child serum PFAS 
concentrations.  
Some PFAS measured in prenatal maternal serum samples were associated with 
child serum samples (Figure 4.2c and Table S4.4). PFHxS detected in maternal serum 
was positively associated with PFHxS in child serum (β=0.13, 95% CI=0.01, 0.26); 
PFOA in maternal serum was positively associated with n-PFOA in child serum (β=0.17, 
95% CI=0.001, 0.34); and n-PFOS in maternal serum was positively associated with both 
PFOS (β=0.11, 95% CI=0.01, 0.21) and n-PFOS (β=0.10, 95% CI=0.02, 0.19) in child 
serum.  
We found that several PFAS detected in air were predictive of child serum PFAS 
(Figure 4.2 and Table S4.5). MeFOSE detected in air was positively associated with 
PFHxS (β=0.21 ng/mL, 95% CI=0.08, 0.35), PFOS (β=2.2 ng/mL, 95% CI=1.7, 2.8), n-
PFOS (β=1.6 ng/mL, 95% CI=1.1, 2.1), and Sm-PFOS (β=0.64 ng/mL, 95% CI=0.55, 
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0.73) in child serum. EtFOSE in air was positively associated with Sm-PFOS (β=3.6 
ng/mL, 95% CI=1.5, 5.8) in child serum. Some of the positive associations between 
PFAS in child serum and air samples that reached statistical significance were between 
compounds in air that are not precursors of those found in serum, such as MeFOSE 
detected in air and PFNA (β=0.08 ng/mL, 95% CI=0.02, 0.15), PFOA (β=0.54 ng/mL, 
95% CI=0.13, 0.94) and n-PFOA (β=0.49 ng/mL, 95% CI=0.16, 0.83) in child serum; 
EtFOSE in air and PFOA (β=15.6 ng/mL, 95% CI=5.1, 26.1) and n-PFOA (β=12.4 
ng/mL, 95% CI=2.7, 22.2) in child serum; 6:2 FTOH (β=0.01 ng/mL, 95% CI=0.001, 
0.02), 8:2 FTOH (β=0.04 ng/mL, 95% CI=0.02, 0.06), and 10:2 FTOH (β=0.12 ng/mL, 
95% CI=0.02, 0.21) in air and PFHxS in child serum.  
Generally, PFAS detected in handwipes and dust (Table S4.4) were not predictive 
of child serum PFAS, nor were PFAS detected in wristbands (Table S4.5). It is possible 
that with a larger sample size of wristbands we may have seen a stronger association 
between MeFOSE in wristbands and PFOS (β=263 ng/mL, 95% CI=-62.2, 239) and/or n-




 In our child participants (aged 3-6 years) sampled between 2014 and 2016 in 
central North Carolina, we found evidence that, similar to previous study findings, both 
food and water were predictors of child serum PFOA concentrations. Consumption of 
municipal water compared to well water in this region of North Carolina was a stronger 
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predictor (29% higher) of serum concentrations than eating out one or more times per 
week (compared to eating out less).  We also found that those that ate microwave 
popcorn more frequently had higher concentrations of PFHxS than those that ate it once 
or less per month. Certain demographic factors were predictive of PFAS exposure: 
children with non-Hispanic black mothers had lower serum concentrations of several 
PFAS than those with non-Hispanic white mothers, and male children generally appeared 
to have lower serum concentrations of PFAS than female children, though only PFNA 
reached statistical significance. Prenatal maternal serum and air concentrations of certain 
PFAS were good predictors of several PFAS in children’s serum, although other 
environmental predictors did not appear to be associated. 
Based on the results of the environmental samples we collected, we found that 
participants were exposed to a number of different PFAS (Table 4.2). In handwipes, 
wristbands, and air, 6:2 FTOH was the PFAS with the highest geometric mean 
concentration, while 8:2 FTOH was the PFAS with the highest geometric mean 
concentration in dust, which is similar to findings from previous studies that included 
environmental samples (Fraser et al., 2012, 2013). As observed in previous studies, a 
number of different PFAS were detected in both maternal and child serum (Table 4.2), 
with PFOS having the highest serum concentrations in both mothers and children (Calafat 
et al., 2007; Harris et al., 2017; Hu et al., 2018; Kingsley et al., 2018; Sagiv et al., 2015). 
Mothers, whose serum samples were collected during an earlier time period than 
children’s serum samples, generally had higher geometric mean concentrations of PFAS 
than children, with the exception of PFOA and n-PFOA, which had similar 
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concentrations in both children’s and maternal serum. This is reflective of other studies 
that have found that certain PFAS concentrations have decreased over time, that children 
in the same age range as our study tend to have lower concentrations of many PFAS than 
adults, and that PFAS concentrations generally increase with age (Barton et al., 2020; Hu 
et al., 2018; Pitter Gisella et al., n.d.). 
Although we did not ask specifically what type(s) of food participants consumed, 
we found that children that ate out more frequently had 0.41 ng/mL higher concentrations 
of PFOA than those that ate out less. PFAS have been commonly used as oil- and water-
resistant paper and cardboard coatings for fast-food paper and cardboard containers and 
in microwave popcorn bags (Begley et al., 2005, 2008; Tittlemier et al., 2007). Previous 
studies have observed that people that consumed fast food recently and/or frequently had 
higher concentrations of PFAS, including: PFOA, PFNA, PFDA, PFHxS, PFOS, and 
MeFOSAA in their bodies than those that ate it less frequently (Boronow et al., 2019; 
Harris et al., 2017; Susmann et al., 2019). We observed that children that ate microwave 
popcorn more frequently had higher concentrations of perfluorosulfonic acids (range 0.07 
to 0.40 ng/mL), with PFHxS reaching statistical significance compared to those that did 
not eat it as frequently, which is similar to some previous findings (Susmann et al., 2019). 
Unlike other study findings that people who regularly and/or recently consumed 
microwave popcorn had higher concentrations of serum PFOA and PFNA (Susmann et 
al., 2019; Wu et al., 2015), we did not observe higher concentrations of perfluorinated 
carboxylic acids with more frequent microwave popcorn consumption.   
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We found that drinking water was a predictor of PFOA exposure in our study 
participants. Almost three quarters of the children in this study resided in Durham, which 
uses water from Lake Michie and Little River Reservoir as sources of drinking water. 
This surface water may have a higher potential for contamination from PFAS in runoff 
water than ground water from wells in this region. Previous studies have found that 
drinking water is an important predictor of PFAS exposure, with those that drank water 
from a highly PFAS-contaminated source having higher serum concentrations of PFAS 
compared to those with non-contaminated water sources (Barton et al., 2020; Boronow et 
al., 2019; Daly et al., 2018; Hu et al., 2019; Pitter Gisella et al., n.d.). Whether or not the 
child drank mostly bottled water and/or the use of a water filter did not appear to affect 
child serum PFAS concentrations in our study, although some previous studies have 
found that those that drank only bottled water or a mix of bottled, well, and tap water had 
lower concentrations of certain PFAS compared to those that drank only tap water 
(Barton et al., 2020; Pitter Gisella et al., n.d.). This may be due in part to the fact that we 
did not have a large enough sample size to separate out different types of water filters, 
some of which may be more effective of reducing PFAS concentrations than others 
(Herkert et al., 2020).  
 Maternal race was a strong predictor of PFAS exposure with children of non-
Hispanic white mothers having higher concentrations of PFHxS, PFOA, n-PFOS, PFOS, 
n-PFOS, and Sm-PFOS. Similarly, previous studies have found that race is an important 
predictor of PFAS exposure (Boronow et al., 2019), and that children of non-Hispanic 
black mothers have lower concentrations of certain PFAS than those of non-Hispanic 
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white mothers (Harris et al., 2017; Kingsley et al., 2018). Although some previous studies 
found that Hispanic participants had lower serum concentrations of certain PFAS than 
non-Hispanic white participants (Barton et al., 2020), we did not find a strong difference 
in serum concentrations between children of non-Hispanic white and Hispanic mothers, 
perhaps due to the inclusion of only a very small number of children with Hispanic 
mothers in our study (n=9).  
 We found evidence that male children had lower serum concentrations of PFNA 
than females, but did not find strong evidence that concentrations of other PFAS differed 
by sex. In the HOME study, males sampled at age 3 and 8 generally had lower 
concentrations of PFAS than females, though none reached statistical significance 
(Kingsley et al., 2018). In contrast, some other studies have found that males, in 
adolescence and adulthood, generally have higher concentrations of certain PFAS than 
females (Barton et al., 2020; Hu et al., 2018; Pitter Gisella et al., n.d.; Wu et al., 2015). 
Unlike previous study findings that PFAS is present in breastmilk (Jin et al., 2020; 
Mogensen et al., 2015; Nyberg et al., 2018), that breastfeeding is predictive of PFAS 
levels in infancy (Harris et al., 2017; Kingsley et al., 2018; Mogensen et al., 2015; Wu et 
al., 2015), and that maternal PFAS concentrations decrease with increased breastfeeding 
duration (Brantsæter et al., 2013), we did not find a large difference in serum PFAS 
concentrations between children that ever breastfed compared to those that never 
breastfed, perhaps due to the low number of participants that never breastfed in our study 
(n=12). We did not observe an association between child BMI and PFAS serum 
concentrations among our study participants; one previous study found that children with 
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a higher BMI had lower concentrations of certain PFAS (Harris et al., 2017), while 
another found that certain PFAS were highest among obese adults compared to those 
with a lower BMI (Brantsæter et al., 2013). Despite previous studies that found an 
association between maternal parity and maternal and/or child serum samples (Brantsæter 
et al., 2013; Kingsley et al., 2018; Pitter Gisella et al., n.d.; Sagiv et al., 2015; Shu et al., 
2018), our study found that maternal parity was only weakly associated with child serum 
PFAS concentrations. Unlike previous study findings that maternal educational 
attainment was positively associated with certain PFAS exposures in child and/or 
maternal serum (Brantsæter et al., 2013; Harris et al., 2017), we did not find strong 
evidence of an association between child serum PFAS and maternal education. Although 
we did not collect information on household income, which was found to be predictive of 
certain PFAS exposures in previous studies (Brantsæter et al., 2013; Harris et al., 2017), 
information on educational attainment is often reflective of socioeconomic status. We did 
not observe a difference in child serum PFAS associated with maternal age, unlike some 
previous studies (Harris et al., 2017; Kingsley et al., 2018). Finally, we found that 
children whose serum was collected in the fall had higher concentrations of PFOA than 
those that were sampled in the winter, though we did not observe any other seasonal 
differences in serum concentrations. Though exposure to some compounds has been 
shown in previous studies to vary by season (D. Wang et al., 2019), the estimated 
elimination half-life of PFOA is years; thus there may not be a true difference in 




We found that certain maternal PFAS serum concentrations, measured while the 
child participants were in utero, were still associated with child serum PFAS at age 3 to 6 
years. Specifically, prenatal PFHxS was associated with child PFHxS, prenatal PFOA 
was associated with child n-PFOA, and prenatal n-PFOS was associated with child 
PFOS. Previous studies have also found that certain prenatal serum samples were 
associated with corresponding PFAS in child serum samples years later (Harris et al., 
2017). Based on a review of previous literature (ATSDR, 2018), the estimated half-life of 
those PFAS in humans is 4.7 to 35 years for PFHxS, 2.1 to 10.1 years for PFOA, and 3.1 
to 27 years for PFOS. Thus, some of the PFASs measured in child serum are likely 
attributable to prenatal exposure, while some may reflect a shared environment (Fraser et 
al., 2012; Makey et al., 2017).  
We found an association between PFAS in air and child serum PFHxS, PFOA, n-
PFOA, PFOS, n-PFOS, and Sm-PFOS concentrations, which is similar to previous study 
findings that have examined associations between PFAS detected in serum and air in 
adults (Beesoon et al., 2012; Fraser et al., 2012; Makey et al., 2017; Poothong et al., 
2020), and the first to our knowledge to observe these associations in children. Previous 
studies have demonstrated associations between serum concentrations and environmental 
exposures to PFAS and their precursors through inhalation of contaminated indoor air 
(presumably derived from products in home and/or office environments) (Balk et al., 
2019; Beesoon et al., 2012; Fraser et al., 2012; Poothong et al., 2020). This is indicative 
that the home environment is an important route of exposure to PFAS. Some of the PFAS 
precursors detected in air in our study are associated with derivatives of those compounds 
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(e.g., MeFOSE in air and PFHxS and PFOS in serum), however other PFAS precursors 
detected in air were associated with PFAS that are not derivatives of those compounds 
(e.g., MeFOSE and EtFOSE in air and PFOA and n-PFOA in serum, and 8:2 FTOH and 
10:2 FTOH in air and PFHxS in serum). The latter results may be due to the fact that 
PFAS derivatives detected in child serum were all correlated with each other.  
We did not find strong evidence of an association between child serum and PFAS 
detected in handwipes, dust, or wristbands. Despite our results, inhalation and ingestion 
of contaminated dust has been suggested in some studies to be a source of environmental 
PFAS exposure (Balk et al., 2019; Beesoon et al., 2012; Poothong et al., 2020), though 
the association is not as clear in other studies (Fraser et al., 2013; Wu et al., 2015). As a 
potential source of exposure to PFAS, some previous studies have found that having 
carpet in the home (Hu et al., 2018), particularly if treated for stain-resistance (Beesoon 
et al., 2012; Boronow et al., 2019), and/or sleeping in a room with a carpet or rug is 
predictive of certain PFAS exposures (Harris et al., 2017); however we did not find 
evidence of this in our study. There have been fewer studies exploring potential dermal 
and hand-to-mouth routes of PFAS exposure by examining associations between PFAS 
detected on handwipes and serum samples; however, one such study found that PFDS, 
which we did not measure in our study, detected in handwipes was correlated with serum 




Strengths and limitations 
A strength of our study is that it is the first, to our knowledge, to examine multiple 
PFAS exposure pathways (maternal serum, water, demographics, BMI, behavior, and 
environmental samples), in children. We also examined many different PFAS in both 
environmental media and serum samples. Finally our study population is fairly diverse, 
which allows us to generalize our results to a wider population, since many previous 
studies have been conducted in relatively homogeneous populations (e.g. (Harris et al., 
2017; Kingsley et al., 2018; Sagiv et al., 2017)). 
A limitation of this study is the relatively small sample size; a larger study 
population would likely have given us a clearer picture of predictors of child serum PFAS 
concentrations and increased the precision of associations that we observed in our 
analyses. For example, only a fraction of the participants wore wristbands or had air 
samplers placed in their homes. Socioeconomic status is complicated; we collected 
information about maternal race and education, but not household income, an important 
predictor of PFAS exposure (Brantsæter et al., 2013; Harris et al., 2017; Sagiv et al., 
2017). The dietary information that we collected was limited; we asked about the 
frequency of eating out, but did not ask the type(s) of restaurants or foods that 
participants were eating, which are predictors of PFAS exposure based on other studies 
(Boronow et al., 2019; Brantsæter et al., 2013; Hansen et al., 2016; Hu et al., 2018; Lin et 
al., 2020; Pitter Gisella et al., n.d.; Poothong et al., 2020; Timmermann et al., 2019; Wu 
et al., 2015). We did not ask any questions about personal care product use, another 
potential source of PFAS exposure (Boronow et al., 2019). Drinking water can be an 
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important source of PFAS exposure (Boronow et al., 2019; Daly et al., 2018; Hu et al., 
2019; Pitter Gisella et al., n.d.). Although we asked participants if they mostly drank tap, 
bottled, or a mix of both types of water and whether they had well or city water, we did 
not collect any water samples, which would have given us information on actual 
participant-level PFAS exposures from drinking water. Finally, care is needed in the 




In our relatively diverse population of children aged 3 to 6 years sampled between 
2014 and 2016, we found that frequency of eating out and eating microwave popcorn, 
maternal race, drinking water source, maternal serum and air PFAS concentrations were 
predictive of certain PFAS detected in child serum samples. Future studies should 
examine predictors of PFAS in air, collect water samples to further examine drinking 





Figure 4.1. Study population and sample sizes for serum and environmental samples 
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Table 4.1. Characteristics of Study Participants (n=84 Mother/Child Pairs) 
Child Characteristics Maternal Characteristics 
 Mean +/- SD 
or N (%) 
 Mean +/- SD 
or N (%) 
Child’s Age at Blood Draw (years) 4.4 +/- 0.56 Maternal Age at Delivery 29.7 +/- 5.7 
Sex  Maternal Race/Ethnicity  
     Male 51 (60.7)      Non-Hispanic White 38 (45.2) 
     Female 33 (39.3)      Non-Hispanic Black 35 (41.7) 
Breastfeeding Duration       Hispanic 9 (10.7) 
     Never 12 (14.3)      Other 2 (2.4) 
     Ever 68 (81.0) Maternal Parity  
     ≥3 Months 43 (51.2)      0 30 (35.7) 
     Missing 4 (4.8)      ≥1 50 (59.5) 
BMI (Percentile)       Missing 4 (4.8) 
     Underweight/Normal (<85th) 59 (70.2) Maternal Education During Pregnancy 
     Overweight (85-<95th) 16 (19.1)      <High School 15 (17.9) 
     Obese (≥95th) 9 (10.7)      HS Diploma or GED 16 (19.1) 
Hours Spent Inside the Home Per Day       Some College 14 (16.7) 
     ≤12 22 (26.2)      College Degree or Higher 39 (46.4) 
     13-18 46 (54.8) Maternal Education at Child Sampling 
     ≥19 16 (19.0)      <High School 11 (13.1) 
Time Spent Inside a Car Per Day       HS Diploma or GED 11 (13.1) 
     ≤30 minutes 35 (41.7)      Some College 17 (20.2) 
     31 minutes to 1 hour 27 (32.1)      Associate’s Degree or Higher 45 (53.6) 
     >1 hour 22 (26.2) Mother Married or Cohabitating  
Frequency of Hand Washing Per day       No 23 (27.4) 
     1-2 6 (7.1)      Yes 60 (71.4) 
     3-6 51 (60.7)      Missing 1 (1.2) 
     ≥7 27 (32.1) Gestational Age at Blood Draw  
Frequency of Eating Out       1st Trimester 49 (58.3) 
     <1 time a week 42 (50.0)      2nd Trimester 30 (35.7) 
     1-2 times a week 25 (29.8)      3rd Trimester 5 (6.0) 
     ≥3 times a week 17 (20.2)   
Frequency of Eating Microwave 
Popcorn 
   
     <1 time a month 47 (56.0)   
     1-3 times a month            23 (27.4)   
     ≥4 times a month 14 (16.7)   
Season Sampled    
     Winter 18 (21.4)   
     Spring 19 (22.6)   
     Summer 21 (25.0)   
     Fall 26 (31.0)   
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Table 4.1 (Continued). Characteristics of Study Participants (n=84 Mother/Child 
Pairs) 
Housing Characteristics  Drinking Water Characteristics 
 Mean +/- SD or N (%)  
Mean +/- SD 
or N (%) 
Housing Type  Drinking Water Type  
     Mobile Home or Trailer 1 (1.2)      Usually Tap 29 (34.5) 
     Apartment 22 (26.2)      Usually Bottled 25 (29.8) 
     One Family Attached House 5 (6.0)      A Mix of Tap and Bottled 30 (35.7) 
     One Family Detached House 56 (66.7) Well or City Water  
Year Home Was Built       City 73 (86.9) 
     Before 1959 6 (7.1)      Well 11 (13.1) 
     1960-1977 16 (19.0) Water Company  
     1978-1999 19 (22.6)      Durham  61 (72.6) 
     2000 to present 21 (27.8)      Other than Durham 22 (26.2) 
     Don’t know 22 (25.6)      Missing 1 (1.2) 
Number of Years Family in Home  House Water Filter  
     <2 Years 22 (26.2)      Yes 8 (9.5) 
     2-5.5 Years 34 (40.5)      No 40 (47.6) 
     6-9 Years 21 (25.0)      Missing 36 (42.9) 
     ≥10 Years 7 (8.3) Faucet Water Filter  
Carpet in Child’s Bedroom        Yes 6 (7.1) 
     Yes 61 (72.6)      No 78 (92.9) 
     No 23 (27.4) Refrigerator Water Filter   
Carpet in Child’s Play Room       Yes 22 (26.2) 
     Yes 47 (56.0)      No 29 (34.5) 
     No 37 (44.0)      Missing 33 (37.1) 
Carpet in Living Room  Pitcher Water Filter  
     Yes 37 (44.0)      Yes 9 (10.7) 
     No 47 (56.0)      No 39 (46.4) 
Number of Times Vacuum       Missing 36 (42.9) 
     None 13 (15.5) Unknown Water Treatment  
     1-3 Times a Month 16 (19.0)      Yes 2 (2.4) 
     4-6 Times a Month 19 (22.6)      No 45 (53.6) 
     >6 Times a Month 36 (42.9)      Missing 37 (44.0) 
  Any Water Filter or Treatment  
       Yes 40 (47.6) 





















(NG/ML) N=84       
      ETFOSAA 1 (1.2) N/A <LOD <LOD 0.80 N/A 
      MEFOSAA 35 (41.7) N/A <LOD <LOD 3.4 N/A 
      PFDA 49 (58.3) N/A <LOD 0.20 1.1 0.10 (<LOD, 0.13) 
      PFHXS 84 (100) 0.71 0.20 0.70 10.0 0.72 (0.62, 0.83) 
      PFNA 83 (98.8) 0.42 <LOD 0.40 1.4 0.76 (0.63, 0.93) 
      PFOA 84 (100) 1.7 0.40 1.8 4.0 2.0 (1.8, 2.3) 
      N-PFOA 84 (100) 1.5 0.40 1.6 3.9 1.9 (1.6, 2.2) 
      SB-PFOA 43 (51.2) N/A <LOD 0.10 1.7 N/A 
      PFOS   84 (100) 2.6 0.20 3.0 20.0 3.4 (3.0, 3.8) 
      N-PFOS 83 (98.8) 2.0 <LOD 2.0 20.0 2.2 (2.0, 2.5) 
      SM-PFOS 82 (97.6) 0.51 <LOD 0.50 3.0 1.0 (0.87, 1.2) 
      PFOSA 0 (0.0) N/A <LOD <LOD      <LOD N/A 
MATERNAL SERUMA 
(NG/ML) N=73       
      ETFOSAA 0 (0.0) N/A <LOD <LOD <LOD N/A 
      MEFOSAA 19 (26.0) N/A <LOD <LOD 1.0 0.15 (0.06, 0.25) 
      PFDA 67 (91.8) 0.26 <LOD 0.20 1.0 0.23 (0.14, 0.33) 
      PFHXS 73 (100) 0.90 0.20 0.90 3.6 0.87 (0.78, 0.96) 
      PFNA 73 (100) 0.79 0.30 0.70 2.1 0.97 (0.87, 1.1) 
      PFOA 73 (100) 1.8 0.70 2.0 6.6 2.2 (2.1, 2.3) 
      N-PFOA 73 (100) 1.7 0.60 1.8 6.4 N/A 
      SB-PFOA 28 (38.4) N/A <LOD <LOD 0.30 N/A 
      PFOS 73 (100) 6.0 1.1 6.1 29.0 5.6 (5.5, 5.7) 
      N-PFOS 73 (100) 4.5 1.0 4.6 21.0 N/A 
      SM-PFOS 73 (100) 1.4 0.10 1.4 7.8 N/A 
      PFOSA 0 (0.0) N/A <LOD <LOD <LOD N/A 





bChild Serum Data compared to NHANES data for children aged 3-5 years (n=181) 2013-2014; Maternal Serum Data Compared to NHANES 




















     
      6:2 FTOH  80 (95.2) 78.0 <MDL 75.5 10,629 
      8:2 FTOH 60 (71.4) 15.3 <MDL 19.4 150 
      ETFOSE 57 (67.9) 1.3 <MDL 1.5 38.2 
      MEFOSE  45 (53.6) 0.89 <MDL 0.63 2,209 
DUST (NG/G) 
N=82      
      6:2 FTOH  78 (95.1) 548 <MDL 594 29,464 
      8:2 FTOH  82 (100) 1,512 97.3 1,342 44,222 
      ETFOSE 14 (17.1) N/A <MDL <MDL 366 
      MEFOSE 15 (18.3) N/A <MDL <MDL 7,981 
      6:2 DIPAP 82 (100) 122 1.1 119 34,360 
      8:2 DIPAP 31 (37.8) N/A <MDL <MDL 5,128 
      PFBS 1 (1.2) N/A <MDL <MDL 473 
      PFBA 9 (11.0) N/A <MDL <MDL 502 
      PFHPA 12 (14.6) 11.1 <MDL <MDL 713 
      PFHXA 79 (96.3) 10.0 <MDL 9.6 1,382 
      PFHXS 52 (63.4) 1.3 <MDL 1.2 187 
      PFNA 82 (100) 4.2 0.26 3.3 208 
      PFOA 82 (100) 10.6 0.67 10.3 2,354 
      PFOS 73 (89.0) 5.4 <MDL 5.1 892 
WRISTBANDS 
(NG/G) N=26      
      6:2 FTOH  25 (96.2) 167 <MDL 208 3,688 
      8:2 FTOH  17 (65.4) 27.3 <MDL 26.0 107 
      10:2 FTOH 23 (88.5) 7.2 <MDL 9.4 61.3 
      ETFOSE 24 (92.3) 1.0 <MDL 1.2 14.9 
      MEFOSE 24 (92.3) 1.4 <MDL 1.6 6.7 
      6:2 DIPAPC 24 (100) 13.3 0.11 14.3 437 
      8:2 DIPAPC 22 (91.7) 1.8 <MDL 1.9 52.9 
      PFBSC 2 (8.3) N/A <MDL <MDL 0.35 
      PFBAC 0 (0.0) N/A <MDL <MDL <MDL 
      PFHPAC 2 (8.3) N/A <MDL <MDL 0.34 
      PFHXAC 5 (20.8) N/A <MDL <MDL 0.34 
      PFDAA 13 (54.2) N/A <MDL 0.26 0.34 
      PFHXSA 2 (8.3) N/A <MDL <MDL 0.34 
      PFNAA 16 (66.7) 0.08 <MDL 0.06 0.34 
      PFOAA 5 (20.8) N/A <MDL <MDL 0.15 
      PFOSA 9 (37.5) N/A <MDL <MDL 0.56 
AIR (NG/M3) 
N=17      
      6:2 FTOH  13 (76.5) 3.2 <MDL 3.3 49.6 
      8:2 FTOH 17 (100) 2.3 0.06 3.3 13.2 
      10:2 FTOH 13 (76.5) 0.74 <MDL 0.99 3.5 
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      ETFOSE 13 (76.5) 0.03 <MDL 0.03 0.67 
      MEFOSE 17 (100) 0.21 0.01 0.20 4.0 





Figure 4.2. Associations and Confidence Intervals from Robust Regression Models for Predictors of PFAS 
Concentrations in TESIE participant Child Serum Samples 
a. Core Model: sex, breastfeeding, child BMI, race, parity, and education (mutually adjusted) 












































PFHxS PFNA PFOAsum n-PFOA PFOSsum n-PFOS Sm-PFOS
Male vs.           Ever vs. Never BMI Black vs.             Hispanic vs Nulliparous <HS vs.                 HS vs.            




Figure 4.2 (Continued). Adjusted Associations† and Confidence Intervals from Robust Regression Models for 
Predictors of PFAS Concentrations in TESIE participant Child Serum Samples 
b1. Predictors, analyzed one at a time† 
†Adjusted for core variables: sex, breastfeeding, child BMI, race, parity, and education 









































PFHxS PFNA PFOAsum n-PFOA PFOSsum n-PFOS Sm-PFOS
Child Age  Handwash   Ate out  Mic Popcorn  ≤12 vs. >12  ≤30 vs. >30  Mom's Age   Partner      Spring vs.    Summer vs.    Fall vs.                             
(Months)   1-2 vs. >2   ≥ 1 vs. <1 >1 vs. ≤1    Hrs in House  Mins. in Car  (years) at     Cohabit       Winter         Winter          Winter 




Figure 4.2 (Continued). Adjusted Associations† and Confidence Intervals from Robust Regression Models for 
Predictors of PFAS Concentrations in TESIE participant Child Serum Samples 
b2. Predictors, analyzed one at a time† 
†Adjusted for core variables: sex, breastfeeding, child BMI, race, parity, and education 







































PFHxS PFNA PFOAsum n-PFOA PFOSsum n-PFOS Sm-PFOS
Muni vs.          Water Filter   Mostly bottled  Detached House   House built         Months              Carpet             Carpet               Carpet            Vacuum 
well water           vs. none     vs. other water        vs. other        after vs. before     in home     in child bedroom  in playroom          in living          >3 imes vs. 




Figure 4.2 (Continued). Adjusted Associations† and Confidence Intervals from Robust Regression Models for 
Predictors of PFAS Concentrations in TESIE participant Child Serum Samples 
c. Maternal Serum PFAS¥, analyzed one at a time† 
 
†Adjusted for core variables: sex, breastfeeding, child BMI, race, parity, and education 
¥Maternal PFDA not included in graph 












































PFHxS PFNA PFOAsum n-PFOA PFOSsum n-PFOS Sm-PFOS
PFHxS               PFNA                PFOA               n-PFOA                PFOS                n-PFOS             Sm-PFOS




Figure 4.3. Adjusted Associations† and Confidence Intervals from Robust Regression Models for PFAS Concentrations 
in Air (ng/m3) and TESIE Participant Child Serum Samples  
 
†Adjusted for race 





























































































































Table S4.1. Spearman correlations between PFAS in child serum samples (n=84) 
 PFHxS PFNA PFOA n-PFOA PFOS n-PFOS Sm-PFOS 
PFHxS 1 0.39* 0.60* 0.65* 0.72* 0.69* 0.78* 
PFNA  1 0.55* 0.59* 0.44* 0.46* 0.37* 
PFOA   1 0.97* 0.67* 0.66* 0.68* 
n-PFOA    1 0.71* 0.70* 0.70* 
PFOS     1 0.99* 0.91* 
n-PFOS      1 0.86* 
Sm-PFOS       1 
*p<0.05 
 
Table S4.2. Spearman correlations between PFAS in maternal serum during pregnancy and child serum samples 
(n=73) 
 Child 




PFDAa 0.13 0.14 0.28* 0.30* 0.31* 0.31* 0.27* 
PFHxS 0.27* 0.02 0.28* 0.27* 0.16 0.13 0.23 
PFNA 0.17 0.20 0.31* 0.32* 0.23 0.24* 0.15 
PFOA 0.08 0.05 0.30* 0.31* 0.12 0.12 0.11 
n-PFOA 0.06 0.05 0.29* 0.30* 0.11 0.11 0.09 
PFOS 0.19 0.15 0.16 0.20 0.25* 0.25* 0.23 
n-PFOS 0.16 0.18 0.16 0.18 0.27* 0.28* 0.21 




Table S4.3. Spearman correlations between PFAS in hand wipes, wristbands, air, 
dust, and child serum samples 
 Child Serum 
 PFHxS PFNA PFOA n-PFOA PFOS n-PFOS Sm-PFOS 
Handwipes (n=84)        
  6:2 FTOH 0.12 -0.05 -0.07 -0.05 -0.003 -0.01 0.02 
  8:2 FTOH 0.07 -0.18 -0.08 -0.06 -0.04 -0.05 -0.03 
  EtFOSE 0.11 -0.14 -0.005 0.02 0.15 0.14 0.12 
Dust (n=82)        
  6:2 FTOH 0.13 0.19 0.18 0.23* 0.20 0.22 0.16 
  8:2 FTOH -0.11 -0.02 0.11 0.11 -0.02 -0.002 -0.06 
  6:2 diPAP 0.12 0.05 0.02 0.005 0.11 0.09 0.12 
  PFHxA 0.16 0.04 0.05 0.06 0.09 0.08 0.13 
  PFNA 0.03 0.07 -0.06 -0.05 -0.02 -0.03 0.01 
  PFOA 0.22 0.03 0.09 0.12 0.15 0.13 0.24* 
  PFOS 0.19 -0.006 0.08 0.06 0.16 0.15 0.18 
Wristbands (n=26)        
  6:2 FTOH 0.11 0.11 -0.18 -0.07 -0.09 -0.11 -0.10 
  8:2 FTOH 0.11 0.20 -0.14 -0.06 -0.21 -0.24 -0.11 
  10:2 FTOH 0.17 0.07 -0.17 -0.04 -0.10 -0.13 -0.02 
  EtFOSE 0.03 -0.13 -0.02 0.04 0.15 0.16 0.06 
  MeFOSE 0.06 -0.03 0.04 0.13 0.34 0.35 0.22 
  6:2 diPAPa -0.03 0.10 0.006 0.09 -0.13 -0.13 -0.15 
  8:2 diPAPa 0.07 0.07 -0.07 0.05 -0.17 -0.17 -0.17 
  PFNAa 0.33 -0.08 0.41* 0.33 0.04 0.03 0.22 
Air (n=17)        
  6:2 FTOH 0.33 -0.02 0.03 0.06 0.04 0.04 0.10 
  8:2 FTOH 0.64* 0.44 0.34 0.43 0.28 0.28 0.35 
  10:2 FTOH 0.50* 0.39 0.36 0.44 0.15 0.16 0.25 
  EtFOSE 0.13 -0.05 0.49* 0.42 0.47 0.42 0.38 





Table S4.4. Adjusted Associations† from Robust Regression Models for Multiple Predictors of PFAS Concentrations in TESIE 
participant Child Serum Samples  
 Beta Estimates of Child Serum PFAS Concentration† (ng/mL) (95% Confidence Interval) 
Core Model PFHxS PFNA PFOA n-PFOA PFOS n-PFOS Sm-PFOS 








































































































































Child washed their hands 1 to 2 































Child ate Microwave Popcorn  















Child spent 12 or less hrs vs.  















Child spent 30 or less mins vs. > 




















Table S4.4 (Continued). Adjusted Associations† from Robust Regression Models for Multiple Predictors of PFAS Concentrations 
in TESIE participant Child Serum Samples  
 Beta Estimates of Child Serum PFAS Concentration† (ng/mL) (95% Confidence Interval) 
Covariates PFHxS PFNA PFOA n-PFOA PFOS n-PFOS Sm-PFOS 

















































































































































































































Vacuum 3 or less vs. 4 or more times 




















Table S4.4 (Continued). Adjusted Associations† from Robust Regression Models for Multiple Predictors of PFAS Concentrations 
in TESIE participant Child Serum Samples  
 Beta Estimates of Child Serum PFAS Concentration† (ng/mL) (95% Confidence Interval) 
















































































































Handwipes (pg/wipe)        

















































Table S4.4 (Continued). Adjusted Associations† from Robust Regression Models for Multiple Predictors of PFAS 
Concentrations in TESIE participant Child Serum Samples  
 Beta Estimates of Child Serum PFAS Concentration† (ng/mL) (95% Confidence Interval) 
Dust (pg/g) PFHxS PFNA PFOA n-PFOA PFOS n-PFOS Sm-PFOS 




































































































Table S4.5. Adjusted Associations† from Robust Regression Models for Air and Wristband Predictors of PFAS 
Concentrations in TESIE participant Child Serum Samples  
 Beta Estimates of Child Serum PFAS Concentration† (ng/mL) (95% Confidence Interval) 
 PFHxS PFNA PFOA n-PFOA PFOS n-PFOS Sm-PFOS 




























































































































































†Adjusted for maternal race 
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CHAPTER FIVE: CONCLUSION 
This research aimed to examine exposures to SVOCs among nail salon workers, 
pregnant women, and children, and to evaluate effects of prenatal exposure to PFAS on 
birth outcomes. We conducted analyses utilizing data from a study of female nail salon 
workers in the Greater Boston Area, from the NEST study, a birth cohort based in central 
North Carolina, and from the TESIE study, a subset of NEST study offspring. In Chapter 
2, we examined occupational exposures to phthalates, phthalate alternatives, and OPEs in 
nail salon workers. In Chapter 3, we assessed associations between prenatal exposure to 
individual and a mixture of PFAS and birth outcomes, including gestational age at birth, 
birth weight, and birth weight for gestational age z-score. Additionally, we examined 
predictors of maternal serum PFAS concentrations. In Chapter 4, we examined 
environmental, demographic, and behavioral predictors of child serum PFAS 
concentrations. 
 
Chapter 2. Exposure of nail salon workers to phthalates, di(2-ethylhexyl) terephthalate, 
and organophosphate esters: A pilot study 
We assessed exposure to SVOCs by quantifying and comparing pre- and post-
shift urinary concentrations of phthalates, phthalate alternatives, and OPEs along with 
levels measured on SWBs worn by nail salon workers during a single work shift. We 
found evidence that nail salon workers are occupationally exposed to the phthalate 
alternative DEHTP, with post-shift urinary concentrations of a DEHTP metabolite 
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(MECPTP) more than triple the concentrations of pre-shift concentrations. This change 
was moderately correlated with DEHTP levels on SWBs, suggesting an occupational 
exposure source rather than primarily other exposure sources such as diet that are 
unlikely to be picked up by SWBs. Although not previously examined in nail salon 
workers, increases of MECPTP during the day have previously been observed in general 
populations, however these increases were generally lower than what we observed for our 
pre- to post-shift change. Concentrations of DEHTP metabolites (MECPTP and 
MEHHTP) in nail technician post-shift urine samples were also higher than what was 
observed in US females.  
While there was an upward trend for SVOC urinary metabolites from pre- to post-
shift in our study, none reached statistical significance, perhaps due to small sample size. 
Post-shift urinary concentrations from our study participants were generally lower than 
concentrations from US females from NHANES, with the exception of urinary 
metabolites of DEHTP, TCEP, and TPHP.  
Our pilot study demonstrated relatively high detection frequencies of a number of 
SVOCs on SWBs after having been worn by nail salon workers for only one shift (e.g., 6 
to 11 hours). TPHP concentrations on lapel and wrist SWBs were not correlated, perhaps 
suggesting that different exposure sources of these compounds are encountered based on 
contact with skin and surfaces (more likely with wrist SWBs) versus those in the air 




Chapter 3. Per- and polyfluoroalkyl substances serum concentrations in pregnant women 
from North Carolina: Predictors and associations with birth outcomes 
 We examined associations between prenatal exposure to individual and a mixture 
of PFAS based on maternal serum samples collected between 5.6 and 29.6 weeks 
gestation (mean 12.6 weeks) and gestational age at birth, birth weight, and birth weight 
for gestational age z-score. In WQS analyses, we observed negative associations between 
the PFAS mixture index and gestational age at birth among all offspring with the linear 
isomer of PFOA (n-PFOA) contributing the most to this association. In sex-stratified 
models, we observed a negative association between the PFAS mixture index and 
gestational age at birth among male offspring, similarly with n-PFOA contributing most 
to this association, while the association was not as strong among females. The results for 
the other birth outcomes for all and sex-stratified analyses were not as clear. While it 
appears that there is a negative association between PFAS and birth weight among male 
offspring, we found evidence of confounding by physiology in that association, and that 
the mechanism of the association between prenatal serum PFAS concentrations and birth 
weight may in part be through shortened gestational length. Results for the association 
between maternal serum PFAS concentrations and birth weight for gestational age z-
score were mostly null.  
 We also examined predictors of maternal serum PFAS concentrations. We 
detected several PFAS in maternal serum samples with PFOS and PFOA having the 
highest concentrations. As observed in previous studies there was some variability in 
maternal serum PFAS concentrations between racial/ethnic groups, with non-Hispanic 
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whites trending towards higher PFAS concentrations than non-Hispanic black and 
Hispanic mothers. With the exception of those who had a high school diploma or GED, 
mothers with a college degree or higher tended to have higher serum concentrations of 
certain PFAS compared to those with less education. Consistent with previous studies, 
parous mothers in our study had lower concentrations of serum PFAS, on average, than 
nulliparous mothers, likely due to placental transfer during pregnancy and/or excretion of 
PFAS through breastmilk. Finally, we observed that PFAS concentrations generally 
decreased with increasing week of pregnancy during which maternal serum samples were 
collected, which may be due to plasma volume expansion and increased glomerular 
filtration rate. 
 
Chapter 4. Predictors of per- and polyfluoroalkyl substances (PFAS) concentrations in 
children’s serum from the Toddlers Exposure to Semi-Volatile Organic Compounds in 
Indoor Environments (TESIE) Study 
We examined environmental, demographic, and behavioral predictors of child 
serum PFAS concentrations. Based on the results of the environmental samples that we 
collected, we found that participants were exposed to a number of different PFAS. In 
handwipes, wristbands, and air, 6:2 FTOH was the PFAS with the highest geometric 
mean concentration, while 8:2 FTOH was the PFAS with the highest geometric mean 
concentration in dust. Compared to children’s serum samples, which were collected 
during a later time period than maternal serum samples, maternal serum samples had 
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higher geometric mean concentrations of PFAS, with the exception of PFOA and n-
PFOA, which had similar concentrations in both children’s and maternal serum.  
 We found evidence that both food and water were predictors of child serum 
PFOA concentrations in our study, with consumption of municipal water compared to 
well water in the region of North Carolina that participants inhabited being a stronger 
predictor (29% higher) of serum concentrations than the comparison between children 
that ate out one or more time per week and those that ate out less. Whether or not the 
child drank mostly bottled water and/or the use of a water filter did not appear to affect 
child serum PFAS concentrations in our study, which may be due in part to the fact that 
we did not have a large enough sample size to separate out different types of water filters, 
some of which may be more effective at reducing PFAS concentrations than others. We 
also found that children that ate microwave popcorn more frequently had higher 
concentrations of PFHxS than those that ate it one or less time per month. Certain 
demographic factors were predictive of PFAS exposure: children with non-Hispanic 
black mothers had lower serum concentrations of several PFASs than those with non-
Hispanic white mothers, and male children generally appeared to have lower serum 
concentrations of PFAS than female children, though only PFNA reached statistical 
significance. Other demographic and behavioral factors were only weakly or not 
associated with children’s serum PFAS concentrations. Finally, we found that prenatal 
serum and air concentrations of certain PFAS were good predictors of several PFASs in 





Study-specific limitations are discussed in detail in Chapters 2-4. A common 
limitation in all of our studies was a relatively small sample size that limited our 
statistical power. Additionally a consistent challenge that we encountered with all of our 
studies was a limitation in data that we gathered from our questionnaires. For example, 
from previous studies we know that diet is an important route of exposure for many 
SVOCs (Boronow et al., 2019; Brantsæter et al., 2013; Hansen et al., 2016; Hu et al., 
2018; Lin et al., 2020; Pitter Gisella et al., n.d.; Poothong et al., 2020; Sagiv et al., 2015; 
Timmermann et al., 2019; Wu et al., 2015). Because we did not ask any dietary questions 
in the study of nail salon workers or in the NEST cohort, and only asked about frequency 
of eating out and microwave popcorn in the TESIE study, we were not able to exclude 
diet as a source of exposure to SVOCs among nail salon workers, or examine dietary 
predictors of maternal and child serum SVOCs in detail. We collected information about 
maternal race and education in the NEST and TESIE studies, but not household income, 
an important predictor of SVOC exposure (Brantsæter et al., 2013; Harris et al., 2017; 
Sagiv et al., 2015, 2017; Wenzel et al., 2018), limiting our ability to control for this 
variable in our studies. Finally, we did not ask any questions about personal care product 
use in our studies, another potential source of SVOC exposure based on previous findings 
(Boronow et al., 2019; Koniecki et al., 2011), which limits our ability to control for this 
variable in our studies. 
In Chapters 3 and 4 we measured maternal serum PFAS concentrations to 
characterize prenatal exposure to PFAS. Although the majority of serum samples were 
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collected early in pregnancy where pregnancy-induced changes in physiology are reduced 
(>58% during the first trimester of pregnancy in both studies), a potential limitation as 
discussed in Chapter 3 is that plasma volume expansion and changes in glomerular 
filtration rate during pregnancy may lead to exposure misclassification and/or confound 
the association between prenatal PFAS exposure and birth weight (Bach et al., 2015; 
Steenland et al., 2018; Verner et al., 2015). We did not measure albumin or creatinine 
(potential markers for PVE and GFR, respectively) as other studies (e.g., Project VIVA) 
have done (Sagiv et al., 2017), and thus could not control for those measures.  
 
Study strengths 
Strengths of our study of nail salon workers include the use of biomonitoring, 
demonstration of the use of SWBs, collection of these samples in a sometimes difficult to 
reach population, and analysis for a wide spectrum of SVOCs. An additional strength is 
the paired use of biomonitoring and SWB data, which suggested that the increase of 
urinary DEHTP metabolites was due to occupational exposure rather than other sources 
such as diet. A major strength of our study examining associations between prenatal 
PFAS exposure and birth outcomes is the estimation of the effect of a PFAS mixture on 
birth outcomes, which reduces the potential for mutual confounding by other PFAS and 
allows us to determine which PFAS contribute most to the PFAS mixture index effect on 
birth outcomes. A strength of our study characterizing predictors of child serum PFAS is 
that it is the first, to our knowledge, to examine multiple exposure pathways (maternal 
serum, water, demographics, BMI, behavior, certain aspects of diet, and environmental 
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samples) of multiple PFAS exposures, in children. Additionally, both the NEST and 
TESIE study populations are fairly diverse, which allows us to generalize our results to a 
wider population, since many previous studies have been conducted in relatively 
homogenous populations (e.g. (Harris et al., 2017; Kingsley et al., 2018; Sagiv et al., 
2017)).  
 
Public health implications 
Results from Chapter 2 suggest that nail salon workers are occupationally 
exposed to a number of phthalates, phthalate alternatives, and OPEs. Metabolites of 
DEHTP showed the largest increase across the work day, with higher urinary metabolite 
concentrations from nail salon workers than US females. Urinary metabolites of DEHTP 
have increased in the US over time as DEHTP has replaced some of the more toxic 
phthalates used in consumer products (Koch et al., 2017; Silva et al., 2019; Zota et al., 
2014). A dietary study of DEHTP fed to F-344 rats over 104 weeks found reduced weight 
gain and exacerbated geriatric retinal degeneration with chronic, high dietary exposure 
(6,000 or 12,000 ppm) (Deyo, 2008), although very little is known about the health 
impacts associated with exposures to DEHTP in humans. In the expanding nail salon 
industry, occupational exposures to phthalate alternatives could have important public 
health implications highlighting the need for future research on this topic.  
Previous studies examining health impacts associated with occupational 
exposures among nail salon workers are limited, but have largely focused on self-
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reported, acute symptoms based on self-report (Harris-Roberts et al., 2011; Roelofs et al., 
2008; Shendell et al., 2018). Common symptoms reported by nail salon workers include 
headaches, musculoskeletal, respiratory, eye, nose, throat, and skin irritation (Harris-
Roberts et al., 2011; Roelofs et al., 2008; Shendell et al., 2018). The majority of nail 
salon workers are female, many of whom are of reproductive age, and therefore prenatal 
exposures are of public health concern for pregnant women within that industry. A 
previous study found evidence of adverse birth outcomes, including infants that were 
small for gestational age, gestational diabetes, and placenta previa among manicurists (T 
Quach et al., 2015). Studies examining long-term occupational exposure to nail salon 
workers are lacking, and would help to better determine the public health impacts of 
working in this industry. Our research demonstrates the need for future studies to 
examine phthalate alternatives, including DEHTP and other novel SVOC exposures, and 
to better characterize potential health implications of occupational exposure to these 
SVOCs among nail salon workers, a vulnerable population in a growing industry.  
 Chapter 3 adds to the body of literature examining associations between PFAS 
exposure and birth outcomes. To our knowledge, our study is one of only a handful 
published that examined the cumulative effect of a mixture of prenatal PFAS on birth 
outcomes, and one of the first to examine both linear and branched isomers of PFOS and 
PFOA. In WQS models including all offspring, we observed a negative association 
between the PFAS mixture index and gestational age at birth with n-PFOA contributing 
most to this association. Our data suggest gestational age at birth among male offspring 
may be more susceptible to exposure to multiple PFASs than females. Preterm birth can 
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increase risk of mortality, and lead to a number of health complication for the premature 
infant, including respiratory, gastrointestinal, immunologic, central nervous system, 
hearing and vision problems (Institute of Medicine (US) Committee on Understanding 
Premature Birth and Assuring Healthy Outcomes, 2007). Although the magnitude of the 
association that we observed between PFAS exposure and gestational age at birth may 
not lead to significant health consequences for an individual, there could be significant 
public health implications on the population level. Our results add to more recent findings 
that suggest that previous findings of a negative association between PFAS exposure and 
birth weight may be confounded by changes in physiology during pregnancy (Bach et al., 
2015; Steenland et al., 2018; Verner et al., 2015). Our results highlight the importance of 
examining associations between mixtures of multiple PFAS and birth outcomes rather 
than individual PFAS to examine cumulative effects and to reduce the potential for 
mutual confounding by other PFAS. Finally, we found evidence that the mechanism of 
the association observed between PFAS concentrations and birth weight may partly be 
through reduced gestational age rather than growth restriction, which should be examined 
further in future research.  
 Chapter 4 represents the first study to examine multiple PFAS exposure pathways 
(maternal serum, water, demographics, BMI, behavior, and environmental samples), in 
children. This study is also one of the first to examine many different PFAS in both 
environmental media and serum samples. As observed in previous studies, we found that 
frequency of eating out and consumption of municipal water in central North Carolina 
were predictors of child serum PFOA concentrations with drinking water being the 
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stronger predictor of exposure. This highlights the need to include these predictors in 
future studies. Similar to some studies, we found that microwave popcorn was predictive 
of higher serum concentrations of perfluorosulfonic acids (Susmann et al., 2019) 
(PFSAs), but not perfluorinated carboxylic acids (PFCAs) as observed in other studies 
(Susmann et al., 2019; Wu et al., 2015). Historically, PFCAs such as PFOA, were more 
commonly used to coat microwave popcorn bags (Wu et al., 2015); our finding of an 
association between microwave popcorn consumption and higher serum concentrations 
of PFSAs (PFHxS in particular), but not PFCAs, perhaps reflects the phase out of PFOA, 
and a transition to using PFSAs, which should be examined in future studies. 
Alternatively, an explanation for our observation might be confounding by another 
dietary source or factor. We observed that air concentrations of certain PFAS were good 
predictors of several PFASs in children’s serum, as observed for adults in previous 
studies (Fraser et al., 2012). There is a small body of literature examining health impacts 
associated with PFAS exposure among children. In previous studies, childhood exposure 
to PFAS has been associated with dyslipidemia, excess adiposity, increased risk of 
obesity and/or overweight, reduced vaccine response, asthma, impaired renal function, 
and later age at menarche (Braun, 2017; Rappazzo et al., 2017). Given our findings of 
widespread exposure to PFAS through multiple pathways, it is likely that PFAS exposure 
could present a substantial public health concern. Thus, further research on the health 
implications of childhood exposure to PFAS is necessary to better understand the 




 Directions for future research 
In Chapter 2, one of the phthalate alternatives that we determined that nail salon 
workers were exposed to was DEHTP. DEHTP is used as a replacement for the phthalate 
DEHP, and previous literature on DEHTP exposure is limited, but suggests increasing 
exposure in the US and Europe (Nagorka et al., 2011; Silva et al., 2017, 2019). DEHTP is 
not a traditional SVOC in nail polish and we do not know the source of the DEHTP in 
nail salons. Although DEHTP may be present in some nail polishes, we found no 
evidence for this in a recent nail product study (Young et al., 2018); however it may be 
present in other personal care products or materials used in nail salons, such as lotions, 
waxes, or skin scrubbing exfoliants. Further research is necessary to determine the source 
of occupational DEHTP exposure in nail salon workers. Also, in Chapter 2, TPHP 
concentrations on lapel and wrist SWBs were not correlated, perhaps suggesting that 
different exposure sources of these compounds are encountered based on contact with 
skin and surfaces (more likely with wrist SWBs) versus those in the air (more likely with 
lapel SWBs). More research is needed to understand this difference and its implications 
for exposure routes.  
The replacement of phthalates with alternatives, and the corresponding increased 
exposure to the latter, is of concern since often we do not fully understand the toxicity of 
the alternatives (Lakind & Birnbaum, 2010). For example, DEHTP is thought of as a 
safer alternative to DEHP, a known male reproductive toxicant, since it has not been 
shown to cause reproductive toxicity (Gray et al., 2000). However, due to the lack of 
studies examining the health consequences associated with DEHTP exposure in humans 
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to date, we do not fully understand whether increasing human exposure or long-term 
exposure to low levels of it will negatively impact human health. TPHP, another 
replacement chemical found in nail polish, has recently been identified as an endocrine 
disrupter that may be negatively associated with thyroid function and reproductive health 
(Carignan et al., 2017; Meeker & Stapleton, 2010; Preston et al., 2017). Future, larger 
biomonitoring studies of nail salon workers will help to verify and identify phthalates and 
replacement chemicals of particular concern from changes in formulations to products 
used in nail salons. These studies should also collect additional 24- to 48-hour post-work 
shift urine samples to better identify SVOC exposures, and examine associations between 
occupational exposures and health impacts in nail salon workers. 
As discussed in Chapter 3, examining associations between mixtures of PFAS 
and birth outcomes is likely more important than examining associations between birth 
outcomes and individual PFAS. WQS regression may not be the most appropriate method 
of assessing the cumulative effect of exposure to PFAS on birth outcomes, given that the 
assumption that the components all act in the same direction was violated for some of the 
models. Future studies examining associations between exposure to mixtures of PFAS 
and birth outcomes should examine using more flexible statistical methods for mixtures, 
such as Bayesian kernel machine regression. To control for potential confounding by 
physiology, future studies examining associations between PFAS exposure and birth 
outcomes should solely collect 1st trimester serum samples, and/or measure albumin or 




 Collecting additional information from participants would help to better 
characterize predictors of PFAS exposure in adults and children in future studies. For 
example, it is well known that diet is an important predictor of PFAS exposure (Boronow 
et al., 2019; Brantsæter et al., 2013; Hansen et al., 2016; Hu et al., 2018; Lin et al., 2020; 
Pitter Gisella et al., n.d.; Poothong et al., 2020; Timmermann et al., 2019; Wu et al., 
2015), and asking participants to keep a dietary log for several days before serum 
samples are collected or for more detailed information on diet and frequency of eating 
foods known to be associated with PFAS exposure would lead to better, more accurate 
information on dietary predictors. As demonstrated in Chapter 4 and previous studies 
(Boronow et al., 2019; Daly et al., 2018; Hu et al., 2019; Pitter Gisella et al., n.d.), 
drinking water is another important predictor of PFAS exposure. Future studies would 
benefit from analyses of water samples from individual participant homes and/or 
municipal water sources. Finally, a larger sample size in future studies would help to 
better characterize predictors of PFAS exposure in adults and children, particularly with 
environmental samples such as air and SWB. 
 As demonstrated in Chapters 2-4, nail salon workers, pregnant women, and 
children are exposed to a number of different SVOCs used commonly in consumer 
products. As these are all potentially vulnerable populations it is important to focus future 
studies on better understanding sources of exposure to SVOCs and the potential health 
impacts associated with those exposures. The future studies outlined above should 
advance understanding of those issues, and help inform future recommendations of 
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